{"users":[{"location":"Amsterdam, Nederland","url":"http://t.co/wld9xoWe8y","profile_image_url":"https://pbs.twimg.com/profile_images/855440526195261440/DLfsCtAz_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/wld9xoWe8y","expanded_url":"http://www.ema.europa.eu","display_url":"ema.europa.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-02-23T11:05:21.000Z","name":"EU Medicines Agency","description":"Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ‚â† endorsement.","verified":true,"public_metrics":{"followers_count":112839,"following_count":323,"tweet_count":21160,"listed_count":1737},"id":"116716199","username":"EMA_News","protected":false},{"location":"Miami, FL","url":"https://t.co/fk6lt54q8z","profile_image_url":"https://pbs.twimg.com/profile_images/666987878535294976/adXeB483_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/fk6lt54q8z","expanded_url":"http://www.provedivolo.it","display_url":"provedivolo.it"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-11-05T14:32:13.000Z","name":"Luca Pani","description":"Father_to_3_Writer_Aspie_MD Prof. Pharmacol. & Psych. Univ of Modena & Miami; Former Regulator EMA & Director Italian AIFA. Opinions, what else? üáÆüáπüá∫üá∏","verified":false,"public_metrics":{"followers_count":5549,"following_count":1642,"tweet_count":4442,"listed_count":84},"id":"2176193576","username":"luca__pani","protected":false},{"url":"https://t.co/lGL3PD55BE","profile_image_url":"https://pbs.twimg.com/profile_images/610808945674850305/dYK8Kz5H_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/lGL3PD55BE","expanded_url":"http://www.euro.who.int/immunization","display_url":"euro.who.int/immunization"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-04-23T13:16:13.000Z","name":"WHO/Europe - VPI","description":"Vaccine-preventable Diseases and Immunization programme of the WHO Regional Office for Europe","verified":false,"public_metrics":{"followers_count":4803,"following_count":403,"tweet_count":6618,"listed_count":139},"id":"561122363","username":"WHO_Europe_VPI","protected":false},{"location":"Global","url":"https://t.co/LfseEd2o8g","profile_image_url":"https://pbs.twimg.com/profile_images/1410654169732636676/nllsBE-q_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LfseEd2o8g","expanded_url":"http://www.path.org","display_url":"path.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-06-04T23:40:50.000Z","name":"PATH","description":"PATH is a global team of innovators working to increase health equity so people, communities, and economies can thrive.","verified":true,"public_metrics":{"followers_count":60623,"following_count":1121,"tweet_count":15095,"listed_count":1317},"id":"44763075","username":"PATHtweets","protected":false},{"location":"Stockholm, Sweden","url":"http://t.co/HzZhkGX9HG","profile_image_url":"https://pbs.twimg.com/profile_images/791269606996443136/9oft8kxO_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/HzZhkGX9HG","expanded_url":"http://ecdc.europa.eu","display_url":"ecdc.europa.eu"}]},"description":{"hashtags":[{"start":80,"end":87,"tag":"Europe"}],"urls":{},"mentions":{}}},"created_at":"2010-10-19T11:51:29.000Z","name":"ECDC","description":"The European Centre for Disease Prevention and Control. We aim at strengthening #Europe's defences against infectious diseases.","verified":true,"public_metrics":{"followers_count":95566,"following_count":511,"tweet_count":10138,"listed_count":1912},"id":"204752573","username":"ECDC_EU","protected":false,"pinned_tweet_id":"1494301501535277065"},{"location":"London","url":"http://t.co/y3q78101Dc","profile_image_url":"https://pbs.twimg.com/profile_images/1187044773900771329/XlelFzYz_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/y3q78101Dc","expanded_url":"http://www.nature.com/nrd","display_url":"nature.com/nrd"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-04-28T13:41:39.000Z","name":"Nature Reviews Drug Discovery","description":"Editorial team of Nature Reviews Drug Discovery.","verified":true,"public_metrics":{"followers_count":28613,"following_count":469,"tweet_count":2893,"listed_count":0},"id":"36066745","username":"NatRevDrugDisc","protected":false},{"location":"Brussels","url":"https://t.co/gnUbdkHHZN","profile_image_url":"https://pbs.twimg.com/profile_images/1471407862664597512/JZHX6gMZ_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/gnUbdkHHZN","expanded_url":"http://www.ihi.europa.eu","display_url":"ihi.europa.eu"}]},"description":{"hashtags":[{"start":79,"end":94,"tag":"EUPartnerships"},{"start":95,"end":105,"tag":"HorizonEU"}],"urls":{},"mentions":{}}},"created_at":"2010-06-09T09:52:19.000Z","name":"Innovative Health Initiative","description":"We are an EU public-private partnership funding health research and innovation #EUPartnerships #HorizonEU","verified":false,"public_metrics":{"followers_count":12195,"following_count":2573,"tweet_count":12546,"listed_count":296},"id":"153741027","username":"IHIEurope","protected":false,"pinned_tweet_id":"1493185456552480768"},{"location":"Saint-Denis - France","url":"https://t.co/moRQ1GX93P","profile_image_url":"https://pbs.twimg.com/profile_images/1009044497479684096/4zF_ucYo_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/moRQ1GX93P","expanded_url":"http://ansm.sante.fr/","display_url":"ansm.sante.fr"}]},"description":{"hashtags":[{"start":2,"end":9,"tag":"Agence"},{"start":23,"end":32,"tag":"s√©curit√©"},{"start":36,"end":47,"tag":"m√©dicament"},{"start":55,"end":64,"tag":"produits"}],"urls":{},"mentions":{}}},"created_at":"2014-04-14T08:07:27.000Z","name":"ANSM","description":"L‚Äô#Agence nationale de #s√©curit√© du #m√©dicament et des #produits de sant√©\nagit au nom de l‚ÄôEtat pour des produits de sant√© s√ªrs, efficaces et innovants.","verified":true,"public_metrics":{"followers_count":39967,"following_count":106,"tweet_count":3096,"listed_count":472},"id":"2443530930","username":"ansm","protected":false,"pinned_tweet_id":"1487007554479738884"},{"location":"Strasbourg, France","url":"https://t.co/4IexEaPjBp","profile_image_url":"https://pbs.twimg.com/profile_images/553133717808349185/-VYrkUOb_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/4IexEaPjBp","expanded_url":"https://www.edqm.eu","display_url":"edqm.eu"}]},"description":{"hashtags":{},"urls":[{"start":103,"end":126,"url":"https://t.co/z098GhaGS9","expanded_url":"http://bit.ly/1LySOip","display_url":"bit.ly/1LySOip"}],"mentions":{}}},"created_at":"2013-12-12T11:05:00.000Z","name":"EDQM","description":"Dedicated to protecting and promoting human and animal health in Europe. Read our social media policy: https://t.co/z098GhaGS9","verified":false,"public_metrics":{"followers_count":2309,"following_count":1407,"tweet_count":3553,"listed_count":61},"id":"2242197968","username":"edqm_news","protected":false},{"location":"Uppsala, Sweden","url":"http://t.co/64KbbhfHCs","profile_image_url":"https://pbs.twimg.com/profile_images/434253778/Lakemedelsverket_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/64KbbhfHCs","expanded_url":"http://www.lakemedelsverket.se/","display_url":"lakemedelsverket.se"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-09-24T21:30:22.000Z","name":"L√§kemedelsverket LV","description":"LV arbetar med l√§kemedel, kosmetika & medicinteknik. 8-18 m√•-fr svarar L√§kemedelsupplysningen p√• l√§kemedelsfr√•gor 0771-46 70 10. √Ñrenden: registrator@mpa.se","verified":false,"public_metrics":{"followers_count":6198,"following_count":211,"tweet_count":2753,"listed_count":133},"id":"77047226","username":"LV_MPA","protected":false,"pinned_tweet_id":"1458715946504306689"},{"location":"Rockville, MD","url":"https://t.co/hm1dApfXhx","profile_image_url":"https://pbs.twimg.com/profile_images/773149834354262016/nTLTzOCW_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hm1dApfXhx","expanded_url":"http://www.fda.gov/AnimalVeterinary/default.htm","display_url":"fda.gov/AnimalVeterina‚Ä¶"}]},"description":{"hashtags":{},"urls":[{"start":98,"end":121,"url":"https://t.co/9TEBV9LwSQ","expanded_url":"http://fda.gov/privacy","display_url":"fda.gov/privacy"}],"mentions":{}}},"created_at":"2010-01-28T15:33:09.000Z","name":"FDA CVM","description":"News from FDA Center for Veterinary Medicine. This account does not collect comments or messages, https://t.co/9TEBV9LwSQ. Contact us at AskCVM@fda.hhs.gov.","verified":true,"public_metrics":{"followers_count":20372,"following_count":45,"tweet_count":3415,"listed_count":462},"id":"109290405","username":"FDAanimalhealth","protected":false},{"location":"Espa√±a","url":"https://t.co/yW8X0gBz8i","profile_image_url":"https://pbs.twimg.com/profile_images/1369221235838775299/6RotinPV_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yW8X0gBz8i","expanded_url":"https://www.aemps.gob.es/","display_url":"aemps.gob.es"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2011-06-30T15:49:14.000Z","name":"AEMPS","description":"Agencia Espa√±ola de Medicamentos y Productos Sanitarios","verified":true,"public_metrics":{"followers_count":49866,"following_count":139,"tweet_count":2066,"listed_count":812},"id":"326845755","username":"AEMPSGOB","protected":false,"pinned_tweet_id":"1473998737999638534"},{"location":"Poland","url":"https://t.co/yOlqIh8cmt","profile_image_url":"https://pbs.twimg.com/profile_images/2150354867/image_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yOlqIh8cmt","expanded_url":"http://www.urpl.gov.pl","display_url":"urpl.gov.pl"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-04-18T08:30:51.000Z","name":"URPL","description":"The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products | UrzƒÖd Rejestracji Prod. Leczniczych, Wyrob√≥w Med. i Prod. Biob√≥jczych","verified":true,"public_metrics":{"followers_count":2117,"following_count":376,"tweet_count":6647,"listed_count":23},"id":"556679074","username":"URPLWMiPB","protected":false},{"location":"Stockholm, Sweden","url":"https://t.co/KcsNrCCIod","profile_image_url":"https://pbs.twimg.com/profile_images/1062264156328325121/5ql-vtG5_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/KcsNrCCIod","expanded_url":"http://antibiotic.ecdc.europa.eu","display_url":"antibiotic.ecdc.europa.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":146,"end":154,"username":"ECDC_EU"}]}},"created_at":"2013-09-03T12:07:23.000Z","name":"EAAD","description":"European Antibiotic Awareness Day, every 18 November, raises awareness on the public health threat of antibiotic resistance. It is coordinated by @ECDC_EU","verified":true,"public_metrics":{"followers_count":4390,"following_count":154,"tweet_count":2326,"listed_count":76},"id":"1725283578","username":"EAAD_EU","protected":false,"pinned_tweet_id":"1486269708957532165"},{"location":"Poland","url":"https://t.co/jTYELiOaYt","profile_image_url":"https://pbs.twimg.com/profile_images/1134087083709140993/nDgYr-uy_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/jTYELiOaYt","expanded_url":"http://www.urpl.gov.pl","display_url":"urpl.gov.pl"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-04-18T13:24:10.000Z","name":"ùóöùóøùòáùó≤ùó¥ùóºùóøùòá ùóñùó≤ùòÄùòÄùóÆùó∏","description":"President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products; Member of the EMA‚Äôs Management Board & CHMP, Ph.D.","verified":true,"public_metrics":{"followers_count":4926,"following_count":795,"tweet_count":12800,"listed_count":78},"id":"556859372","username":"GCessak","protected":false},{"url":"https://t.co/CONU4aYXMs","profile_image_url":"https://pbs.twimg.com/profile_images/1434764255111401472/WJMrdyO-_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/CONU4aYXMs","expanded_url":"http://www.filippalentzos.com","display_url":"filippalentzos.com"}]},"description":{"hashtags":{},"urls":[{"start":134,"end":157,"url":"https://t.co/FVY1F9ytcs","expanded_url":"http://filippalentzos.com","display_url":"filippalentzos.com"}],"mentions":[{"start":20,"end":29,"username":"KCL_CSSS"}]}},"created_at":"2013-03-24T11:45:51.000Z","name":"Dr Filippa Lentzos","description":"Senior Lecturer and @KCL_CSSS Co-Director at King's College London researching biological threats, biosecurity and biorisk management https://t.co/FVY1F9ytcs","verified":false,"public_metrics":{"followers_count":5242,"following_count":433,"tweet_count":3885,"listed_count":111},"id":"1294931262","username":"FilippaLentzos","protected":false},{"location":"Midlands","url":"https://t.co/iiKue1G5G9","profile_image_url":"https://pbs.twimg.com/profile_images/871994934781497345/IjT69QEC_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/iiKue1G5G9","expanded_url":"http://fiddaman.blogspot.com","display_url":"fiddaman.blogspot.com"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-05-30T13:03:43.000Z","name":"BOB FIDDAMAN","description":"It's not about what they tell you, it's about what they don't.\n\nResearching Drug Company and Regulator malfeasance for 16+ years\n\nVilla fan. AC/DC Nut.","verified":false,"public_metrics":{"followers_count":4332,"following_count":369,"tweet_count":41982,"listed_count":104},"id":"43524728","username":"Fiddaman","protected":false,"pinned_tweet_id":"1493972329633882115"},{"location":"Gentilly","url":"https://t.co/5hrYSC0kh6","profile_image_url":"https://pbs.twimg.com/profile_images/1489270704696668174/njUHKtKp_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/5hrYSC0kh6","expanded_url":"http://www.sanofi.fr","display_url":"sanofi.fr"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-08-21T13:29:41.000Z","name":"Sanofi en France","description":"Nous poursuivons les miracles de la science pour am√©liorer la vie des gens.","verified":true,"public_metrics":{"followers_count":27261,"following_count":485,"tweet_count":11692,"listed_count":448},"id":"771517543","username":"SanofiFR","protected":false,"pinned_tweet_id":"1489274804700131336"},{"location":"Bridgewater, NJ","url":"https://t.co/EhP1EkkWwZ","profile_image_url":"https://pbs.twimg.com/profile_images/1489270481270325249/YHQtAM79_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/EhP1EkkWwZ","expanded_url":"http://www.sanofi.us","display_url":"sanofi.us"}]},"description":{"hashtags":{},"urls":[{"start":83,"end":106,"url":"https://t.co/pxa3CmSFxS","expanded_url":"http://surl.sanofi.com/cq","display_url":"surl.sanofi.com/cq"}],"mentions":{}}},"created_at":"2010-08-26T00:25:41.000Z","name":"Sanofi US","description":"Official SanofiUS Twitter feed: news, updates & other info. For US residents only. https://t.co/pxa3CmSFxS","verified":true,"public_metrics":{"followers_count":83254,"following_count":6117,"tweet_count":17987,"listed_count":1024},"id":"183033795","username":"SanofiUS","protected":false},{"location":"Paris","url":"https://t.co/BCXS4YfjjJ","profile_image_url":"https://pbs.twimg.com/profile_images/1489269202183725061/gk8zjFFb_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/BCXS4YfjjJ","expanded_url":"http://www.sanofi.com","display_url":"sanofi.com"}]},"description":{"hashtags":{},"urls":[{"start":119,"end":142,"url":"https://t.co/CkTT9iI8TU","expanded_url":"https://bit.ly/sanofi-terms","display_url":"bit.ly/sanofi-terms"}],"mentions":{}}},"created_at":"2009-04-27T20:14:07.000Z","name":"Sanofi","description":"We chase the miracles of science to improve people‚Äôs lives.\nInteractions with this account must comply with the Terms: https://t.co/CkTT9iI8TU","verified":true,"public_metrics":{"followers_count":146569,"following_count":196,"tweet_count":6830,"listed_count":1477},"id":"35846368","username":"sanofi","protected":false},{"location":"Global","url":"https://t.co/SQ7v682pOk","profile_image_url":"https://pbs.twimg.com/profile_images/1163440166561865730/aUHQdgjo_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/SQ7v682pOk","expanded_url":"http://www.DIAglobal.org","display_url":"DIAglobal.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-04-04T21:03:36.000Z","name":"DIA","description":"DIA is your essential partner in catalyzing knowledge creation and sharing to accelerate health care product development. Get started by joining our email list.","verified":false,"public_metrics":{"followers_count":13615,"following_count":2897,"tweet_count":18905,"listed_count":404},"id":"28870127","username":"DrugInfoAssn","protected":false},{"location":"Silver Spring, MD","url":"https://t.co/4XwENQl3Ov","profile_image_url":"https://pbs.twimg.com/profile_images/773141404860162061/WK4RgHMx_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/4XwENQl3Ov","expanded_url":"https://www.fda.gov/coronavirus","display_url":"fda.gov/coronavirus"}]},"description":{"hashtags":{},"urls":[{"start":60,"end":83,"url":"https://t.co/LbTJXYRXVP","expanded_url":"http://go.usa.gov/xFfG8","display_url":"go.usa.gov/xFfG8"}],"mentions":{}}},"created_at":"2010-10-26T17:31:41.000Z","name":"U.S. FDA","description":"Our tweets are FDA Approved!               Privacy Policy - https://t.co/LbTJXYRXVP","verified":true,"public_metrics":{"followers_count":527617,"following_count":161,"tweet_count":16544,"listed_count":4977},"id":"208120290","username":"US_FDA","protected":false},{"location":"Parma, Italy","url":"http://t.co/qDrFy4Jq9C","profile_image_url":"https://pbs.twimg.com/profile_images/378800000244103520/36fba9985ee59f6fecc544c695200c83_normal.jpeg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/qDrFy4Jq9C","expanded_url":"http://www.efsa.europa.eu/efsajournal","display_url":"efsa.europa.eu/efsajournal"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-06-03T15:12:13.000Z","name":"EFSAJournal","description":"The EFSA Journal is an open-access, online scientific journal that publishes the scientific outputs of the European Food Safety Authority.","verified":false,"public_metrics":{"followers_count":835,"following_count":6,"tweet_count":634,"listed_count":19},"id":"1479912948","username":"EFSAJournal","protected":false},{"location":"Silver Spring, MD","url":"http://t.co/H4sA9qW2ey","profile_image_url":"https://pbs.twimg.com/profile_images/773146881891397632/NaOSMFd1_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/H4sA9qW2ey","expanded_url":"http://www.fda.gov/medicalcountermeasures","display_url":"fda.gov/medicalcounter‚Ä¶"}]},"description":{"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/8Udd9QWfKC","expanded_url":"http://fda.gov/privacy","display_url":"fda.gov/privacy"}],"mentions":{}}},"created_at":"2013-07-19T14:28:35.000Z","name":"FDA Medical Countermeasures Initiative","description":"FDA's Medical Countermeasures Initiative (MCMi) - protecting national health and security. Privacy policy - http://t.co/8Udd9QWfKC","verified":true,"public_metrics":{"followers_count":5297,"following_count":1104,"tweet_count":6250,"listed_count":146},"id":"1606025952","username":"FDA_MCMi","protected":false,"pinned_tweet_id":"1479526255275954178"},{"location":"Europe","url":"","profile_image_url":"https://pbs.twimg.com/profile_images/1384085535694589962/2G5cU-bV_normal.jpg","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-07-13T21:07:32.000Z","name":"EUnetHTA","description":"Official account for the European Network for Health Technology Assessment. Retweets are not endorsements.","verified":false,"public_metrics":{"followers_count":2785,"following_count":194,"tweet_count":1073,"listed_count":37},"id":"56493220","username":"EUnetHTA","protected":false},{"location":"San Bruno, CA","url":"https://t.co/bUisN3Gqbw","profile_image_url":"https://pbs.twimg.com/profile_images/1427292844612595720/RC1YSvuT_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/bUisN3Gqbw","expanded_url":"http://youtube.com","display_url":"youtube.com"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2007-11-13T21:43:46.000Z","name":"YouTube","description":"like and subscribe.","verified":true,"public_metrics":{"followers_count":74326958,"following_count":1207,"tweet_count":42681,"listed_count":79841},"id":"10228272","username":"YouTube","protected":false},{"location":"London, England","url":"http://t.co/Ec7fWJf5Zu","profile_image_url":"https://pbs.twimg.com/profile_images/1259873615258009602/4YcNuLSz_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Ec7fWJf5Zu","expanded_url":"http://gov.uk/mhra","display_url":"gov.uk/mhra"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":30,"end":40,"username":"MHRAgovuk"},{"start":59,"end":71,"username":"MHRAdevices"},{"start":85,"end":99,"username":"MHRAmedicines"}]}},"created_at":"2011-07-07T13:42:13.000Z","name":"MHRA News Centre","description":"Press releases and statements @MHRAgovuk Corporate Twitter @MHRAdevices Devices info @MHRAmedicines Medicines","verified":true,"public_metrics":{"followers_count":10024,"following_count":147,"tweet_count":1608,"listed_count":177},"id":"330990243","username":"MHRApress","protected":false},{"location":"Brussels, Europe","url":"https://t.co/scnw6D6rWZ","profile_image_url":"https://pbs.twimg.com/profile_images/707954305807073285/v-BmAueN_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/scnw6D6rWZ","expanded_url":"http://www.medicinesforeurope.com","display_url":"medicinesforeurope.com"}]},"description":{"hashtags":[{"start":66,"end":75,"tag":"patients"},{"start":76,"end":84,"tag":"quality"},{"start":85,"end":91,"tag":"value"},{"start":92,"end":107,"tag":"sustainability"},{"start":108,"end":120,"tag":"partnership"}],"urls":{},"mentions":{}}},"created_at":"2014-01-28T16:34:24.000Z","name":"Medicines for Europe","description":"Official Twitter account for Medicines for Europe. Our 5 pillars: #patients #quality #value #sustainability #partnership. IGBA member. RTs not endorsement","verified":false,"public_metrics":{"followers_count":5551,"following_count":2327,"tweet_count":11515,"listed_count":457},"id":"2315763655","username":"medicinesforEU","protected":false,"pinned_tweet_id":"1446358044208738329"},{"url":"http://t.co/56tHrsd6vL","profile_image_url":"https://pbs.twimg.com/profile_images/378800000673019629/fdfbae10d3768e14d6f870bc38051b94_normal.png","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/56tHrsd6vL","expanded_url":"http://grip-network.org","display_url":"grip-network.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-10-31T09:48:41.000Z","name":"GRiP Network","description":"Global Research in Paediatrics - a network of scientists developing knowledge and safe use of medicines in children. Funded by the EU (7th Framework Programme).","verified":false,"public_metrics":{"followers_count":49,"following_count":16,"tweet_count":11,"listed_count":0},"id":"2166362149","username":"GRiPNetwork","protected":false},{"location":"Luxembourg","url":"https://t.co/CsokjLzx73","profile_image_url":"https://pbs.twimg.com/profile_images/875697385753772034/DvkLauXt_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/CsokjLzx73","expanded_url":"http://ted.europa.eu","display_url":"ted.europa.eu"}]},"description":{"hashtags":[{"start":52,"end":70,"tag":"publicprocurement"},{"start":111,"end":119,"tag":"tenders"},{"start":129,"end":144,"tag":"EUinstitutions"}],"urls":{},"mentions":{}}},"created_at":"2011-05-06T12:50:59.000Z","name":"EU Tenders (TED)","description":"TED is your website for business opportunities with #publicprocurement in the EU + beyond! Here we tweet about #tenders with the #EUinstitutions.","verified":true,"public_metrics":{"followers_count":10249,"following_count":1006,"tweet_count":12939,"listed_count":261},"id":"294046348","username":"EUTenders","protected":false,"pinned_tweet_id":"1491428900819578883"},{"url":"","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":[{"start":62,"end":72,"username":"EU_Growth"},{"start":108,"end":119,"username":"EU_Finance"}]}},"created_at":"2014-10-08T15:21:50.000Z","name":"EU Markt   ","description":"Follow Internal Market policies of the European Commission at @EU_Growth and Financial Services policies at @EU_Finance","verified":false,"public_metrics":{"followers_count":41,"following_count":0,"tweet_count":0,"listed_count":2},"id":"2815632681","username":"EU_Markt","protected":false},{"location":"Helsinki","url":"https://t.co/aKQRmvJWUa","profile_image_url":"https://pbs.twimg.com/profile_images/1489518390066753536/DMVnHTDj_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/aKQRmvJWUa","expanded_url":"http://echa.europa.eu","display_url":"echa.europa.eu"}]},"description":{"hashtags":[{"start":12,"end":27,"tag":"SaferChemicals"},{"start":55,"end":74,"tag":"ChemicalsInOurLife"}],"urls":{},"mentions":[{"start":112,"end":125,"username":"HansenB_ECHA"}]}},"created_at":"2011-07-08T12:45:45.000Z","name":"European Chemicals Agency - ECHA üá™üá∫","description":"Working for #SaferChemicals in the EU, informing about #ChemicalsInOurLife. See also ECHA's Executive Director: @HansenB_ECHA. RT‚â†endorsements.","verified":true,"public_metrics":{"followers_count":15085,"following_count":937,"tweet_count":8790,"listed_count":270},"id":"331604970","username":"EU_ECHA","protected":false,"pinned_tweet_id":"1493879109193191430"},{"location":"Vienna","url":"https://t.co/1Qqz1E9r0x","profile_image_url":"https://pbs.twimg.com/profile_images/1217448646888869888/UTa0vNZr_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/1Qqz1E9r0x","expanded_url":"http://www.ueg.eu","display_url":"ueg.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-02-09T08:14:50.000Z","name":"my_UEG","description":"Meet. Exchange. Evolve","verified":false,"public_metrics":{"followers_count":12479,"following_count":4571,"tweet_count":10312,"listed_count":143},"id":"487344065","username":"my_ueg","protected":false,"pinned_tweet_id":"1488587980432449538"},{"location":"Utrecht, The Netherlands","url":"http://t.co/Scww78jp0r","profile_image_url":"https://pbs.twimg.com/profile_images/1739557977/EFPC-logo-4-k_nieuwe_versiel_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Scww78jp0r","expanded_url":"http://www.euprimarycare.org","display_url":"euprimarycare.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-07-09T22:05:03.000Z","name":"EUPrimaryCareForum","description":"Coordinator of the European Forum for Primary Care (EFPC)","verified":false,"public_metrics":{"followers_count":2230,"following_count":958,"tweet_count":3003,"listed_count":69},"id":"164835748","username":"PrimaryCare4um","protected":false,"pinned_tweet_id":"1477051691992117250"},{"location":"Paris, France","url":"https://t.co/DGPKr0AOXu","profile_image_url":"https://pbs.twimg.com/profile_images/1480143824362037249/TG6ccvk1_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/DGPKr0AOXu","expanded_url":"http://www.irdes.fr","display_url":"irdes.fr"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-10-22T14:05:34.000Z","name":"IRDES","description":"Institut de Recherche et Documentation en Economie de la Sant√©\r\nFrench Institute for research and information in health economics","verified":false,"public_metrics":{"followers_count":8080,"following_count":51,"tweet_count":1529,"listed_count":198},"id":"84332464","username":"irdes","protected":false},{"location":"Paris","url":"https://t.co/GkEzHuNZcA","profile_image_url":"https://pbs.twimg.com/profile_images/1293141629247913987/wC-oLoyL_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/GkEzHuNZcA","expanded_url":"http://www.eurordis.org","display_url":"eurordis.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-03-27T12:29:29.000Z","name":"Rare Diseases Europe","description":"An alliance of over 900 rare disease patient organisations working together to improve the lives of the 30m people living with a rare disease in Europe","verified":false,"public_metrics":{"followers_count":28479,"following_count":1865,"tweet_count":6732,"listed_count":483},"id":"26993786","username":"eurordis","protected":false},{"location":"Stockholm, Sweden","url":"http://t.co/KF7zot2KyQ","profile_image_url":"https://pbs.twimg.com/profile_images/453897307226767360/v_WHnT1g_normal.jpeg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/KF7zot2KyQ","expanded_url":"http://ecdc.europa.eu/en/activities/diseaseprogrammes/programme_on_influenza/Pages/index.aspx","display_url":"ecdc.europa.eu/en/activities/‚Ä¶"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-04-22T09:02:28.000Z","name":"ECDC Influenza","description":"This is the official account of the European Centre for Disease Prevention and Control's Influenza and other Respiratory Viruses programme","verified":true,"public_metrics":{"followers_count":7626,"following_count":167,"tweet_count":2089,"listed_count":213},"id":"1371668696","username":"ECDC_Flu","protected":false,"pinned_tweet_id":"1479470568718098432"},{"location":"Lugano - Switzerland","url":"http://t.co/d58pSFlZZR","profile_image_url":"https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_normal.jpeg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/d58pSFlZZR","expanded_url":"http://www.esmo.org","display_url":"esmo.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-08-27T07:45:16.000Z","name":"ESMO - Eur. Oncology","description":"The European Society for Medical Oncology (ESMO) supports oncology professionals in providing cancer patients  with the most effective treatment and care.","verified":false,"public_metrics":{"followers_count":56775,"following_count":734,"tweet_count":14968,"listed_count":697},"id":"69232855","username":"myESMO","protected":false,"pinned_tweet_id":"1492227448372703234"},{"location":"Geneva, Switzerland","url":"https://t.co/wVulKuROWG","profile_image_url":"https://pbs.twimg.com/profile_images/875476478988886016/_l61qZdR_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/wVulKuROWG","expanded_url":"http://www.who.int","display_url":"who.int"}]},"description":{"hashtags":[{"start":11,"end":25,"tag":"UnitedNations"},{"start":43,"end":56,"tag":"HealthForAll"},{"start":95,"end":103,"tag":"COVID19"}],"urls":{},"mentions":{}}},"created_at":"2008-04-23T19:56:27.000Z","name":"World Health Organization (WHO)","description":"We are the #UnitedNations‚Äô health agency - #HealthForAll.\n‚ñ∂Ô∏è Always check our latest tweets on #COVID19 for updated advice/information.","verified":true,"public_metrics":{"followers_count":10681278,"following_count":1747,"tweet_count":67849,"listed_count":34828},"id":"14499829","username":"WHO","protected":false,"pinned_tweet_id":"1494589193359478784"},{"url":"","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2016-10-13T10:06:29.000Z","name":"Dg Rtd","description":"","verified":false,"public_metrics":{"followers_count":95,"following_count":0,"tweet_count":1,"listed_count":1},"id":"786508396245639172","username":"innovationunion","protected":false,"pinned_tweet_id":"795897448208142336"},{"location":"European Union","url":"https://t.co/PScwvTrDmJ","profile_image_url":"https://pbs.twimg.com/profile_images/1230127825434402816/PB5FSHSM_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/PScwvTrDmJ","expanded_url":"https://ec.europa.eu/info/research-and-innovation","display_url":"ec.europa.eu/info/research-‚Ä¶"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":45,"end":59,"username":"EU_Commission"},{"start":70,"end":80,"username":"HorizonEU"},{"start":109,"end":123,"username":"GabrielMariya"},{"start":146,"end":157,"username":"JEPaquetEU"}]}},"created_at":"2010-09-21T13:58:07.000Z","name":"EUScience&Innovationüá™üá∫","description":"Official account of DG Research & Innovation @EU_Commission, managing @HorizonEU & implementing Commissioner @GabrielMariya strategy. Follow also @JEPaquetEU","verified":true,"public_metrics":{"followers_count":112618,"following_count":738,"tweet_count":37798,"listed_count":2556},"id":"193301414","username":"EUScienceInnov","protected":false,"pinned_tweet_id":"1493877084799881216"},{"location":"London and Manchester, UK","url":"http://t.co/QIhW6SIslO","profile_image_url":"https://pbs.twimg.com/profile_images/826386986277732353/1srg9dyN_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/QIhW6SIslO","expanded_url":"http://www.nice.org.uk","display_url":"nice.org.uk"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-10-27T12:18:46.000Z","name":"NICE","description":"Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.","verified":true,"public_metrics":{"followers_count":246084,"following_count":1009,"tweet_count":13997,"listed_count":2097},"id":"85555796","username":"NICEComms","protected":false},{"location":"London and Manchester","url":"https://t.co/5n5flLuKqw","profile_image_url":"https://pbs.twimg.com/profile_images/826446083559714816/7-j5wR01_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/5n5flLuKqw","expanded_url":"http://www.nice.org.uk/scientificadvice","display_url":"nice.org.uk/scientificadvi‚Ä¶"}]},"description":{"hashtags":[{"start":33,"end":40,"tag":"pharma"},{"start":41,"end":49,"tag":"medtech"},{"start":50,"end":62,"tag":"diagnostics"},{"start":63,"end":75,"tag":"celltherapy"},{"start":76,"end":88,"tag":"genetherapy"},{"start":97,"end":101,"tag":"HTA"}],"urls":{},"mentions":[{"start":0,"end":10,"username":"NICEcomms"},{"start":127,"end":136,"username":"EMA_News"},{"start":138,"end":148,"username":"MHRAgovuk"},{"start":150,"end":159,"username":"EUnetHTA"}]}},"created_at":"2014-10-16T16:34:49.000Z","name":"NICE Scientific Advice","description":"@NICEcomms programme - advice to #pharma #medtech #diagnostics #celltherapy #genetherapy from UK #HTA perspective (can be with @EMA_News, @MHRAgovuk, @EUnetHTA)","verified":false,"public_metrics":{"followers_count":1744,"following_count":1157,"tweet_count":1888,"listed_count":56},"id":"2834291205","username":"NICESciAdvice","protected":false},{"location":"Silver Spring, Maryland, USA","url":"https://t.co/jxIVq0Dfxr","profile_image_url":"https://pbs.twimg.com/profile_images/773215388029124608/Ri_w_2af_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/jxIVq0Dfxr","expanded_url":"https://www.fda.gov/medical-devices/","display_url":"fda.gov/medical-device‚Ä¶"}]},"description":{"hashtags":{},"urls":[{"start":124,"end":147,"url":"https://t.co/hfXZUjyrJx","expanded_url":"http://fda.gov/privacy","display_url":"fda.gov/privacy"}],"mentions":{}}},"created_at":"2010-05-05T13:22:53.000Z","name":"FDA Medical Devices","description":"Official FDA - device recalls, safety, approvals, radiation-emitting products. Contact us DICE@fda.hhs.gov or 800-638-2041  https://t.co/hfXZUjyrJx","verified":true,"public_metrics":{"followers_count":97989,"following_count":435,"tweet_count":6822,"listed_count":1481},"id":"140427956","username":"FDADeviceInfo","protected":false},{"location":"Roma","url":"https://t.co/X8Gax5dj4o","profile_image_url":"https://pbs.twimg.com/profile_images/1410593679299911689/cV-Qg8dx_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/X8Gax5dj4o","expanded_url":"http://www.aifa.gov.it","display_url":"aifa.gov.it"}]},"description":{"hashtags":[{"start":54,"end":59,"tag":"AIFA"}],"urls":[{"start":94,"end":117,"url":"https://t.co/gCLzpL6nAb","expanded_url":"http://bit.ly/AIFA-SM-Policy","display_url":"bit.ly/AIFA-SM-Policy"}],"mentions":{}}},"created_at":"2011-12-20T15:44:17.000Z","name":"AIFA","description":"Profilo ufficiale dell'Agenzia Italiana del Farmaco | #AIFA ‚úâ ufficiostampaaifa@aifa.gov.it | https://t.co/gCLzpL6nAb","verified":false,"public_metrics":{"followers_count":37445,"following_count":1043,"tweet_count":5995,"listed_count":358},"id":"441940097","username":"Aifa_ufficiale","protected":false},{"location":"Silver Spring, MD","url":"","profile_image_url":"https://pbs.twimg.com/profile_images/773147883642163201/5IorSslR_normal.jpg","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":[{"start":98,"end":121,"url":"https://t.co/oPsmakGDOp","expanded_url":"http://fda.gov/privacy","display_url":"fda.gov/privacy"}],"mentions":{}}},"created_at":"2009-08-13T17:30:17.000Z","name":"FDAWomen","description":"The latest women's health information from the U.S. Food and Drug Administration. Privacy Policy: https://t.co/oPsmakGDOp","verified":true,"public_metrics":{"followers_count":77480,"following_count":714,"tweet_count":11322,"listed_count":1303},"id":"65416742","username":"FDAWomen","protected":false,"pinned_tweet_id":"1488512700581924868"},{"location":"London","url":"https://t.co/1Y2RCgHRz9","profile_image_url":"https://pbs.twimg.com/profile_images/537914224299626496/jKE63aZ8_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/1Y2RCgHRz9","expanded_url":"http://www.iapo.org.uk","display_url":"iapo.org.uk"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-08-20T09:46:24.000Z","name":"IAPO","description":"A global alliance representing patients of all nations across all disease areas and promoting patient-centred healthcare across the world.","verified":false,"public_metrics":{"followers_count":3562,"following_count":1658,"tweet_count":7763,"listed_count":106},"id":"180728609","username":"IAPOvoice","protected":false},{"location":"Silver Spring","url":"http://t.co/KF8gl4wGzV","profile_image_url":"https://pbs.twimg.com/profile_images/774289732582903808/kU8p7iWI_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/KF8gl4wGzV","expanded_url":"http://www.fda.gov/AboutDDI","display_url":"fda.gov/AboutDDI"}]},"description":{"hashtags":{},"urls":[{"start":124,"end":146,"url":"http://t.co/DUce95M3Ty","expanded_url":"http://www.fda.gov/privacy","display_url":"fda.gov/privacy"}],"mentions":{}}},"created_at":"2009-07-02T11:39:43.000Z","name":"FDA Drug Information","description":"Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or druginfo@fda.hhs.gov. Privacy Policy - http://t.co/DUce95M3Ty.","verified":true,"public_metrics":{"followers_count":334051,"following_count":68,"tweet_count":7538,"listed_count":4339},"id":"53039176","username":"FDA_Drug_Info","protected":false,"pinned_tweet_id":"1482032594053214209"},{"location":"Amsterdam, The Netherlands","url":"https://t.co/0Q7qKxb8LI","profile_image_url":"https://pbs.twimg.com/profile_images/1135188412301041665/s4E2JTb3_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0Q7qKxb8LI","expanded_url":"http://www.ema.europa.eu","display_url":"ema.europa.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":33,"end":42,"username":"EMA_News"}]}},"created_at":"2010-02-10T21:32:44.000Z","name":"Martin Harvey","description":"Head of International Affairs at @EMA_News. Tweets reflect my interests & what catches my eye, ‚â† official views of EMA. MCIPR FDIA","verified":false,"public_metrics":{"followers_count":697,"following_count":321,"tweet_count":546,"listed_count":32},"id":"113148426","username":"Martinharvey100","protected":false},{"location":"Brussels","url":"https://t.co/7GCosREhd5","profile_image_url":"https://pbs.twimg.com/profile_images/648845031965487104/TM1cuwrq_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7GCosREhd5","expanded_url":"http://www.eahp.eu","display_url":"eahp.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-10-16T02:42:15.000Z","name":"EAHP","description":"European Association of Hospital Pharmacists","verified":false,"public_metrics":{"followers_count":5049,"following_count":3471,"tweet_count":8265,"listed_count":131},"id":"203357203","username":"EAHPtweet","protected":false},{"location":"Brussels, Belgium","url":"https://t.co/JooRnYJttM","profile_image_url":"https://pbs.twimg.com/profile_images/1460560236138438659/UrnEa2g7_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/JooRnYJttM","expanded_url":"https://europa.eu/next-generation-eu/index_en","display_url":"europa.eu/next-generatio‚Ä¶"}]},"description":{"hashtags":{},"urls":[{"start":92,"end":115,"url":"https://t.co/3fIsD1hPfD","expanded_url":"https://ec.europa.eu/info/social-media-use","display_url":"ec.europa.eu/info/social-me‚Ä¶"}],"mentions":{}}},"created_at":"2010-06-21T12:28:34.000Z","name":"European Commission üá™üá∫","description":"News and information from the European Commission. Social media and data protection policy: https://t.co/3fIsD1hPfD","verified":true,"public_metrics":{"followers_count":1578563,"following_count":634,"tweet_count":43243,"listed_count":13476},"id":"157981564","username":"EU_Commission","protected":false,"pinned_tweet_id":"1494302767812382726"},{"location":"Brussels","url":"http://t.co/sAnU1o2xbl","profile_image_url":"https://pbs.twimg.com/profile_images/441577017171927040/pFBBN4hg_normal.jpeg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/sAnU1o2xbl","expanded_url":"http://ec.europa.eu/research/innovation-union/index_en.cfm?pg=home","display_url":"ec.europa.eu/research/innov‚Ä¶"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":26,"end":38,"username":"LuciaCaudet"},{"start":98,"end":113,"username":"mikejenningsEU"}]}},"created_at":"2012-06-20T09:35:43.000Z","name":"Michael Jennings","description":"Account archived.  Follow @LuciaCaudet the nee spokesperson responsible for research.  I'm now at @mikejenningsEU","verified":false,"public_metrics":{"followers_count":2162,"following_count":539,"tweet_count":1629,"listed_count":128},"id":"613378164","username":"ECspokesScience","protected":false},{"location":"Bordeaux, France","url":"https://t.co/xebfz3gqwJ","profile_image_url":"https://pbs.twimg.com/profile_images/464739847370838016/nelz21hk_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/xebfz3gqwJ","expanded_url":"https://www.eu2p.org","display_url":"eu2p.org"}]},"description":{"hashtags":[{"start":0,"end":18,"tag":"Pharmacovigilance"},{"start":19,"end":28,"tag":"PharmEpi"},{"start":29,"end":40,"tag":"DrugSafety"},{"start":81,"end":90,"tag":"HigherEd"},{"start":91,"end":104,"tag":"ContinuingEd"},{"start":105,"end":114,"tag":"OnlineEd"}],"urls":{},"mentions":[{"start":144,"end":151,"username":"IMI_JU"}]}},"created_at":"2011-11-24T11:06:59.000Z","name":"Eu2P","description":"#Pharmacovigilance #PharmEpi #DrugSafety Short Courses, Certificates, MSc & PhD.\n#HigherEd #ContinuingEd #OnlineEd\nEU public-private consortium @IMI_JU","verified":false,"public_metrics":{"followers_count":1459,"following_count":774,"tweet_count":3091,"listed_count":0},"id":"420241833","username":"Eu2P","protected":false},{"location":"Brussels","url":"http://t.co/kGrDP4le","profile_image_url":"https://pbs.twimg.com/profile_images/600282411314712576/oSBUt3G9_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":20,"url":"http://t.co/kGrDP4le","expanded_url":"http://www.efpia.eu","display_url":"efpia.eu"}]},"description":{"hashtags":[{"start":76,"end":87,"tag":"WeWontRest"},{"start":88,"end":101,"tag":"TeamVaccines"}],"urls":[{"start":102,"end":125,"url":"https://t.co/y1FLniUcoT","expanded_url":"http://efpia.eu","display_url":"efpia.eu"}],"mentions":{}}},"created_at":"2009-06-29T15:16:42.000Z","name":"EFPIA","description":"EFPIA is the voice of the research-based pharmaceutical industry in Europe \n#WeWontRest #TeamVaccines\nhttps://t.co/y1FLniUcoT","verified":false,"public_metrics":{"followers_count":25729,"following_count":3889,"tweet_count":27405,"listed_count":610},"id":"52084584","username":"EFPIA","protected":false,"pinned_tweet_id":"1406907697275060226"},{"location":"Brussels","url":"http://t.co/yVKoqWvw6D","profile_image_url":"https://pbs.twimg.com/profile_images/1424711872708849669/SAC8yUN8_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/yVKoqWvw6D","expanded_url":"http://noharm-europe.org","display_url":"noharm-europe.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2011-04-14T13:41:39.000Z","name":"HCWH Europe","description":"Working towards sustainable healthcare and a healthier environment.","verified":false,"public_metrics":{"followers_count":2876,"following_count":1264,"tweet_count":4853,"listed_count":167},"id":"282063958","username":"HCWHeurope","protected":false},{"location":"Portugal","url":"https://t.co/LbGbUn6bK3","profile_image_url":"https://pbs.twimg.com/profile_images/3672803012/f16d5bdb04d2f2dc11f3c41e53c7ea80_normal.jpeg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LbGbUn6bK3","expanded_url":"http://www.infarmed.pt","display_url":"infarmed.pt"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-04-30T16:39:51.000Z","name":"INFARMED, I. P.","description":"Twiiter oficial do INFARMED, I.P. Pedidos de informa√ß√£o para cimi@infarmed.pt.","verified":true,"public_metrics":{"followers_count":9678,"following_count":25,"tweet_count":3559,"listed_count":69},"id":"1392501529","username":"INFARMED_IP","protected":false},{"location":"Brussels, Europe","url":"https://t.co/jl7d63THyO","profile_image_url":"https://pbs.twimg.com/profile_images/1468268139053998080/OeUjzZPG_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/jl7d63THyO","expanded_url":"http://www.cpme.eu","display_url":"cpme.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2011-12-19T12:48:57.000Z","name":"European Doctors","description":"The Standing Committee of European Doctors (CPME) represents national medical associations across Europe.\n(NB: retweet ‚â† endorsement)","verified":false,"public_metrics":{"followers_count":3981,"following_count":929,"tweet_count":4917,"listed_count":104},"id":"440810430","username":"CPME_EUROPA","protected":false,"pinned_tweet_id":"1458399536670560260"},{"location":"Europe","url":"https://t.co/SQlkcFlKEd","profile_image_url":"https://pbs.twimg.com/profile_images/882148227906228224/Vjpsr0BS_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/SQlkcFlKEd","expanded_url":"http://ec.europa.eu/commission/2014-2019_en","display_url":"ec.europa.eu/commission/201‚Ä¶"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-07-22T09:12:28.000Z","name":"Jean-Claude Juncker","description":"Luxembourger. European.","verified":true,"public_metrics":{"followers_count":702761,"following_count":948,"tweet_count":1849,"listed_count":5018},"id":"169426475","username":"JunckerEU","protected":false,"pinned_tweet_id":"1186633212254179329"},{"location":"Parma, Italy","url":"https://t.co/2iJKf7s730","profile_image_url":"https://pbs.twimg.com/profile_images/1046703737438437377/yhI1br33_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/2iJKf7s730","expanded_url":"http://www.efsa.europa.eu","display_url":"efsa.europa.eu"}]},"description":{"hashtags":{},"urls":[{"start":82,"end":105,"url":"https://t.co/Zcha2yD55B","expanded_url":"http://ow.ly/IsDa30m64aq","display_url":"ow.ly/IsDa30m64aq"}],"mentions":{}}},"created_at":"2009-10-23T12:51:18.000Z","name":"EFSA","description":"European Food Safety Authority - Trusted science for safe food | \nData protection https://t.co/Zcha2yD55B","verified":true,"public_metrics":{"followers_count":42056,"following_count":348,"tweet_count":8197,"listed_count":867},"id":"84582815","username":"EFSA_EU","protected":false},{"url":"http://t.co/jzdL6JlsQf","profile_image_url":"https://pbs.twimg.com/profile_images/845245641739702272/m1QoL00u_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/jzdL6JlsQf","expanded_url":"http://www.ese-hormones.org","display_url":"ese-hormones.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-11-29T16:27:35.000Z","name":"European Society of Endocrinology (ESE)","description":"The European Society of Endocrinology, the voice for endocrinology. \nAt the centre of Europe's endocrine community.","verified":false,"public_metrics":{"followers_count":10044,"following_count":341,"tweet_count":4676,"listed_count":97},"id":"221055586","username":"ESEndocrinology","protected":false},{"location":"Luxembourg","url":"","profile_image_url":"https://pbs.twimg.com/profile_images/818506064148701184/NwC_w76Z_normal.jpg","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":[{"start":15,"end":38,"url":"https://t.co/3K6fSwLJ8P","expanded_url":"http://cordis.europa.eu","display_url":"cordis.europa.eu"}],"mentions":[{"start":52,"end":62,"username":"CORDIS_EU"}]}},"created_at":"2017-01-09T17:11:26.000Z","name":"CORDIS","description":"this is CORDIS https://t.co/3K6fSwLJ8P Follow us as @CORDIS_EU","verified":false,"public_metrics":{"followers_count":31,"following_count":1,"tweet_count":16,"listed_count":2},"id":"818505470608572416","username":"myCORDIS","protected":false},{"location":"Luxembourg","url":"https://t.co/cyIQcUJMM2","profile_image_url":"https://pbs.twimg.com/profile_images/1146086552071806976/BiEM-gjj_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/cyIQcUJMM2","expanded_url":"http://cordis.europa.eu","display_url":"cordis.europa.eu"}]},"description":{"hashtags":[{"start":84,"end":95,"tag":"EUresearch"},{"start":131,"end":144,"tag":"CORDIScovery"}],"urls":{},"mentions":{}}},"created_at":"2010-01-19T09:36:54.000Z","name":"EU Research Results","description":"Official CORDIS account üá™üá∫\nNews and information on EU-funded research projects üî¨üë©üèΩ‚Äçüíª#EUresearch \nCheck out our new science podcast #CORDIScovery üéß","verified":true,"public_metrics":{"followers_count":43471,"following_count":6078,"tweet_count":16752,"listed_count":1088},"id":"106364904","username":"CORDIS_EU","protected":false},{"location":"Geneva, Switzerland","url":"https://t.co/VpaN4jL5dN","profile_image_url":"https://pbs.twimg.com/profile_images/930419168289140736/WOYDSdjU_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/VpaN4jL5dN","expanded_url":"http://www.ihf-fih.org/","display_url":"ihf-fih.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-02-06T13:35:10.000Z","name":"International Hospital Federation","description":"The International Hospital Federation is a non-profit, non-gov int'l membership organization helping hospitals & healthcare organizations deliver better health.","verified":false,"public_metrics":{"followers_count":1826,"following_count":548,"tweet_count":4969,"listed_count":28},"id":"1154042060","username":"IHF_FIH","protected":false},{"location":"Reno, NV","url":"http://t.co/fDQjnmVRjQ","profile_image_url":"https://pbs.twimg.com/profile_images/556235735661940736/ViwaAhxK_normal.png","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/fDQjnmVRjQ","expanded_url":"http://www.sureclinical.com","display_url":"sureclinical.com"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-02-23T01:34:25.000Z","name":"SureClinical","description":"SureClinical is a leader in delivering innovative life science cloud applications to streamline and accelerate the delivery of new drugs and devices to patients","verified":false,"public_metrics":{"followers_count":140,"following_count":269,"tweet_count":117,"listed_count":1},"id":"1210298131","username":"sureclinical","protected":false,"pinned_tweet_id":"1471842639234445321"},{"location":"Europe","url":"http://t.co/dIZcuVSbny","profile_image_url":"https://pbs.twimg.com/profile_images/3639457056/773d66965cededb04c0b5f3ec9535022_normal.png","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/dIZcuVSbny","expanded_url":"http://www.mabsot.eu/","display_url":"mabsot.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-05-10T09:51:08.000Z","name":"MABSOT","description":"FP7 Health Project. Development of OPN-305 as an orphan drug for the treatment of delayed Graft Function post solid organ transplantation.","verified":false,"public_metrics":{"followers_count":9,"following_count":16,"tweet_count":10,"listed_count":3},"id":"1417699849","username":"FP7MABSOT","protected":false},{"location":"Silver Spring, MD","url":"http://t.co/Zdksi76zRH","profile_image_url":"https://pbs.twimg.com/profile_images/773151018058145792/GTpCJal8_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Zdksi76zRH","expanded_url":"http://www.fda.gov/BiologicsBloodVaccines/default.htm","display_url":"fda.gov/BiologicsBlood‚Ä¶"}]},"description":{"hashtags":{},"urls":[{"start":129,"end":151,"url":"http://t.co/5Fo6rzyhYQ","expanded_url":"http://www.fda.gov/privacy","display_url":"fda.gov/privacy"}],"mentions":{}}},"created_at":"2011-05-23T12:13:52.000Z","name":"FDA Biologics","description":"Latest information from the Center for Biologics Evaluation and Research. Contact us at 1-800-835-4709 or ocod@fda.hhs.gov.  \r\n\r\nhttp://t.co/5Fo6rzyhYQ","verified":true,"public_metrics":{"followers_count":21691,"following_count":215,"tweet_count":3584,"listed_count":337},"id":"303777686","username":"FDACBER","protected":false},{"location":"California","url":"http://t.co/Aw87OJ6EYo","profile_image_url":"https://pbs.twimg.com/profile_images/1551654777/biorunup_official_logo_100x100_twitter_normal.png","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Aw87OJ6EYo","expanded_url":"http://www.biorunup.com","display_url":"biorunup.com"}]},"description":{"hashtags":{},"urls":[{"start":11,"end":34,"url":"https://t.co/GWXyofPPU3","expanded_url":"http://BioRunUp.com","display_url":"BioRunUp.com"}],"mentions":{}}},"created_at":"2010-01-07T00:36:55.000Z","name":"BioRunUp","description":"Founder of https://t.co/GWXyofPPU3. Tweets are not investment advice and are not recommendations of any kind. I may have positions in the names I discuss","verified":false,"public_metrics":{"followers_count":50648,"following_count":58,"tweet_count":551,"listed_count":1226},"id":"102527566","username":"BioRunUp","protected":false,"pinned_tweet_id":"1238462146930823168"},{"location":"Brussels, Europe","url":"https://t.co/Xb07O4HXBc","profile_image_url":"https://pbs.twimg.com/profile_images/907604041215201280/IuRPoVdN_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xb07O4HXBc","expanded_url":"http://ec.europa.eu/health","display_url":"ec.europa.eu/health"}]},"description":{"hashtags":[{"start":104,"end":116,"tag":"HealthUnion"}],"urls":{},"mentions":[{"start":147,"end":155,"username":"Food_EU"}]}},"created_at":"2012-06-12T13:41:08.000Z","name":"EU Health","description":"EU Commission's DG Health & Food Safety (SANTE). We are building the foundations of a stronger European #HealthUnion RT ‚â† endorsement. Food tweets @Food_EU","verified":true,"public_metrics":{"followers_count":82896,"following_count":3183,"tweet_count":24961,"listed_count":1870},"id":"606325697","username":"EU_Health","protected":false,"pinned_tweet_id":"1494228952214388738"},{"location":"Silver Spring, MD","url":"http://t.co/IlOtR68BnU","profile_image_url":"https://pbs.twimg.com/profile_images/773215176866824192/Pg2FG-Fs_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/IlOtR68BnU","expanded_url":"http://www.fda.gov/MedicalDevices/NewsEvents/ucm177150.htm","display_url":"fda.gov/MedicalDevices‚Ä¶"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":32,"end":48,"username":"FDACDRHIndustry"},{"start":63,"end":77,"username":"FDADeviceInfo"}]}},"created_at":"2009-08-17T14:35:56.000Z","name":"FDA/CDRH Industry","description":"This is the archived account of @FDACDRHIndustry. Follow us at @FDADeviceInfo for the latest on medical device & radiation-emitting products info from the FDA.","verified":true,"public_metrics":{"followers_count":39768,"following_count":196,"tweet_count":3359,"listed_count":807},"id":"66367559","username":"FDAcdrhIndustry","protected":false,"pinned_tweet_id":"1127984760981057537"},{"location":"Manchester","url":"http://t.co/OJ5hjhP8HH","profile_image_url":"https://pbs.twimg.com/profile_images/660912236735676416/MrtBaZUN_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/OJ5hjhP8HH","expanded_url":"http://www.facebook.com/adtilsoncom","display_url":"facebook.com/adtilsoncom"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-12-06T17:33:32.000Z","name":"#IAMRELENTLESS","description":"Advocate for Duchenne Muscular Dystrophy living with Duchenne, superhero and aspiring actor. Love superheroes!","verified":false,"public_metrics":{"followers_count":1774,"following_count":0,"tweet_count":10532,"listed_count":38},"id":"95037503","username":"ActionTilson","protected":false},{"location":"Vienna, Austria","url":"https://t.co/fU45KMDhit","profile_image_url":"https://pbs.twimg.com/profile_images/1486012351329538056/VPj__93t_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/fU45KMDhit","expanded_url":"http://fra.europa.eu","display_url":"fra.europa.eu"}]},"description":{"hashtags":[{"start":30,"end":48,"tag":"FundamentalRights"},{"start":64,"end":76,"tag":"humanrights"}],"urls":[{"start":125,"end":148,"url":"https://t.co/N7difRB4Ix","expanded_url":"http://fra.europa.eu/en/contact","display_url":"fra.europa.eu/en/contact"}],"mentions":{}}},"created_at":"2010-11-19T13:56:13.000Z","name":"EU Fundamental Rights ‚û°Ô∏è #HumanRights","description":"The European Union Agency for #FundamentalRights tweets to make #humanrights a reality for everyone in the üá™üá∫ EU. üìß Contact: https://t.co/N7difRB4Ix","verified":true,"public_metrics":{"followers_count":69595,"following_count":1237,"tweet_count":11440,"listed_count":1317},"id":"217422465","username":"EURightsAgency","protected":false,"pinned_tweet_id":"1493511411208802305"},{"location":"Brussels, Belgium","url":"https://t.co/L1P7tk2GKj","profile_image_url":"https://pbs.twimg.com/profile_images/1454070113066524672/e5Js3MOo_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/L1P7tk2GKj","expanded_url":"http://www.eu-patient.eu","display_url":"eu-patient.eu"}]},"description":{"hashtags":[{"start":62,"end":80,"tag":"EuropeForPatients"}],"urls":[{"start":104,"end":127,"url":"https://t.co/kT19QzDldc","expanded_url":"http://epfcongress.eu","display_url":"epfcongress.eu"}],"mentions":{}}},"created_at":"2012-04-04T16:35:04.000Z","name":"European Patients' Forum","description":"We are the leading voice of patient organisations in Europe. \n#EuropeForPatients\n\nPRE-REGISTER FOR 2022 https://t.co/kT19QzDldc","verified":false,"public_metrics":{"followers_count":12923,"following_count":1060,"tweet_count":9891,"listed_count":248},"id":"545343465","username":"eupatientsforum","protected":false,"pinned_tweet_id":"1494616623893946372"},{"location":"Brussels","url":"https://t.co/OrWBLIfvRB","profile_image_url":"https://pbs.twimg.com/profile_images/1370372262398988293/RtFm3lCv_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/OrWBLIfvRB","expanded_url":"http://www.emsp.org","display_url":"emsp.org"}]},"description":{"hashtags":[{"start":111,"end":129,"tag":"MultipleSclerosis"}],"urls":{},"mentions":{}}},"created_at":"2012-06-05T13:29:12.000Z","name":"European MS Platform","description":"Advocacy, awareness-raising, knowledge and expertise for the benefit of more than 1 million people living with #MultipleSclerosis (MS) in Europe","verified":false,"public_metrics":{"followers_count":4607,"following_count":872,"tweet_count":5401,"listed_count":100},"id":"600110872","username":"eumsplatform","protected":false,"pinned_tweet_id":"1484179283056549894"},{"url":"","profile_image_url":"https://pbs.twimg.com/profile_images/378800000515904853/efec4a73edf7bf32656bf218fa0e6af1_normal.jpeg","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-07-19T09:38:13.000Z","name":"Tonio Borg","description":"Former EU commissioner for Health","verified":false,"public_metrics":{"followers_count":2070,"following_count":0,"tweet_count":258,"listed_count":116},"id":"1605512862","username":"borgton","protected":false},{"location":"France","url":"http://t.co/9AtDvV3nwA","profile_image_url":"https://pbs.twimg.com/profile_images/1346405559671672832/S5aOaP0__normal.png","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/9AtDvV3nwA","expanded_url":"http://anses.fr","display_url":"anses.fr"}]},"description":{"hashtags":[{"start":44,"end":57,"tag":"alimentation"},{"start":64,"end":78,"tag":"environnement"},{"start":85,"end":93,"tag":"travail"},{"start":127,"end":135,"tag":"risques"}],"urls":{},"mentions":{}}},"created_at":"2013-01-21T10:01:58.000Z","name":"Anses","description":"Agence nationale de s√©curit√© sanitaire de l‚Äô#alimentation, de l‚Äô#environnement et du #travail ‚Äì Une expertise pour √©valuer les #risques et prot√©ger au quotidien","verified":true,"public_metrics":{"followers_count":23334,"following_count":1188,"tweet_count":6665,"listed_count":476},"id":"1108628533","username":"Anses_fr","protected":false,"pinned_tweet_id":"1493537582906499074"},{"location":"Luxembourg, Luxembourg","url":"https://t.co/RCmEWR0fxD","profile_image_url":"https://pbs.twimg.com/profile_images/1117717426735652864/nRrKu78A_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/RCmEWR0fxD","expanded_url":"http://www.alzheimer-europe.org","display_url":"alzheimer-europe.org"}]},"description":{"hashtags":[{"start":22,"end":31,"tag":"dementia"},{"start":96,"end":102,"tag":"32AEC"}],"urls":[{"start":61,"end":84,"url":"https://t.co/K7PH2uUs6i","expanded_url":"http://bit.ly/AE_news_signup","display_url":"bit.ly/AE_news_signup"},{"start":117,"end":140,"url":"https://t.co/BJJNMlWsQL","expanded_url":"http://linktr.ee/AlzheimerEurope","display_url":"linktr.ee/AlzheimerEurope"}],"mentions":{}}},"created_at":"2013-06-21T10:48:43.000Z","name":"Alzheimer Europe","description":"Non-profit NGO making #dementia a European priority\nGet news https://t.co/K7PH2uUs6i\nConference #32AEC \nOur channels https://t.co/BJJNMlWsQL","verified":false,"public_metrics":{"followers_count":12775,"following_count":5429,"tweet_count":22592,"listed_count":289},"id":"1536274003","username":"AlzheimerEurope","protected":false,"pinned_tweet_id":"1493198297225441285"},{"url":"","profile_image_url":"https://pbs.twimg.com/profile_images/446810067/expo2015_logo_normal.png","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-03-20T15:15:34.000Z","name":"Expo 2015","description":"","verified":false,"public_metrics":{"followers_count":726,"following_count":46,"tweet_count":16616,"listed_count":25},"id":"25518771","username":"expo2015","protected":false},{"location":"Worldwide","url":"https://t.co/WQ9QM6Z1Uq","profile_image_url":"https://pbs.twimg.com/profile_images/1450114122650107906/HFgAhkDQ_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/WQ9QM6Z1Uq","expanded_url":"http://www.worldhepatitisalliance.org","display_url":"worldhepatitisalliance.org"}]},"description":{"hashtags":[{"start":31,"end":41,"tag":"hepatitis"}],"urls":{},"mentions":{}}},"created_at":"2009-02-05T18:11:50.000Z","name":"World Hepatitis Alliance","description":"Fighting for a world free from #hepatitis by 2030. Follow to help eliminate this deadly disease, which claims one life every 30 seconds.","verified":false,"public_metrics":{"followers_count":11490,"following_count":2244,"tweet_count":15572,"listed_count":209},"id":"20170584","username":"Hep_Alliance","protected":false,"pinned_tweet_id":"1460216014885441537"},{"location":"United Kingdom","url":"http://t.co/Ec7fWJf5Zu","profile_image_url":"https://pbs.twimg.com/profile_images/1359177868870311936/ooRMF1mW_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Ec7fWJf5Zu","expanded_url":"http://gov.uk/mhra","display_url":"gov.uk/mhra"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2011-07-07T13:47:46.000Z","name":"MHRAgovuk","description":"The MHRA is a global leader in protecting and improving public health and supporting innovation through scientific research and development.","verified":true,"public_metrics":{"followers_count":29431,"following_count":541,"tweet_count":5187,"listed_count":312},"id":"330993102","username":"MHRAgovuk","protected":false,"pinned_tweet_id":"1484528605849862146"},{"location":"London, UK","url":"http://t.co/g9BZpBSaMX","profile_image_url":"https://pbs.twimg.com/profile_images/877479896951517184/dG7tGDYM_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/g9BZpBSaMX","expanded_url":"http://www.topra.org","display_url":"topra.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2009-03-26T12:42:51.000Z","name":"TOPRA","description":"TOPRA is the professional membership organisation for individuals working in healthcare regulatory affairs.","verified":false,"public_metrics":{"followers_count":2464,"following_count":720,"tweet_count":11647,"listed_count":58},"id":"26739900","username":"TOPRANEWS","protected":false,"pinned_tweet_id":"1481280406141997058"},{"location":"Biotech investor, US","url":"","profile_image_url":"https://pbs.twimg.com/profile_images/522128576955817985/SPCLChAI_normal.jpeg","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2014-10-14T20:20:24.000Z","name":"FarmaZutical","description":"","verified":false,"public_metrics":{"followers_count":30,"following_count":33,"tweet_count":161,"listed_count":4},"id":"2830257207","username":"farmazutical","protected":false},{"location":"HQ: Brussels","url":"https://t.co/U3Nlh7CLuo","profile_image_url":"https://pbs.twimg.com/profile_images/948912101216739329/KtpzsV_b_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/U3Nlh7CLuo","expanded_url":"http://eeas.europa.eu/","display_url":"eeas.europa.eu"}]},"description":{"hashtags":[{"start":99,"end":111,"tag":"EUDiplomacy"},{"start":112,"end":125,"tag":"EUInTheWorld"}],"urls":{},"mentions":[{"start":57,"end":71,"username":"JosepBorrellF"}]}},"created_at":"2009-10-08T08:53:18.000Z","name":"European External Action Service - EEAS üá™üá∫","description":"We are the EU's Foreign & Security Policy Service led by @JosepBorrellF RTs/follows ‚â† endorsements #EUDiplomacy #EUInTheWorld","verified":true,"public_metrics":{"followers_count":386337,"following_count":993,"tweet_count":29333,"listed_count":4272},"id":"80803819","username":"eu_eeas","protected":false},{"location":"Amsterdam, Nederland","url":"","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":[{"start":35,"end":48,"username":"HAImedicines"}]}},"created_at":"2015-06-09T07:55:13.000Z","name":"HAI Europe","description":"We've moved our Twitter account to @HAImedicines. Please follow us there!","verified":false,"public_metrics":{"followers_count":2,"following_count":0,"tweet_count":1,"listed_count":3},"id":"3314634701","username":"HAIEurope","protected":false},{"location":"Amsterdam, The Netherlands","url":"https://t.co/sT6goFNitq","profile_image_url":"https://pbs.twimg.com/profile_images/1477916124767571968/O1tT3ggc_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/sT6goFNitq","expanded_url":"http://www.haiweb.org","display_url":"haiweb.org"}]},"description":{"hashtags":[{"start":48,"end":65,"tag":"access2medicines"}],"urls":{},"mentions":{}}},"created_at":"2011-12-05T15:53:20.000Z","name":"Health Action International","description":"Over 40 years of advancing policies that enable #access2medicines & rational medicine use for people around the world.","verified":false,"public_metrics":{"followers_count":4233,"following_count":1000,"tweet_count":6671,"listed_count":127},"id":"429122255","username":"HAImedicines","protected":false,"pinned_tweet_id":"1491711580827967493"},{"url":"","profile_image_url":"https://pbs.twimg.com/profile_images/1141956062343553024/qnNVxj91_normal.jpg","entities":{"url":{"urls":{}},"description":{"hashtags":[{"start":68,"end":74,"tag":"EUeic"},{"start":76,"end":91,"tag":"EICAccelerator"},{"start":94,"end":108,"tag":"EICPathfinder"}],"urls":{},"mentions":[{"start":60,"end":66,"username":"EUeic"}]}},"created_at":"2017-06-13T11:38:42.000Z","name":"SME Instrument - EIC pilot","description":"üì¶ We have moved! üè° Follow the European Innovation Council  \n@EUeic, #EUeic, #EICAccelerator & #EICPathfinder. This account is not maintained.","verified":false,"public_metrics":{"followers_count":338,"following_count":0,"tweet_count":1,"listed_count":3},"id":"874591855626858496","username":"H2020SME","protected":false,"pinned_tweet_id":"1141952400686813189"},{"url":"","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","entities":{"url":{"urls":{}},"description":{"hashtags":[{"start":88,"end":98,"tag":"HorizonEU"}],"urls":{},"mentions":[{"start":0,"end":9,"username":"EU_H2020"},{"start":17,"end":27,"username":"HorizonEU"}]}},"created_at":"2017-10-17T11:26:19.000Z","name":"Horizon 2020","description":"@EU_H2020 is now @HorizonEU, make sure you follow it to learn everything about the EU's #HorizonEU research and innovation programme.","verified":false,"public_metrics":{"followers_count":1119,"following_count":0,"tweet_count":0,"listed_count":4},"id":"920249612329504768","username":"EU_H2020","protected":false},{"location":"European Union","url":"https://t.co/xYvu7h7yXw","profile_image_url":"https://pbs.twimg.com/profile_images/1372451533732913153/1sL0wuZo_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/xYvu7h7yXw","expanded_url":"https://eic.ec.europa.eu/","display_url":"eic.ec.europa.eu"}]},"description":{"hashtags":[{"start":79,"end":85,"tag":"EUeic"}],"urls":[{"start":129,"end":152,"url":"https://t.co/cON5wifKzD","expanded_url":"http://europa.eu/!fc89kC","display_url":"europa.eu/!fc89kC"}],"mentions":[{"start":86,"end":96,"username":"EU_EISMEA"},{"start":97,"end":111,"username":"EU_commission"}]}},"created_at":"2014-02-25T13:51:47.000Z","name":"European Innovation Council","description":"üá™üá∫ üöÄ Investing in market-creating research & innovation | Official account for #EUeic @EU_EISMEA @EU_commission. Data protection https://t.co/cON5wifKzD","verified":true,"public_metrics":{"followers_count":44899,"following_count":1650,"tweet_count":16644,"listed_count":1061},"id":"2361119438","username":"EUeic","protected":false,"pinned_tweet_id":"1493910999631552513"},{"location":"Brussels","url":"https://t.co/WJdV3X5glJ","profile_image_url":"https://pbs.twimg.com/profile_images/1468217923617673216/oHA98tT4_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/WJdV3X5glJ","expanded_url":"http://www.animalhealtheurope.eu","display_url":"animalhealtheurope.eu"}]},"description":{"hashtags":[{"start":93,"end":113,"tag":"AnimalHealthMatters"},{"start":114,"end":131,"tag":"MorethanMedicine"}],"urls":{},"mentions":{}}},"created_at":"2012-12-17T09:14:15.000Z","name":"AnimalhealthEurope","description":"AnimalhealthEurope represents manufacturers of animal health products and services in Europe #AnimalHealthMatters #MorethanMedicine","verified":false,"public_metrics":{"followers_count":6882,"following_count":926,"tweet_count":7560,"listed_count":87},"id":"1017044760","username":"animalhealthEU","protected":false,"pinned_tweet_id":"1488156259174043650"},{"location":"Stockholm, Sweden","url":"http://t.co/HzZhkGX9HG","profile_image_url":"https://pbs.twimg.com/profile_images/503906753285591040/B4rE-3Py_normal.jpeg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/HzZhkGX9HG","expanded_url":"http://ecdc.europa.eu","display_url":"ecdc.europa.eu"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2014-08-22T09:35:03.000Z","name":"ECDC Outbreaks","description":"Disease outbreaks and potential health threats to the EU. Run by the European Centre for Disease Prevention and Control","verified":true,"public_metrics":{"followers_count":23748,"following_count":74,"tweet_count":2152,"listed_count":655},"id":"2754484003","username":"ECDC_Outbreaks","protected":false,"pinned_tweet_id":"1486674806607122435"},{"location":"Brussels, Belgium","url":"https://t.co/cxJdSfOv6c","profile_image_url":"https://pbs.twimg.com/profile_images/939139994907705344/VXFk_XiI_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/cxJdSfOv6c","expanded_url":"http://ec.europa.eu/digital-single-market/eHealth","display_url":"ec.europa.eu/digital-single‚Ä¶"}]},"description":{"hashtags":[{"start":73,"end":81,"tag":"digital"},{"start":127,"end":133,"tag":"H2020"},{"start":134,"end":142,"tag":"eHealth"},{"start":143,"end":154,"tag":"AgeingWell"}],"urls":{},"mentions":[{"start":97,"end":111,"username":"EU_Commission"},{"start":114,"end":124,"username":"DigitalEU"}]}},"created_at":"2009-03-13T08:10:53.000Z","name":"eHealth_EU","description":"Working to improve EU health & care via policy, innovation & research in #digital tools. Part of @EU_Commission & @DigitalEU.  #H2020 #eHealth #AgeingWell","verified":false,"public_metrics":{"followers_count":29902,"following_count":9357,"tweet_count":14522,"listed_count":1353},"id":"24145340","username":"eHealth_EU","protected":false},{"location":"Montr√©al, Qu√©bec","url":"","profile_image_url":"https://pbs.twimg.com/profile_images/975227389641764864/OybnNO9K_normal.jpg","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2013-02-27T00:37:40.000Z","name":"PP","description":"Twittering for a Living","verified":false,"public_metrics":{"followers_count":113,"following_count":1014,"tweet_count":3418,"listed_count":1},"id":"1223273226","username":"PedroPedroso81","protected":false},{"url":"https://t.co/CwltvkVL64","profile_image_url":"https://pbs.twimg.com/profile_images/1472112291835518983/iR7b-_7A_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/CwltvkVL64","expanded_url":"http://www.epda.eu.com","display_url":"epda.eu.com"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-09-13T12:18:57.000Z","name":"European Parkinson's Disease Association (EPDA)","description":"European Parkinson's disease umbrella organisation - THE advocate for the rights and needs of 1.2m people with Parkinson‚Äôs AND their families in Europe.","verified":false,"public_metrics":{"followers_count":5328,"following_count":926,"tweet_count":13815,"listed_count":148},"id":"190227425","username":"euparkinsons","protected":false,"pinned_tweet_id":"1488502373039362051"},{"location":"Norge","url":"https://t.co/15V6ELTOWL","profile_image_url":"https://pbs.twimg.com/profile_images/776399903744462848/HnLwnppN_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/15V6ELTOWL","expanded_url":"http://legemiddelverket.no","display_url":"legemiddelverket.no"}]},"description":{"hashtags":{},"urls":[{"start":125,"end":148,"url":"https://t.co/15V6ELTOWL","expanded_url":"http://legemiddelverket.no","display_url":"legemiddelverket.no"}],"mentions":{}}},"created_at":"2009-11-13T22:12:05.000Z","name":"Legemiddelverket","description":"Nasjonal myndighet for legemidler og medisinsk utstyr. Vi er ikke lenger aktive p√• Twitter. Kontakt oss p√• Facebook eller p√• https://t.co/15V6ELTOWL.","verified":false,"public_metrics":{"followers_count":5500,"following_count":778,"tweet_count":1565,"listed_count":88},"id":"89806212","username":"Legemiddelinfo","protected":false},{"location":"Europe","url":"https://t.co/8PBLq9mnAU","profile_image_url":"https://pbs.twimg.com/profile_images/1367015286721957890/NBLDvvzN_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/8PBLq9mnAU","expanded_url":"http://www.ecpc.org","display_url":"ecpc.org"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":142,"end":155,"username":"ChallengeCAN"}]}},"created_at":"2010-05-05T07:43:41.000Z","name":"ECPC","description":"We are the voice of over 450 cancer patient organisations, covering the most common to the rarest cancers.\n\nECPC is providing Secretariat for @ChallengeCAN","verified":false,"public_metrics":{"followers_count":6006,"following_count":1849,"tweet_count":13662,"listed_count":172},"id":"140344419","username":"cancereu","protected":false,"pinned_tweet_id":"1447517527366643712"},{"location":"Brussels","url":"https://t.co/CuyHbxOnLv","profile_image_url":"https://pbs.twimg.com/profile_images/823590341098045440/_KnSOqm1_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/CuyHbxOnLv","expanded_url":"http://www.euractiv.com/","display_url":"euractiv.com"}]},"description":{"hashtags":[{"start":149,"end":159,"tag":"eaDebates"}],"urls":[{"start":123,"end":146,"url":"https://t.co/5QW6JPZ0fl","expanded_url":"http://eurac.tv/support","display_url":"eurac.tv/support"}],"mentions":{}}},"created_at":"2008-05-17T05:33:45.000Z","name":"EURACTIV","description":"Independent, multilingual, pan-European, & constructive. We build the European public sphere. Become a EURACTIV supporter: https://t.co/5QW6JPZ0fl | #eaDebates","verified":true,"public_metrics":{"followers_count":142142,"following_count":2399,"tweet_count":73373,"listed_count":2958},"id":"14808226","username":"EURACTIV","protected":false},{"url":"https://t.co/VZ5MiR5IkP","profile_image_url":"https://pbs.twimg.com/profile_images/1064557237098684419/dcUzJ9sL_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/VZ5MiR5IkP","expanded_url":"http://www.europeanlung.org","display_url":"europeanlung.org"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":138,"end":152,"username":"european_lung"}]}},"created_at":"2010-03-10T14:01:15.000Z","name":"European Lung Foundation","description":"ELF is dedicated to lung health throughout Europe, providing patient information and raising awareness about lung conditions. \nInstagram: @european_lung","verified":false,"public_metrics":{"followers_count":12844,"following_count":519,"tweet_count":5135,"listed_count":171},"id":"121759520","username":"EuropeanLung","protected":false},{"location":"Eindhoven, The Netherlands","url":"https://t.co/MGvGHxQVvu","profile_image_url":"https://pbs.twimg.com/profile_images/1381299571410747392/afcQ3wis_normal.png","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/MGvGHxQVvu","expanded_url":"https://egonw.github.io/","display_url":"egonw.github.io"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":31,"end":39,"username":"the_cdk"},{"start":41,"end":54,"username":"wikipathways"},{"start":56,"end":65,"username":"BridgeDb"},{"start":67,"end":77,"username":"WDScholia"},{"start":79,"end":89,"username":"bigcat_um"},{"start":91,"end":103,"username":"MaastrichtU"}]}},"created_at":"2009-03-05T12:13:25.000Z","name":"Egon Willigh‚ìêgen","description":"Studies the chemistry of life. @the_cdk, @wikipathways, @BridgeDb, @WDScholia, @bigcat_um, @MaastrichtU, Open Science. 0000-0001-7542-0286 (tweets personal)","verified":false,"public_metrics":{"followers_count":5028,"following_count":1238,"tweet_count":115166,"listed_count":453},"id":"22911650","username":"egonwillighagen","protected":false,"pinned_tweet_id":"1403299501947899907"},{"location":"Brussels and Strasbourg","url":"https://t.co/VzlgvxtB2z","profile_image_url":"https://pbs.twimg.com/profile_images/878202452872499202/89P8qZGJ_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/VzlgvxtB2z","expanded_url":"http://eptwitter.eu/qjxu","display_url":"eptwitter.eu/qjxu"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-10-06T07:55:08.000Z","name":"EP PressService","description":"The Press Service of the European Parliament","verified":true,"public_metrics":{"followers_count":100974,"following_count":893,"tweet_count":13255,"listed_count":2084},"id":"199196447","username":"EuroParlPress","protected":false},{"location":"Brussels/Strasbourg","url":"https://t.co/Ys0rjSNwoO","profile_image_url":"https://pbs.twimg.com/profile_images/878206338593062914/WUBMbkeB_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Ys0rjSNwoO","expanded_url":"http://bit.ly/1iC3S3H","display_url":"bit.ly/1iC3S3H"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-11-16T09:20:03.000Z","name":"ITRE Committee Press","description":"European Parliament Committee on Industry, Research, Telecoms & Energy. Managed by Baptiste Chatain. RTs ‚â† endorsement","verified":true,"public_metrics":{"followers_count":18597,"following_count":543,"tweet_count":2016,"listed_count":576},"id":"951326846","username":"EP_Industry","protected":false},{"location":"Brussels/Strasbourg","url":"http://t.co/jnWSxSQxTA","profile_image_url":"https://pbs.twimg.com/profile_images/878207051176054785/vL0RLJGk_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/jnWSxSQxTA","expanded_url":"http://bit.ly/1xS1MXH","display_url":"bit.ly/1xS1MXH"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-11-16T09:37:41.000Z","name":"IMCO Committee Press","description":"European Parliament Committee on Internal Market and Consumer Protection. Managed by Isabel Teixeira Nadkarni. RTs ‚â† endorsement.","verified":true,"public_metrics":{"followers_count":12764,"following_count":657,"tweet_count":3769,"listed_count":457},"id":"951348098","username":"EP_SingleMarket","protected":false},{"location":"London, England","url":"https://t.co/SpUgdFHGPu","profile_image_url":"https://pbs.twimg.com/profile_images/1259874594749644800/vfr8Ej_D_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/SpUgdFHGPu","expanded_url":"http://mhra.gov.uk","display_url":"mhra.gov.uk"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-11-20T12:59:48.000Z","name":"MHRA Meds Safety","description":"Medicines safety updates from the MHRA, listing medicines information and safety alerts.","verified":true,"public_metrics":{"followers_count":7485,"following_count":22,"tweet_count":1089,"listed_count":108},"id":"960436586","username":"MHRAmedicines","protected":false},{"location":"Leverkusen","url":"https://t.co/JTIpORLxFP","profile_image_url":"https://pbs.twimg.com/profile_images/1423275007438897164/T0JxaZP2_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/JTIpORLxFP","expanded_url":"http://www.bayer.com/","display_url":"bayer.com"}]},"description":{"hashtags":{},"urls":[{"start":90,"end":113,"url":"https://t.co/eBDcZTEYJ2","expanded_url":"https://www.bayer.com/en/glob-tw-bayer-en-dps-imprint.aspx","display_url":"bayer.com/en/glob-tw-bay‚Ä¶"}],"mentions":{}}},"created_at":"2010-04-26T12:35:25.000Z","name":"Bayer AG","description":"Advancing life - that's what we at Bayer are all about. Data Privacy Statement / Imprint: https://t.co/eBDcZTEYJ2","verified":true,"public_metrics":{"followers_count":181828,"following_count":930,"tweet_count":10973,"listed_count":1339},"id":"137319302","username":"Bayer","protected":false},{"location":"COLOMBIA","url":"https://t.co/hPKVFLgOQM","profile_image_url":"https://pbs.twimg.com/profile_images/1337119859042344968/0Mx4l50m_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hPKVFLgOQM","expanded_url":"http://www.invima.gov.co/","display_url":"invima.gov.co"}]},"description":{"hashtags":{},"urls":{},"mentions":[{"start":18,"end":30,"username":"jaldanabula"}]}},"created_at":"2011-09-16T14:38:43.000Z","name":"Invima","description":"Director General: @jaldanabula - Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima) Autoridad Sanitaria de Colombia.","verified":true,"public_metrics":{"followers_count":44756,"following_count":235,"tweet_count":30207,"listed_count":162},"id":"374557401","username":"invimacolombia","protected":false,"pinned_tweet_id":"1494105498836156419"},{"url":"","profile_image_url":"https://pbs.twimg.com/profile_images/986745564695007238/LmJbTgtF_normal.jpg","entities":{"url":{"urls":{}},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2012-03-03T16:18:03.000Z","name":"Jorge H. Ramirez","description":"","verified":false,"public_metrics":{"followers_count":2722,"following_count":2255,"tweet_count":9839,"listed_count":67},"id":"513331314","username":"Jor_H_R","protected":false},{"url":"https://t.co/7u4gBRzbKd","profile_image_url":"https://pbs.twimg.com/profile_images/1480921460663332874/B6VW3tPm_normal.jpg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7u4gBRzbKd","expanded_url":"http://www.uroweb.org","display_url":"uroweb.org"}]},"description":{"hashtags":{},"urls":{},"mentions":{}}},"created_at":"2010-02-15T13:30:29.000Z","name":"European Association of Urology (EAU)","description":"We are: 18,000+ urologists. We do: Numerous scientific meetings, CME accreditation, scientific publications, research, awareness and more.","verified":true,"public_metrics":{"followers_count":36783,"following_count":13052,"tweet_count":17409,"listed_count":294},"id":"114455333","username":"Uroweb","protected":false}],"tweets":[{"entities":{"mentions":[{"start":105,"end":116,"username":"PATHtweets","id":"44763075"}],"annotations":[{"start":85,"end":93,"probability":0.5126,"type":"Place","normalized_text":"RotaFlash"}],"hashtags":[{"start":28,"end":38,"tag":"rotavirus"},{"start":39,"end":47,"tag":"vaccine"}],"urls":[{"start":117,"end":139,"url":"http://t.co/PHOUVNg1iX","expanded_url":"http://bit.ly/10iaRt1#immunizeEurope","display_url":"bit.ly/10iaRt1#immuni‚Ä¶"}]},"conversation_id":"529676818329374720","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"News on acceleration of new #rotavirus #vaccine devt &amp; latest global introduction in RotaFlash alert @PATHtweets http://t.co/PHOUVNg1iX","id":"529676818329374720","possibly_sensitive":false,"created_at":"2014-11-04T16:49:29.000Z","author_id":"561122363","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":61,"end":66,"probability":0.9917,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":31,"end":38,"tag":"vector"}],"urls":[{"start":121,"end":143,"url":"http://t.co/k0OL1Gzs1d","expanded_url":"http://bit.ly/1phU7OB","display_url":"bit.ly/1phU7OB"}]},"conversation_id":"529676679963496448","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Epidemiology of emerging &amp; #vector-borne diseases: Trends in Europe. 1st chapter of 2014 Annual Epi report released: http://t.co/k0OL1Gzs1d","id":"529676679963496448","possibly_sensitive":false,"created_at":"2014-11-04T16:48:56.000Z","author_id":"204752573","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"Norway"},{"start":34,"end":44,"tag":"rotavirus"},{"start":45,"end":53,"tag":"vaccine"}],"urls":[{"start":95,"end":117,"url":"http://t.co/pw0P1uCVMa","expanded_url":"http://bit.ly/10iaRt1","display_url":"bit.ly/10iaRt1"},{"start":118,"end":140,"url":"http://t.co/i6l9hbbkJp","expanded_url":"https://twitter.com/WHO_Europe_VPI/status/529675751390724097/photo/1","display_url":"pic.twitter.com/i6l9hbbkJp"}]},"conversation_id":"529675751390724097","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"#Norway 70th country to introduce #rotavirus #vaccine to protect children from severe diarrhea http://t.co/pw0P1uCVMa http://t.co/i6l9hbbkJp","id":"529675751390724097","possibly_sensitive":false,"created_at":"2014-11-04T16:45:14.000Z","author_id":"561122363","attachments":{"media_keys":["3_529675750652534785"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":19,"end":34,"username":"NatRevDrugDisc","id":"36066745"}],"annotations":{},"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/94D8OBmO2Y","expanded_url":"http://bit.ly/1Aby4xF","display_url":"bit.ly/1Aby4xF"}]},"conversation_id":"529670209259708416","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Special edition of @NatRevDrugDisc focuses on drug development consortia http://t.co/94D8OBmO2Y - Interesting stuff!","id":"529670209259708416","possibly_sensitive":false,"created_at":"2014-11-04T16:23:13.000Z","author_id":"153741027","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":10,"end":21,"tag":"journalist"},{"start":65,"end":75,"tag":"medicines"},{"start":76,"end":89,"tag":"publichealth"},{"start":94,"end":100,"tag":"media"},{"start":134,"end":139,"tag":"EDQM"}],"urls":[{"start":111,"end":133,"url":"http://t.co/U2nCBAcYbA","expanded_url":"http://bit.ly/1wP9pc4","display_url":"bit.ly/1wP9pc4"}]},"conversation_id":"529648024902193152","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Are you a #journalist? You have 2 weeks left to register for the #medicines #publichealth and #media workshop! http://t.co/U2nCBAcYbA #EDQM","id":"529648024902193152","possibly_sensitive":false,"created_at":"2014-11-04T14:55:04.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":4,"tag":"FDA"}],"urls":[{"start":45,"end":67,"url":"http://t.co/qMqzjq5qRm","expanded_url":"http://1.usa.gov/1ofOy2w","display_url":"1.usa.gov/1ofOy2w"}]},"conversation_id":"529635505894621184","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"#FDA Ensures Your Food from Animals are Safe http://t.co/qMqzjq5qRm","id":"529635505894621184","possibly_sensitive":false,"created_at":"2014-11-04T14:05:19.000Z","author_id":"109290405","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":11,"end":23,"tag":"antibiotics"},{"start":105,"end":110,"tag":"EAAD"}],"urls":{}},"conversation_id":"529559944195244033","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"Never save #antibiotics for later use, take leftover antibiotics or share leftover antibiotics w/ others #EAAD","id":"529559944195244033","possibly_sensitive":false,"created_at":"2014-11-04T09:05:04.000Z","author_id":"1725283578","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":9,"tag":"european"},{"start":10,"end":24,"tag":"pharmacopoeia"},{"start":99,"end":105,"tag":"PhEur"}],"urls":[{"start":118,"end":140,"url":"http://t.co/SCk3ZnbLcV","expanded_url":"http://bit.ly/UKZNTv","display_url":"bit.ly/UKZNTv"}]},"conversation_id":"529554364386791424","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#european #pharmacopoeia texts to be revised or elaborated: read the updated work programme of the #PhEur Commission: http://t.co/SCk3ZnbLcV","id":"529554364386791424","possibly_sensitive":false,"created_at":"2014-11-04T08:42:53.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":86,"end":101,"username":"FilippaLentzos","id":"1294931262"}],"annotations":[{"start":104,"end":113,"probability":0.906,"type":"Person","normalized_text":"Simon Wain"},{"start":115,"end":120,"probability":0.6158,"type":"Person","normalized_text":"Hobson"}],"hashtags":[{"start":19,"end":24,"tag":"DURC"},{"start":130,"end":143,"tag":"ESCAIDE_DURC"}],"urls":{}},"conversation_id":"529551637422309376","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Join 1st debate on #DURC \"Why engineer microbes to be more dangerous to humankind‚Äù w/ @FilippaLentzos &amp; Simon Wain-Hobson use #ESCAIDE_DURC","id":"529551637422309376","possibly_sensitive":false,"created_at":"2014-11-04T08:32:03.000Z","author_id":"204752573","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"SanofiFR","id":"771517543"},{"start":20,"end":29,"username":"SanofiUS","id":"183033795"},{"start":30,"end":37,"username":"sanofi","id":"35846368"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"529288896019185664","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@EMA_News @SanofiFR @SanofiUS @sanofi Why the delay in this warning? How long have you known?","id":"529345886942674945","possibly_sensitive":false,"created_at":"2014-11-03T18:54:28.000Z","author_id":"43524728","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"529312451998023681"}],"in_reply_to_user_id":"116716199"},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":38,"tag":"Ebola"},{"start":66,"end":75,"tag":"vaccines"},{"start":82,"end":94,"tag":"diagnostics"}],"urls":[{"start":119,"end":141,"url":"http://t.co/gaZFnWZk1a","expanded_url":"http://bit.ly/IMI2Call2","display_url":"bit.ly/IMI2Call2"}]},"conversation_id":"529319829350932480","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"IMI is preparing a programme on #Ebola - 1st Call topics to cover #vaccines &amp; #diagnostics. Read the Call summary: http://t.co/gaZFnWZk1a","id":"529319829350932480","possibly_sensitive":false,"created_at":"2014-11-03T17:10:56.000Z","author_id":"153741027","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":24,"end":31,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/Zx6CLTrScm","expanded_url":"http://www.medpagetoday.com/Psychiatry/Addictions/48358","display_url":"medpagetoday.com/Psychiatry/Add‚Ä¶"}]},"conversation_id":"529302608335630337","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"No Clear Consensus from @US_FDA Meeting to Discuss Abuse-Deterrent Opioids http://t.co/Zx6CLTrScm","id":"529302608335630337","possibly_sensitive":false,"created_at":"2014-11-03T16:02:30.000Z","author_id":"28870127","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":56,"end":72,"username":"FDAanimalhealth","id":"109290405"}],"annotations":[{"start":0,"end":2,"probability":0.6248,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/lE2DQLxwvt","expanded_url":"http://go.usa.gov/7pAV","display_url":"go.usa.gov/7pAV"}]},"conversation_id":"529292593373646848","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"FDA Ensures Your Foods From Animals Are Safe, Thanks to @FDAanimalhealth Division of Residue Chemistry http://t.co/lE2DQLxwvt","id":"529292593373646848","possibly_sensitive":false,"created_at":"2014-11-03T15:22:42.000Z","author_id":"208120290","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":108,"end":113,"probability":0.9906,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":19,"end":24,"tag":"EDQM"},{"start":54,"end":67,"tag":"publichealth"},{"start":86,"end":96,"tag":"Medicines"}],"urls":[{"start":115,"end":137,"url":"http://t.co/U2nCBAcYbA","expanded_url":"http://bit.ly/1wP9pc4","display_url":"bit.ly/1wP9pc4"}]},"conversation_id":"529292369037119488","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Still time to join #EDQM and FAHMP to discuss current #publichealth challenges, QC of #Medicines and API in Europe http://t.co/U2nCBAcYbA","id":"529292369037119488","possibly_sensitive":false,"created_at":"2014-11-03T15:21:49.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":9,"username":"SanofiFR","id":"771517543"},{"start":10,"end":19,"username":"SanofiUS","id":"183033795"},{"start":20,"end":27,"username":"sanofi","id":"35846368"},{"start":28,"end":37,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"529288896019185664","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@SanofiFR @SanofiUS @sanofi @EMA_News - Hey guys, is Valporate a teratogen and can it cause birth defects?","id":"529288896019185664","possibly_sensitive":false,"created_at":"2014-11-03T15:08:01.000Z","author_id":"43524728","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"771517543"},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":5,"tag":"PEDV"},{"start":10,"end":16,"tag":"PDCoV"}],"urls":[{"start":17,"end":39,"url":"http://t.co/PZcr90g0JB","expanded_url":"http://www.efsa.europa.eu/en/efsajournal/pub/3877.htm","display_url":"efsa.europa.eu/en/efsajournal‚Ä¶"}]},"conversation_id":"529286140441137154","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"und","text":"#PEDV and #PDCoV http://t.co/PZcr90g0JB","id":"529286140441137154","possibly_sensitive":false,"created_at":"2014-11-03T14:57:04.000Z","author_id":"1479912948","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.8549,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/GwelFElVau","expanded_url":"http://ht.ly/DJeVO","display_url":"ht.ly/DJeVO"},{"start":104,"end":126,"url":"http://t.co/UZuGfmUEbc","expanded_url":"http://ht.ly/DJeVP","display_url":"ht.ly/DJeVP"}]},"conversation_id":"529273099548913665","source":"Hootsuite","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"FDA's Risk Communication Advisory Committee meets Nov. 3-4. Agenda: http://t.co/GwelFElVau View online: http://t.co/UZuGfmUEbc","id":"529273099548913665","possibly_sensitive":false,"created_at":"2014-11-03T14:05:15.000Z","author_id":"1606025952","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":100,"end":108,"username":"YouTube","id":"10228272"}],"annotations":{},"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/UcP8RvPwY0","expanded_url":"http://youtu.be/CAZx4e0lODM?a","display_url":"youtu.be/CAZx4e0lODM?a"}]},"conversation_id":"529265948125970432","source":"Google","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"\"Information Management Infrastructure and Services (EUnetHTA JA2WP6)\"¬†: http://t.co/UcP8RvPwY0 via @YouTube","id":"529265948125970432","possibly_sensitive":false,"created_at":"2014-11-03T13:36:49.000Z","author_id":"56493220","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":27,"end":32,"probability":0.5736,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":81,"end":93,"tag":"HTA2014Rome"}],"urls":[{"start":56,"end":78,"url":"http://t.co/IPdtEdMJcF","expanded_url":"http://www.eunethta.eu/outputs/hta-20-europe-teaming-value-conference-presentations","display_url":"eunethta.eu/outputs/hta-20‚Ä¶"}]},"conversation_id":"529265590880722945","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Presentations from HTA 2.0 Europe conference available: http://t.co/IPdtEdMJcF - #HTA2014Rome","id":"529265590880722945","possibly_sensitive":false,"created_at":"2014-11-03T13:35:24.000Z","author_id":"56493220","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":3,"probability":0.401,"type":"Organization","normalized_text":"MHRA"},{"start":14,"end":29,"probability":0.6063,"type":"Person","normalized_text":"Sir Mike Rawlins"}],"hashtags":{},"urls":[{"start":47,"end":69,"url":"http://t.co/wZeGT9DfEi","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON471139","display_url":"mhra.gov.uk/NewsCentre/Pre‚Ä¶"}]},"conversation_id":"529261102090452993","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":3,"quote_count":0},"lang":"en","text":"MHRA appoints Sir Mike Rawlins as new chairman http://t.co/wZeGT9DfEi","id":"529261102090452993","possibly_sensitive":false,"created_at":"2014-11-03T13:17:34.000Z","author_id":"330990243","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":56,"end":78,"url":"http://t.co/KdQl9jmaSn","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002204.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?‚Ä¶"}]},"conversation_id":"529235587593949184","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Revised framework for development of influenza vaccines http://t.co/KdQl9jmaSn","id":"529235587593949184","possibly_sensitive":false,"created_at":"2014-11-03T11:36:11.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":111,"end":126,"tag":"EGAbiosimilars"}],"urls":[{"start":88,"end":110,"url":"http://t.co/tg1noVC2cY","expanded_url":"http://ow.ly/DIy9S","display_url":"ow.ly/DIy9S"}]},"conversation_id":"529213742761140224","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EGA and EBG welcome a new milestone in the EU biosimilar medicines regulatory framework http://t.co/tg1noVC2cY #EGAbiosimilars","id":"529213742761140224","possibly_sensitive":false,"created_at":"2014-11-03T10:09:23.000Z","author_id":"2315763655","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Antibiotics"},{"start":113,"end":118,"tag":"EAAD"}],"urls":{}},"conversation_id":"529190657781665792","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"#Antibiotics can only be prescribed by a doctor who has examined you. Never try to buy them without prescription #EAAD","id":"529190657781665792","possibly_sensitive":false,"created_at":"2014-11-03T08:37:39.000Z","author_id":"1725283578","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":97,"end":102,"probability":0.7273,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":104,"end":116,"tag":"HTA2014Rome"}],"urls":[{"start":117,"end":139,"url":"http://t.co/rayCkvj8xy","expanded_url":"http://www.eunethta.eu/news/hta-network-strategy-and-eunethta-ja2-recommendations-endorsed-and-go-live-hta-20-europe-rome","display_url":"eunethta.eu/news/hta-netwo‚Ä¶"}]},"conversation_id":"527825113329438720","source":"Twitter for Android","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EUnetHTA Recommendations on implementation of sustainable European network for HTA live! HTA 2.0 Europe #HTA2014Rome http://t.co/rayCkvj8xy","id":"527825113329438720","possibly_sensitive":false,"created_at":"2014-10-30T14:11:28.000Z","author_id":"56493220","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":78,"end":87,"username":"EU_Markt","id":"2815632681"}],"annotations":{},"hashtags":[{"start":111,"end":129,"tag":"PublicProcurement"}],"urls":[{"start":88,"end":110,"url":"http://t.co/jpu9Y7AEIl","expanded_url":"http://owl.li/ARsMU","display_url":"owl.li/ARsMU"}]},"conversation_id":"527833007814877184","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Find out the new rules on public contracts and concessions in this leaflet by @EU_Markt http://t.co/jpu9Y7AEIl #PublicProcurement","id":"527833007814877184","possibly_sensitive":false,"created_at":"2014-10-30T14:42:50.000Z","author_id":"294046348","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":93,"end":115,"url":"http://t.co/nZ3bNWWdhb","expanded_url":"http://bit.ly/1FYTdLR","display_url":"bit.ly/1FYTdLR"}]},"conversation_id":"527835854312841216","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Check out the updated Community Rolling Action Plan for substance evaluation on our website. http://t.co/nZ3bNWWdhb","id":"527835854312841216","possibly_sensitive":false,"created_at":"2014-10-30T14:54:09.000Z","author_id":"331604970","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":11,"end":19,"tag":"UEGWeek"},{"start":62,"end":72,"tag":"Abstracts"}],"urls":[{"start":104,"end":126,"url":"http://t.co/yxX8ngMBZi","expanded_url":"http://ueg.sagepub.com/content/2/1_suppl.toc","display_url":"ueg.sagepub.com/content/2/1_su‚Ä¶"}]},"conversation_id":"527837396269023232","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Access all #UEGWeek abstracts including late breakers and Top #Abstracts in PubMed indexed UEG Journal: http://t.co/yxX8ngMBZi","id":"527837396269023232","possibly_sensitive":false,"created_at":"2014-10-30T15:00:16.000Z","author_id":"487344065","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":80,"end":86,"username":"irdes","id":"84332464"}],"annotations":{},"hashtags":[{"start":0,"end":5,"tag":"EFPC"},{"start":37,"end":49,"tag":"PrimaryCare"},{"start":72,"end":79,"tag":"France"}],"urls":[{"start":126,"end":148,"url":"http://t.co/q7l46GY1nt","expanded_url":"http://www.euprimarycare.org/newsflash/newsflash-2014-%E2%80%93-20-wonca-europe-2015-istanbul-multiprofessional-primary-care-remuneration#.VFJWLCCZjpI.twitter","display_url":"euprimarycare.org/newsflash/news‚Ä¶"}]},"conversation_id":"527842309467955200","source":"Twitter for Websites","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#EFPC Newsflash 20 Multiprofessional #PrimaryCare &amp; remuneration in #France @irdes, behavior change &amp; health outcomes http://t.co/q7l46GY1nt","id":"527842309467955200","possibly_sensitive":false,"created_at":"2014-10-30T15:19:48.000Z","author_id":"164835748","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":37,"end":39,"probability":0.3433,"type":"Person","normalized_text":"TED"}],"hashtags":[{"start":96,"end":108,"tag":"raredisease"}],"urls":[{"start":110,"end":132,"url":"http://t.co/yRHU4Hd6x5","expanded_url":"http://ow.ly/Dt0kP","display_url":"ow.ly/Dt0kP"}]},"conversation_id":"527843692389085185","source":"Hootsuite","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"What do we do with big data? Watch a TED talk on why we need to deepen critical thinking skills #raredisease  http://t.co/yRHU4Hd6x5","id":"527843692389085185","possibly_sensitive":false,"created_at":"2014-10-30T15:25:17.000Z","author_id":"26993786","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":64,"end":75,"tag":"antibiotic"},{"start":133,"end":138,"tag":"EAAD"}],"urls":[{"start":110,"end":132,"url":"http://t.co/ddToK3Lx5S","expanded_url":"http://bit.ly/1tm7ifL","display_url":"bit.ly/1tm7ifL"}]},"conversation_id":"527845153118359553","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Read stories of people whose lives were changed dramatically by #antibiotic-resistant bugs. Share your story: http://t.co/ddToK3Lx5S #EAAD","id":"527845153118359553","possibly_sensitive":false,"created_at":"2014-10-30T15:31:06.000Z","author_id":"1725283578","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":22,"end":25,"probability":0.6144,"type":"Organization","normalized_text":"NCTR"},{"start":28,"end":30,"probability":0.9163,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":106,"end":128,"url":"http://t.co/MGxuiyFSsw","expanded_url":"http://go.usa.gov/7Cwx","display_url":"go.usa.gov/7Cwx"}]},"conversation_id":"527848896580812800","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Read the latest about NCTR, FDA‚Äôs internationally acclaimed research center, in their latest Newsletter ‚Ä¶ http://t.co/MGxuiyFSsw","id":"527848896580812800","possibly_sensitive":false,"created_at":"2014-10-30T15:45:58.000Z","author_id":"208120290","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":10,"tag":"Influenza"}],"urls":[{"start":105,"end":127,"url":"http://t.co/nPdrzQ7Hdq","expanded_url":"http://bit.ly/1sKSdAP","display_url":"bit.ly/1sKSdAP"}]},"conversation_id":"527849577874202626","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Influenza vaccines are updated annually; taking the shot each year offers the best continued protection http://t.co/nPdrzQ7Hdq","id":"527849577874202626","possibly_sensitive":false,"created_at":"2014-10-30T15:48:40.000Z","author_id":"1371668696","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":9,"tag":"EDQM"}],"urls":[{"start":115,"end":137,"url":"http://t.co/1CSYWsWgSe","expanded_url":"http://bit.ly/1wG1Q9T","display_url":"bit.ly/1wG1Q9T"}]},"conversation_id":"527497779435032576","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #EDQM is still looking for a Scientific Programme Officer in the framework of a Secondment. See all positions: http://t.co/1CSYWsWgSe","id":"527497779435032576","possibly_sensitive":false,"created_at":"2014-10-29T16:30:45.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":41,"end":54,"tag":"breastcancer"}],"urls":[{"start":55,"end":77,"url":"http://t.co/8DGSnXE758","expanded_url":"http://ow.ly/Dwg55","display_url":"ow.ly/Dwg55"}]},"conversation_id":"527487332447166464","source":"Hootsuite","public_metrics":{"retweet_count":7,"reply_count":2,"like_count":6,"quote_count":0},"lang":"en","text":"Hormone therapy adherence in early-stage #breastcancer http://t.co/8DGSnXE758","id":"527487332447166464","possibly_sensitive":false,"created_at":"2014-10-29T15:49:14.000Z","author_id":"69232855","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":103,"end":106,"tag":"TB"}],"urls":[{"start":107,"end":129,"url":"http://t.co/EeWfyMms98","expanded_url":"http://goo.gl/QbTlLA","display_url":"goo.gl/QbTlLA"}]},"conversation_id":"527486344994357251","source":"TweetDeck","public_metrics":{"retweet_count":49,"reply_count":2,"like_count":22,"quote_count":0},"lang":"en","text":"WHO strongly recommends acceleration of Phase III trials to inform future policy on delamanid drug for #TB http://t.co/EeWfyMms98","id":"527486344994357251","possibly_sensitive":false,"created_at":"2014-10-29T15:45:19.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":53,"end":68,"probability":0.6267,"type":"Person","normalized_text":"Dr Bruce Aylward"}],"hashtags":[{"start":24,"end":30,"tag":"Ebola"}],"urls":[{"start":70,"end":92,"url":"http://t.co/N9aWGiENay","expanded_url":"http://goo.gl/zvTjlR","display_url":"goo.gl/zvTjlR"}]},"conversation_id":"527485457635217408","source":"Twitter Web Client","public_metrics":{"retweet_count":53,"reply_count":6,"like_count":27,"quote_count":0},"lang":"en","text":"Audio file from today's #Ebola press conference with Dr Bruce Aylward http://t.co/N9aWGiENay","id":"527485457635217408","possibly_sensitive":false,"created_at":"2014-10-29T15:41:47.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":15,"end":18,"tag":"TB"}],"urls":[{"start":89,"end":111,"url":"http://t.co/EeWfyMms98","expanded_url":"http://goo.gl/QbTlLA","display_url":"goo.gl/QbTlLA"}]},"conversation_id":"527485267536384003","source":"TweetDeck","public_metrics":{"retweet_count":41,"reply_count":3,"like_count":17,"quote_count":0},"lang":"en","text":"Info about new #TB drug delamanid is limited. WHO is therefore issuing interim guidance: http://t.co/EeWfyMms98","id":"527485267536384003","possibly_sensitive":false,"created_at":"2014-10-29T15:41:02.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":6,"end":9,"tag":"TB"}],"urls":[{"start":93,"end":115,"url":"http://t.co/EeWfyMms98","expanded_url":"http://goo.gl/QbTlLA","display_url":"goo.gl/QbTlLA"}]},"conversation_id":"527484279870083072","source":"TweetDeck","public_metrics":{"retweet_count":171,"reply_count":3,"like_count":79,"quote_count":0},"lang":"en","text":"A new #TB drug, delamanid, is now available and approved for treatment of adults with MDR-TB http://t.co/EeWfyMms98","id":"527484279870083072","possibly_sensitive":false,"created_at":"2014-10-29T15:37:07.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":94,"end":106,"tag":"RareDisease"}],"urls":[{"start":71,"end":93,"url":"http://t.co/6qyuiOTkyt","expanded_url":"http://ow.ly/Dt08Z","display_url":"ow.ly/Dt08Z"}]},"conversation_id":"527476290207887361","source":"Hootsuite","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"lang":"ro","text":"New video series for primary doctors on Lymphangioleiomyomatosis (LAM) http://t.co/6qyuiOTkyt\n#RareDisease","id":"527476290207887361","possibly_sensitive":false,"created_at":"2014-10-29T15:05:22.000Z","author_id":"26993786","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":67,"end":79,"tag":"raredisease"}],"urls":[{"start":101,"end":123,"url":"http://t.co/0Kncs63QlE","expanded_url":"http://ow.ly/Dsu87","display_url":"ow.ly/Dsu87"}]},"conversation_id":"527457442104610816","source":"Hootsuite","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Applications open for ExPRESS 2015, the EURORDIS Summer School for #raredisease patient empowerment! http://t.co/0Kncs63QlE","id":"527457442104610816","possibly_sensitive":false,"created_at":"2014-10-29T13:50:28.000Z","author_id":"26993786","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":18,"tag":"ResearchHeadlines"},{"start":64,"end":72,"tag":"Cancers"}],"urls":[{"start":116,"end":138,"url":"http://t.co/yAx5GY4mlS","expanded_url":"http://dlvr.it/7M5lKZ","display_url":"dlvr.it/7M5lKZ"}]},"conversation_id":"527451667654922240","source":"dlvr.it","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#ResearchHeadlines - New tests aim to detect breast and ovarian #Cancers earlier: The EU-funded project EPIFEMCARE‚Ä¶ http://t.co/yAx5GY4mlS","id":"527451667654922240","possibly_sensitive":false,"created_at":"2014-10-29T13:27:31.000Z","author_id":"193301414","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":21,"end":40,"probability":0.3049,"type":"Organization","normalized_text":"Commissioner Hamburg"},{"start":45,"end":47,"probability":0.8226,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":0,"end":9,"tag":"FDAVoice"},{"start":93,"end":99,"tag":"Ebola"}],"urls":[{"start":100,"end":122,"url":"http://t.co/uIQW5yBOmt","expanded_url":"http://go.usa.gov/7qQh","display_url":"go.usa.gov/7qQh"}]},"conversation_id":"527442140205690880","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#FDAVoice: Hear from Commissioner Hamburg on FDA as part of a coordinated global response on #Ebola http://t.co/uIQW5yBOmt","id":"527442140205690880","possibly_sensitive":false,"created_at":"2014-10-29T12:49:40.000Z","author_id":"1606025952","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":22,"end":36,"username":"NICESciAdvice","id":"2834291205"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"527428397094678528","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"Follow our colleagues @NICESciAdvice who provide fee-for-service advice to pharmaceutical companies and device manufacturers","id":"527428397094678528","possibly_sensitive":false,"created_at":"2014-10-29T11:55:03.000Z","author_id":"85555796","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.8626,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":48,"end":54,"tag":"Ebola"},{"start":78,"end":82,"tag":"fda"},{"start":83,"end":97,"tag":"medicaldevice"}],"urls":[{"start":55,"end":77,"url":"http://t.co/4eHux5e2kG","expanded_url":"http://1.usa.gov/1thoF1i","display_url":"1.usa.gov/1thoF1i"}]},"conversation_id":"527415102031794177","source":"Hootsuite","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"FDA as part of a coordinated global response on #Ebola http://t.co/4eHux5e2kG #fda #medicaldevice","id":"527415102031794177","possibly_sensitive":false,"created_at":"2014-10-29T11:02:13.000Z","author_id":"140427956","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":68,"end":78,"probability":0.4183,"type":"Place","normalized_text":"Rome, Italy"}],"hashtags":[{"start":41,"end":53,"tag":"RareDisease"}],"urls":[{"start":80,"end":102,"url":"http://t.co/LKzsnJfh0M","expanded_url":"http://ow.ly/DcYZL","display_url":"ow.ly/DcYZL"}]},"conversation_id":"527380646336163840","source":"Hootsuite","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"E-Rare Symposium (Research Programmes on #RareDisease): 30 October, Rome, Italy http://t.co/LKzsnJfh0M","id":"527380646336163840","possibly_sensitive":false,"created_at":"2014-10-29T08:45:19.000Z","author_id":"26993786","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/9vH4qGu3Xy","expanded_url":"http://ow.ly/DtpHr","display_url":"ow.ly/DtpHr"},{"start":91,"end":113,"url":"http://t.co/l32PbeSiYB","expanded_url":"http://ow.ly/i/7nuw8","display_url":"ow.ly/i/7nuw8"}]},"conversation_id":"527137709174042624","source":"Hootsuite","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":4,"quote_count":0},"lang":"en","text":"Mixing medications and dietary supplements can endanger your health http://t.co/9vH4qGu3Xy http://t.co/l32PbeSiYB","id":"527137709174042624","possibly_sensitive":false,"created_at":"2014-10-28T16:39:58.000Z","author_id":"65416742","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":18,"end":24,"tag":"PhEur"},{"start":66,"end":76,"tag":"bacterial"},{"start":77,"end":88,"tag":"endotoxins"}],"urls":[{"start":111,"end":133,"url":"http://t.co/8cAhid7Nb1","expanded_url":"http://bit.ly/ZVCHeK","display_url":"bit.ly/ZVCHeK"}]},"conversation_id":"527037700168495104","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"In June 2014, the #PhEur Commission recommended two approaches to #bacterial #endotoxins. Read the new policy: http://t.co/8cAhid7Nb1","id":"527037700168495104","possibly_sensitive":false,"created_at":"2014-10-28T10:02:34.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":62,"end":84,"url":"http://t.co/JxOjxsHvun","expanded_url":"http://iapo.org.uk/membership","display_url":"iapo.org.uk/membership"}]},"conversation_id":"527068587434213376","source":"Hootsuite","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Interested in becoming an IAPO member? Want to find out more? http://t.co/JxOjxsHvun","id":"527068587434213376","possibly_sensitive":false,"created_at":"2014-10-28T12:05:18.000Z","author_id":"180728609","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4904,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":61,"end":80,"tag":"gynaecologiccancer"}],"urls":[{"start":81,"end":103,"url":"http://t.co/ffxcQRlwr9","expanded_url":"http://ow.ly/DpwH8","display_url":"ow.ly/DpwH8"}]},"conversation_id":"526782458696855552","source":"Hootsuite","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":3,"quote_count":0},"lang":"en","text":"EMA recommends granting marketing authorisation for olaparib #gynaecologiccancer http://t.co/ffxcQRlwr9","id":"526782458696855552","possibly_sensitive":false,"created_at":"2014-10-27T17:08:19.000Z","author_id":"69232855","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":9,"tag":"EDQM"}],"urls":[{"start":111,"end":133,"url":"http://t.co/X5HJAfygZd","expanded_url":"http://bit.ly/1wBMEux","display_url":"bit.ly/1wBMEux"}]},"conversation_id":"526778610733318144","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #EDQM Standard Terms database has undergone major revision for greater flexibility. Read about the launch: http://t.co/X5HJAfygZd","id":"526778610733318144","possibly_sensitive":false,"created_at":"2014-10-27T16:53:02.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":66,"end":88,"url":"http://t.co/LbHKMMBY5z","expanded_url":"http://go.usa.gov/GHBz","display_url":"go.usa.gov/GHBz"}]},"conversation_id":"526764866464649217","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Learn about challenges in neonatal research and drug development: http://t.co/LbHKMMBY5z","id":"526764866464649217","possibly_sensitive":false,"created_at":"2014-10-27T15:58:25.000Z","author_id":"53039176","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":24,"end":30,"tag":"Ebola"}],"urls":[{"start":122,"end":144,"url":"http://t.co/kPxKLmHTZ8","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000624.jsp&mid=WC0b01ac0580841e30","display_url":"ema.europa.eu/ema/index.jsp?‚Ä¶"}]},"conversation_id":"526750580136763392","source":"iOS","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"@EMA_News publishes new #Ebola microsite on its actions since the outbreak, including R&amp;D support for new treatments  http://t.co/kPxKLmHTZ8","id":"526750580136763392","possibly_sensitive":false,"created_at":"2014-10-27T15:01:39.000Z","author_id":"113148426","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"116716199"},{"entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":121,"end":143,"url":"http://t.co/7hGyKcyirO","expanded_url":"http://bit.ly/1t9jZdU","display_url":"bit.ly/1t9jZdU"}]},"conversation_id":"526745250371358720","source":"Twitter for Websites","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The @EMA_News has reviewed safety&amp;effectiveness of products containing antibiotics colistin or colistimethate sodium http://t.co/7hGyKcyirO","id":"526745250371358720","possibly_sensitive":false,"created_at":"2014-10-27T14:40:28.000Z","author_id":"203357203","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":1,"probability":0.5722,"type":"Organization","normalized_text":"EU"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/cVXauXDtWu","expanded_url":"http://europa.eu/!Yt78Gu","display_url":"europa.eu/!Yt78Gu"}]},"conversation_id":"526743262950727680","source":"Twitter for Websites","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EU to boost Ebola research with ‚Ç¨24.4 million funding for 5 projects including large scale clinical trial of vaccine http://t.co/cVXauXDtWu","id":"526743262950727680","possibly_sensitive":false,"created_at":"2014-10-27T14:32:34.000Z","author_id":"203357203","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":14,"end":23,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/pGgIFN4L3S","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002191.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?‚Ä¶"}]},"conversation_id":"526741652895854592","source":"Twitter for Websites","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last week the @EMA_News CHMP recommended 6 new medicines for approval including 2 for orphan conditions http://t.co/pGgIFN4L3S","id":"526741652895854592","possibly_sensitive":false,"created_at":"2014-10-27T14:26:11.000Z","author_id":"203357203","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":83,"end":105,"url":"http://t.co/bC4iDIgy9v","expanded_url":"http://echo4.bluehornet.com/hostedemail/email.htm?CID=28259787330&ch=B519CE01120E3291691BEF45053446FE&h=e17ba255205a0f3318ff5ecbdee68cb1&ei=TDTbmrm0N","display_url":"echo4.bluehornet.com/hostedemail/em‚Ä¶"}]},"conversation_id":"526740485730488321","source":"iOS","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last Chance: How is the New Draft OASIS eTMF Standards Applied in Clinical Trials? http://t.co/bC4iDIgy9v","id":"526740485730488321","possibly_sensitive":false,"created_at":"2014-10-27T14:21:32.000Z","author_id":"28870127","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":16,"tag":"50thanniversary"},{"start":49,"end":54,"tag":"EDQM"}],"urls":[{"start":112,"end":134,"url":"http://t.co/ijWHOSe4Ts","expanded_url":"http://bit.ly/1tZ6l0y","display_url":"bit.ly/1tZ6l0y"}]},"conversation_id":"526740442982133760","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#50thanniversary conference recommendations help #EDQM better understand issues and determine direction to take http://t.co/ijWHOSe4Ts","id":"526740442982133760","possibly_sensitive":false,"created_at":"2014-10-27T14:21:22.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":4,"end":8,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":35,"end":41,"tag":"Ebola"},{"start":42,"end":51,"tag":"Vaccines"}],"urls":[{"start":75,"end":97,"url":"http://t.co/iFjMC1G6af","expanded_url":"http://apne.ws/1tZ3F2Z","display_url":"apne.ws/1tZ3F2Z"}]},"conversation_id":"526735435889139712","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The @WHO Could Deploy Experimental #Ebola #Vaccines To ‚ÄúMillions‚Äù In 2015. http://t.co/iFjMC1G6af","id":"526735435889139712","possibly_sensitive":false,"created_at":"2014-10-27T14:01:28.000Z","author_id":"28870127","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":82,"end":98,"username":"ECspokesScience","id":"613378164"}],"annotations":{},"hashtags":[{"start":0,"end":3,"tag":"EU"},{"start":99,"end":105,"tag":"H2020"}],"urls":[{"start":59,"end":81,"url":"http://t.co/xHPjfVF5Y9","expanded_url":"http://europa.eu/!Mt46gR","display_url":"europa.eu/!Mt46gR"}]},"conversation_id":"526733405229428736","source":"Hootsuite","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"#EU breast cancer research targets personalised treatment: http://t.co/xHPjfVF5Y9 @ECSpokesScience #H2020","id":"526733405229428736","possibly_sensitive":false,"created_at":"2014-10-27T13:53:24.000Z","author_id":"157981564","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":54,"end":63,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":22,"end":26,"tag":"ADR"},{"start":88,"end":103,"tag":"EudraVigilance"}],"urls":[{"start":65,"end":87,"url":"http://t.co/c7mjJz4bcy","expanded_url":"http://youtu.be/PFgXKjChUgQ","display_url":"youtu.be/PFgXKjChUgQ"}]},"conversation_id":"526685715997143040","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"\"Increasing access to #ADR reports on the Web\" by the @EMA_News  http://t.co/c7mjJz4bcy #EudraVigilance","id":"526685715997143040","possibly_sensitive":false,"created_at":"2014-10-27T10:43:54.000Z","author_id":"420241833","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":11,"end":17,"username":"EFPIA","id":"52084584"},{"start":24,"end":35,"username":"HCWHeurope","id":"282063958"}],"annotations":{},"hashtags":[{"start":108,"end":118,"tag":"PieDebate"}],"urls":[{"start":85,"end":107,"url":"http://t.co/4shw5EpW9C","expanded_url":"http://bit.ly/1wB4TA3","display_url":"bit.ly/1wB4TA3"}]},"conversation_id":"526682202504200192","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"PR ALERT - @EFPIA &amp; @HCWHeurope joint Press Release on pharma in the environment http://t.co/4shw5EpW9C #PieDebate","id":"526682202504200192","possibly_sensitive":false,"created_at":"2014-10-27T10:29:57.000Z","author_id":"52084584","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":18,"tag":"ResearchHeadlines"},{"start":53,"end":60,"tag":"Cancer"}],"urls":[{"start":116,"end":138,"url":"http://t.co/FHY9MoSbTf","expanded_url":"http://dlvr.it/7KqTwC","display_url":"dlvr.it/7KqTwC"}]},"conversation_id":"526656697641598976","source":"dlvr.it","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#ResearchHeadlines - New horizons in treating breast #Cancer: Today, in most developed countries, a woman‚Äôs chance‚Ä¶ http://t.co/FHY9MoSbTf","id":"526656697641598976","possibly_sensitive":false,"created_at":"2014-10-27T08:48:36.000Z","author_id":"193301414","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/3q3rBlsqYn","expanded_url":"http://echa.europa.eu/websurvey-2014","display_url":"echa.europa.eu/websurvey-2014"},{"start":98,"end":120,"url":"http://t.co/JV31bvq3TJ","expanded_url":"https://twitter.com/EU_ECHA/status/526656172741255170/photo/1","display_url":"pic.twitter.com/JV31bvq3TJ"}]},"conversation_id":"526656172741255170","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Still time until 4 November to share your views with us about our website. http://t.co/3q3rBlsqYn http://t.co/JV31bvq3TJ","id":"526656172741255170","possibly_sensitive":false,"created_at":"2014-10-27T08:46:31.000Z","author_id":"331604970","attachments":{"media_keys":["3_526656171071897600"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":30,"end":40,"username":"JunckerEU","id":"169426475"}],"annotations":{},"hashtags":[{"start":15,"end":29,"tag":"Pharma4health"},{"start":57,"end":64,"tag":"pharma"},{"start":79,"end":86,"tag":"health"}],"urls":[{"start":97,"end":119,"url":"http://t.co/dC29wtoEI9","expanded_url":"http://bit.ly/1wo4yil","display_url":"bit.ly/1wo4yil"}]},"conversation_id":"524902409085399040","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Breaking news! #Pharma4health @JunckerEU decides to keep #pharma policy in the #health portfolio http://t.co/dC29wtoEI9","id":"524902409085399040","possibly_sensitive":false,"created_at":"2014-10-22T12:37:41.000Z","author_id":"440810430","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.8976,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":85,"end":91,"tag":"Ebola"}],"urls":[{"start":104,"end":126,"url":"http://t.co/tmJRSptCYC","expanded_url":"http://ht.ly/D3vQ9","display_url":"ht.ly/D3vQ9"}]},"conversation_id":"524908716341342209","source":"Hootsuite","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":8,"quote_count":0},"lang":"en","text":"FDA actively using orphan designation (+ other programs) to encourage development of #Ebola treatments. http://t.co/tmJRSptCYC","id":"524908716341342209","possibly_sensitive":false,"created_at":"2014-10-22T13:02:44.000Z","author_id":"1606025952","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"CallForData"},{"start":21,"end":28,"tag":"oxides"},{"start":33,"end":44,"tag":"hydroxides"}],"urls":[{"start":73,"end":95,"url":"http://t.co/zPY9wXvVAT","expanded_url":"http://bit.ly/1wjGopW","display_url":"bit.ly/1wjGopW"}]},"conversation_id":"524923136366882817","source":"Clarabridge Engage","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#CallForData on iron #oxides and #hydroxides (E 172) permitted in the EU http://t.co/zPY9wXvVAT","id":"524923136366882817","possibly_sensitive":false,"created_at":"2014-10-22T14:00:02.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":75,"end":91,"tag":"hyperthyroidism"}],"urls":[{"start":92,"end":114,"url":"http://t.co/b1lf65CXyF","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0254","display_url":"dx.doi.org/10.1530/EJE-14‚Ä¶"}]},"conversation_id":"524930233430835201","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"Juliette Abeillon-du Payrat et al. investigate factors predicting neonatal #hyperthyroidism http://t.co/b1lf65CXyF","id":"524930233430835201","possibly_sensitive":false,"created_at":"2014-10-22T14:28:15.000Z","author_id":"221055586","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":125,"end":136,"tag":"employment"}],"urls":[{"start":102,"end":124,"url":"http://t.co/kGntfgE56x","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}]},"conversation_id":"524936696606257152","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One day left to find our next Junior Laboratory Technician! Read the job description and apply today: http://t.co/kGntfgE56x #employment","id":"524936696606257152","possibly_sensitive":false,"created_at":"2014-10-22T14:53:55.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":14,"end":24,"tag":"influenza"},{"start":25,"end":31,"tag":"virus"},{"start":68,"end":75,"tag":"ribfp7"}],"urls":[{"start":45,"end":67,"url":"http://t.co/IGQDO52MFR","expanded_url":"http://cordis.europa.eu/result/rcn/148965_en.html","display_url":"cordis.europa.eu/result/rcn/148‚Ä¶"}]},"conversation_id":"524939718841339906","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Understanding #influenza #virus transmission http://t.co/IGQDO52MFR #ribfp7","id":"524939718841339906","possibly_sensitive":false,"created_at":"2014-10-22T15:05:56.000Z","author_id":"106364904","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":58,"end":80,"url":"http://t.co/BKx8KDkbHn","expanded_url":"http://us8.campaign-archive2.com/?u=7864f766b10b8edd18f19aa56&id=59ce8b4d76&e=bc4d5ec78c","display_url":"us8.campaign-archive2.com/?u=7864f766b10‚Ä¶"}]},"conversation_id":"524941966170411010","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The October issue of our newsletter NICE News is out now: http://t.co/BKx8KDkbHn","id":"524941966170411010","possibly_sensitive":false,"created_at":"2014-10-22T15:14:52.000Z","author_id":"85555796","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":33,"end":41,"username":"IHF_FIH","id":"1154042060"}],"annotations":{},"hashtags":{},"urls":[{"start":106,"end":128,"url":"http://t.co/Pbt2EO7MDO","expanded_url":"http://ow.ly/Datbo","display_url":"ow.ly/Datbo"}]},"conversation_id":"524948067716726784","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"New resource! Joint journal with @IHF_FIH on patient engagement in hospitals, full of great case studies: http://t.co/Pbt2EO7MDO","id":"524948067716726784","possibly_sensitive":false,"created_at":"2014-10-22T15:39:07.000Z","author_id":"180728609","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":81,"end":116,"probability":0.2495,"type":"Organization","normalized_text":"Anti-TB Drug Resistance Surveillance"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/v6aEhA59Zt","expanded_url":"http://goo.gl/QbqCWl","display_url":"goo.gl/QbqCWl"}]},"conversation_id":"524915856846094336","source":"Twitter Web Client","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":11,"quote_count":0},"lang":"en","text":"Supplement that marks 20th anniversary of establishment of the Global Project on Anti-TB Drug Resistance Surveillance http://t.co/v6aEhA59Zt","id":"524915856846094336","possibly_sensitive":false,"created_at":"2014-10-22T13:31:07.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":91,"end":113,"url":"http://t.co/rt1gOg3nUK","expanded_url":"http://bit.ly/1nyZdoF","display_url":"bit.ly/1nyZdoF"},{"start":114,"end":136,"url":"http://t.co/yVbPeN8N2p","expanded_url":"https://twitter.com/EU_ECHA/status/524920248391462913/photo/1","display_url":"pic.twitter.com/yVbPeN8N2p"}]},"conversation_id":"524920248391462913","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"New webpages for formulators launched with useful information to fulfil their obligations. http://t.co/rt1gOg3nUK http://t.co/yVbPeN8N2p","id":"524920248391462913","possibly_sensitive":false,"created_at":"2014-10-22T13:48:34.000Z","author_id":"331604970","attachments":{"media_keys":["3_524920246872707072"]},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":44,"end":47,"tag":"TB"}],"urls":{}},"conversation_id":"524587094086533120","source":"Twitter Web Client","public_metrics":{"retweet_count":92,"reply_count":3,"like_count":29,"quote_count":0},"lang":"en","text":"Multidrug-resistant tuberculosis is form of #TB caused by bacteria that don't respond at least to the 2 most powerful standard anti-TB drugs","id":"524587094086533120","possibly_sensitive":false,"created_at":"2014-10-21T15:44:44.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/Vjn795zwD7","expanded_url":"http://bit.ly/QOUdwT","display_url":"bit.ly/QOUdwT"}]},"conversation_id":"524578280792670208","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Over 200 experts across the world participate in the scientific workshop on nanomaterials this week. Read more at: http://t.co/Vjn795zwD7","id":"524578280792670208","possibly_sensitive":false,"created_at":"2014-10-21T15:09:42.000Z","author_id":"331604970","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":29,"end":42,"username":"sureclinical","id":"1210298131"}],"annotations":{},"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/5vgWkTfjZ0","expanded_url":"http://bit.ly/1t8pifW","display_url":"bit.ly/1t8pifW"},{"start":117,"end":139,"url":"http://t.co/k77rKMt2EU","expanded_url":"https://twitter.com/DrugInfoAssn/status/524571458924982272/photo/1","display_url":"pic.twitter.com/k77rKMt2EU"}]},"conversation_id":"524571458924982272","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Join DIA in cooperation with @sureclinical 10/28 for a complementary webinar - sign up today! http://t.co/5vgWkTfjZ0 http://t.co/k77rKMt2EU","id":"524571458924982272","possibly_sensitive":false,"created_at":"2014-10-21T14:42:36.000Z","author_id":"28870127","attachments":{"media_keys":["3_524571458115485696"]},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":99,"end":106,"probability":0.5652,"type":"Place","normalized_text":"Brussels"}],"hashtags":[{"start":14,"end":25,"tag":"Innovation"}],"urls":[{"start":115,"end":137,"url":"http://t.co/OAmQhtUnoL","expanded_url":"http://dlvr.it/7Gqs5q","display_url":"dlvr.it/7Gqs5q"}]},"conversation_id":"524570311266549760","source":"dlvr.it","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Fast Track to #Innovation Pilot (2015-2016) A Free Interactive Information Event - 9 January 2015, Brussels: This‚Ä¶ http://t.co/OAmQhtUnoL","id":"524570311266549760","possibly_sensitive":false,"created_at":"2014-10-21T14:38:02.000Z","author_id":"193301414","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/0gmOIwPFSC","expanded_url":"http://bit.ly/1yUHtYY","display_url":"bit.ly/1yUHtYY"}]},"conversation_id":"524566585202057216","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Attend as an observer EFSA‚Äôs meeting on Biological Hazards. Register by 18 Nov http://t.co/0gmOIwPFSC","id":"524566585202057216","possibly_sensitive":false,"created_at":"2014-10-21T14:23:14.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":11,"end":19,"tag":"ESCAIDE"}],"urls":[{"start":122,"end":144,"url":"http://t.co/P5oLJNxsOd","expanded_url":"http://bit.ly/1t3Nxv4","display_url":"bit.ly/1t3Nxv4"}]},"conversation_id":"524521747106643968","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"2 weeks to #ESCAIDE, register online by 27 Oct. This year: special sessions on Ebola &amp; on cross-border health threats http://t.co/P5oLJNxsOd","id":"524521747106643968","possibly_sensitive":false,"created_at":"2014-10-21T11:25:04.000Z","author_id":"204752573","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9148,"type":"Person","normalized_text":"Dr Kieny"},{"start":100,"end":105,"probability":0.9854,"type":"Place","normalized_text":"Africa"}],"hashtags":[{"start":40,"end":46,"tag":"Ebola"}],"urls":{}},"conversation_id":"524512126074114048","source":"Twitter for iPhone","public_metrics":{"retweet_count":74,"reply_count":3,"like_count":21,"quote_count":0},"lang":"en","text":"Dr Kieny: Clinical trials for candidate #Ebola vaccine safety in children will likely take place in Africa","id":"524512126074114048","possibly_sensitive":false,"created_at":"2014-10-21T10:46:50.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9193,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":46,"end":52,"tag":"Ebola"}],"urls":{}},"conversation_id":"524511641179004928","source":"Twitter for iPhone","public_metrics":{"retweet_count":59,"reply_count":4,"like_count":20,"quote_count":0},"lang":"en","text":"Dr Kieny: Volunteers to the current candidate #Ebola vaccine clinical trials are healthy adults, 18-65 years old","id":"524511641179004928","possibly_sensitive":false,"created_at":"2014-10-21T10:44:54.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9387,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":70,"end":76,"tag":"Ebola"}],"urls":{}},"conversation_id":"524511040537886720","source":"Twitter for iPhone","public_metrics":{"retweet_count":67,"reply_count":6,"like_count":32,"quote_count":0},"lang":"en","text":"Dr Kieny: Normal development of a vaccine takes years. Development of #Ebola vaccines has been accelerated","id":"524511040537886720","possibly_sensitive":false,"created_at":"2014-10-21T10:42:31.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9646,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":25,"end":31,"tag":"Ebola"},{"start":35,"end":42,"tag":"taking"},{"start":57,"end":63,"tag":"Ebola"}],"urls":{}},"conversation_id":"524509509382078464","source":"Twitter for iPhone","public_metrics":{"retweet_count":56,"reply_count":5,"like_count":16,"quote_count":0},"lang":"en","text":"Dr Kieny: You cannot get #Ebola by #taking the candidate #Ebola vaccines","id":"524509509382078464","possibly_sensitive":false,"created_at":"2014-10-21T10:36:26.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.915,"type":"Person","normalized_text":"Dr Kieny"},{"start":53,"end":60,"probability":0.9805,"type":"Place","normalized_text":"Lausanne"}],"hashtags":[{"start":35,"end":41,"tag":"Ebola"}],"urls":{}},"conversation_id":"524509030535159808","source":"Twitter for iPhone","public_metrics":{"retweet_count":61,"reply_count":0,"like_count":13,"quote_count":0},"lang":"en","text":"Dr Kieny: Volunteers for candidate #Ebola vaccine in Lausanne to receive 2 doses; in Geneva 5 doses [different candidate vaccines]","id":"524509030535159808","possibly_sensitive":false,"created_at":"2014-10-21T10:34:32.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9274,"type":"Person","normalized_text":"Dr Kieny"},{"start":109,"end":119,"probability":0.9936,"type":"Place","normalized_text":"Switzerland"},{"start":122,"end":137,"probability":0.493,"type":"Place","normalized_text":"Lausanne, Geneva"}],"hashtags":[{"start":46,"end":52,"tag":"Ebola"}],"urls":{}},"conversation_id":"524508503537614848","source":"Twitter for iPhone","public_metrics":{"retweet_count":88,"reply_count":2,"like_count":23,"quote_count":0},"lang":"en","text":"Dr Kieny: Clinical trials from lead candidate #Ebola vaccines to involve abt 250 volunteers. Half of them in Switzerland (Lausanne, Geneva)","id":"524508503537614848","possibly_sensitive":false,"created_at":"2014-10-21T10:32:26.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.8882,"type":"Person","normalized_text":"Dr Kieny"},{"start":87,"end":97,"probability":0.9505,"type":"Place","normalized_text":"West Africa"}],"hashtags":[{"start":10,"end":16,"tag":"Ebola"}],"urls":{}},"conversation_id":"524507331208683520","source":"Twitter for iPhone","public_metrics":{"retweet_count":244,"reply_count":28,"like_count":115,"quote_count":0},"lang":"en","text":"Dr Kieny: #Ebola vaccine [once clinical trials are completed] is expected to be use in West Africa early 2015","id":"524507331208683520","possibly_sensitive":false,"created_at":"2014-10-21T10:27:47.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9436,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":91,"end":97,"tag":"Ebola"}],"urls":{}},"conversation_id":"524506852361789440","source":"Twitter for iPhone","public_metrics":{"retweet_count":29,"reply_count":1,"like_count":14,"quote_count":0},"lang":"en","text":"Dr Kieny: People [live in the countries mentioned earlier] can volunteer for the candidate #Ebola vaccine clinical trials","id":"524506852361789440","possibly_sensitive":false,"created_at":"2014-10-21T10:25:53.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9363,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":42,"end":48,"tag":"Ebola"}],"urls":{}},"conversation_id":"524506010351042560","source":"Twitter for iPhone","public_metrics":{"retweet_count":72,"reply_count":3,"like_count":27,"quote_count":0},"lang":"en","text":"Dr Kieny: Initial data from the candidate #Ebola vaccine clinical trials are expected to be available in December","id":"524506010351042560","possibly_sensitive":false,"created_at":"2014-10-21T10:22:32.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9303,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":46,"end":52,"tag":"Ebola"}],"urls":{}},"conversation_id":"524505448708599808","source":"Twitter for iPhone","public_metrics":{"retweet_count":49,"reply_count":1,"like_count":28,"quote_count":0},"lang":"en","text":"Dr Kieny: What's important from the candidate #Ebola vaccine clinical trials are not only safety, but also to know the right dose level","id":"524505448708599808","possibly_sensitive":false,"created_at":"2014-10-21T10:20:18.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9364,"type":"Person","normalized_text":"Dr Kieny"},{"start":85,"end":88,"probability":0.9889,"type":"Place","normalized_text":"U.S."},{"start":96,"end":102,"probability":0.9976,"type":"Place","normalized_text":"Germany"},{"start":105,"end":115,"probability":0.9824,"type":"Place","normalized_text":"Switzerland"},{"start":127,"end":131,"probability":0.8302,"type":"Place","normalized_text":"Gabon"},{"start":134,"end":138,"probability":0.9135,"type":"Place","normalized_text":"Kenya"}],"hashtags":[{"start":23,"end":29,"tag":"Ebola"}],"urls":{}},"conversation_id":"524503964042420224","source":"Twitter for iPhone","public_metrics":{"retweet_count":50,"reply_count":2,"like_count":23,"quote_count":0},"lang":"en","text":"Dr Kieny: Another lead #Ebola vax - which was donated to WHO, clinical trials in the U.S., also Germany, Switzerland (Geneva), Gabon, Kenya","id":"524503964042420224","possibly_sensitive":false,"created_at":"2014-10-21T10:14:24.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.9528,"type":"Person","normalized_text":"Dr Kieny"},{"start":89,"end":92,"probability":0.9488,"type":"Place","normalized_text":"U.S."},{"start":95,"end":100,"probability":0.7028,"type":"Place","normalized_text":"Oxford"},{"start":103,"end":106,"probability":0.7686,"type":"Place","normalized_text":"Mali"},{"start":112,"end":119,"probability":0.9625,"type":"Place","normalized_text":"Lausanne"},{"start":122,"end":132,"probability":0.7655,"type":"Place","normalized_text":"Switzerland"}],"hashtags":[{"start":32,"end":38,"tag":"Ebola"}],"urls":{}},"conversation_id":"524503318778089472","source":"Twitter for iPhone","public_metrics":{"retweet_count":113,"reply_count":9,"like_count":65,"quote_count":0},"lang":"en","text":"Dr Kieny: One of lead candidate #Ebola vax is currently going thru clinical trial in the U.S., Oxford, Mali. In Lausanne, Switzerland in Nov","id":"524503318778089472","possibly_sensitive":false,"created_at":"2014-10-21T10:11:50.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.6538,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":60,"end":66,"tag":"Ebola"}],"urls":[{"start":101,"end":123,"url":"http://t.co/w5tQrEbNsy","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002190.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?‚Ä¶"}]},"conversation_id":"524502611505213440","source":"Twitter for iPhone","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"EMA encourages developers of treatments or vaccines against #Ebola to apply for orphan designation.  http://t.co/w5tQrEbNsy","id":"524502611505213440","possibly_sensitive":false,"created_at":"2014-10-21T10:09:02.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":47,"tag":"nanotechnology"},{"start":58,"end":67,"tag":"zoonoses"}],"urls":[{"start":99,"end":121,"url":"http://t.co/G9Bspraq7F","expanded_url":"http://bit.ly/1yUck84","display_url":"bit.ly/1yUck84"},{"start":122,"end":144,"url":"http://t.co/nQ9YYZuK8A","expanded_url":"http://bit.ly/1pwlCi4","display_url":"bit.ly/1pwlCi4"}]},"conversation_id":"524497058586046464","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Networks for risk assessment of #nanotechnology &amp; for #zoonoses monitoring meet today.Agendas: http://t.co/G9Bspraq7F http://t.co/nQ9YYZuK8A","id":"524497058586046464","possibly_sensitive":false,"created_at":"2014-10-21T09:46:58.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":60,"tag":"Pharmacovigilance"},{"start":61,"end":66,"tag":"ISoP"}],"urls":[{"start":67,"end":89,"url":"http://t.co/cc00rRFQii","expanded_url":"http://youtu.be/GOrE7Bf_PKQ","display_url":"youtu.be/GOrE7Bf_PKQ"}]},"conversation_id":"524492377788907520","source":"Twitter for Websites","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"The story of the International Society of #Pharmacovigilance #ISoP http://t.co/cc00rRFQii","id":"524492377788907520","possibly_sensitive":false,"created_at":"2014-10-21T09:28:22.000Z","author_id":"420241833","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":35,"end":38,"tag":"EU"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ut5Pk6dkD2","expanded_url":"http://goo.gl/hlle2R","display_url":"goo.gl/hlle2R"}]},"conversation_id":"524476674281574400","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Info. on suspected side effects of #EU nationally authorised medicines now available in 1 website maintained by EMA http://t.co/ut5Pk6dkD2","id":"524476674281574400","possibly_sensitive":false,"created_at":"2014-10-21T08:25:58.000Z","author_id":"69232855","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":38,"end":49,"username":"HCWHeurope","id":"282063958"}],"annotations":{},"hashtags":[{"start":101,"end":111,"tag":"PieDebate"}],"urls":[{"start":112,"end":134,"url":"http://t.co/I8HERrdFcW","expanded_url":"http://bit.ly/1w0TA5E","display_url":"bit.ly/1w0TA5E"}]},"conversation_id":"524475638821191680","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Finding Solutions Together: EFPIA and @HCWHEurope Meet to Discuss Pharmaceuticals in the Environment #PieDebate http://t.co/I8HERrdFcW","id":"524475638821191680","possibly_sensitive":false,"created_at":"2014-10-21T08:21:51.000Z","author_id":"52084584","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.7677,"type":"Organization","normalized_text":"BBC News"},{"start":25,"end":26,"probability":0.8389,"type":"Place","normalized_text":"UK"}],"hashtags":{},"urls":[{"start":51,"end":73,"url":"http://t.co/1rqxnOVu6A","expanded_url":"http://www.bbc.com/news/health-29700476","display_url":"bbc.com/news/health-29‚Ä¶"}]},"conversation_id":"524465314822897664","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"BBC News | Ebola crisis: UK vaccine tests continue http://t.co/1rqxnOVu6A","id":"524465314822897664","possibly_sensitive":false,"created_at":"2014-10-21T07:40:49.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":78,"end":88,"username":"FP7MABSOT","id":"1417699849"}],"annotations":{},"hashtags":[{"start":13,"end":24,"tag":"antibodies"},{"start":35,"end":41,"tag":"organ"},{"start":42,"end":54,"tag":"transplants"}],"urls":[{"start":55,"end":77,"url":"http://t.co/DG9phvUaZp","expanded_url":"http://cordis.europa.eu/news/rcn/121899_en.html","display_url":"cordis.europa.eu/news/rcn/12189‚Ä¶"}]},"conversation_id":"524462913508356096","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Neutralising #antibodies for safer #organ #transplants http://t.co/DG9phvUaZp @FP7MABSOT","id":"524462913508356096","possibly_sensitive":false,"created_at":"2014-10-21T07:31:17.000Z","author_id":"106364904","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":130,"end":144,"username":"unibirmingham","id":"17865542"}],"annotations":{},"hashtags":[{"start":72,"end":80,"tag":"insulin"},{"start":98,"end":106,"tag":"obesity"}],"urls":[{"start":107,"end":129,"url":"http://t.co/N0kBYxk5kN","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0256","display_url":"dx.doi.org/10.1530/EJE-14‚Ä¶"}]},"conversation_id":"524204162527928320","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EJE study evaluates role of glucocorticoid metabolism in development of #insulin resistance &amp; #obesity http://t.co/N0kBYxk5kN @unibirmingham","id":"524204162527928320","possibly_sensitive":false,"created_at":"2014-10-20T14:23:06.000Z","author_id":"221055586","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":46,"tag":"CDC"},{"start":50,"end":56,"tag":"Ebola"}],"urls":[{"start":58,"end":80,"url":"http://t.co/jWZVY4DMMu","expanded_url":"http://go.usa.gov/fsDT","display_url":"go.usa.gov/fsDT"}]},"conversation_id":"524254420700520449","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Get the facts and latest updates from the #CDC on #Ebola. http://t.co/jWZVY4DMMu","id":"524254420700520449","possibly_sensitive":false,"created_at":"2014-10-20T17:42:48.000Z","author_id":"303777686","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":6,"end":10,"tag":"bio"},{"start":22,"end":33,"tag":"diagnostic"},{"start":46,"end":53,"tag":"cancer"},{"start":58,"end":64,"tag":"brain"},{"start":97,"end":104,"tag":"ribfp7"}],"urls":[{"start":74,"end":96,"url":"http://t.co/Q0boSd2gkD","expanded_url":"http://cordis.europa.eu/result/rcn/148931_en.html","display_url":"cordis.europa.eu/result/rcn/148‚Ä¶"}]},"conversation_id":"524154895461797889","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Novel #bio-analytical #diagnostic methods for #cancer and #brain diseases http://t.co/Q0boSd2gkD #ribfp7","id":"524154895461797889","possibly_sensitive":false,"created_at":"2014-10-20T11:07:20.000Z","author_id":"106364904","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":10,"tag":"Alzheimer"},{"start":105,"end":118,"tag":"patientights"}],"urls":[{"start":119,"end":141,"url":"http://t.co/AEciSjLOwY","expanded_url":"http://europa.eu/!Ky64TR","display_url":"europa.eu/!Ky64TR"}]},"conversation_id":"524165551447228418","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Alzheimer report: early diagnosis progress, improving knowledge, sharing best practices &amp; promoting #patientights http://t.co/AEciSjLOwY","id":"524165551447228418","possibly_sensitive":false,"created_at":"2014-10-20T11:49:40.000Z","author_id":"606325697","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":63,"end":85,"url":"http://t.co/O6ONRkeYd9","expanded_url":"http://bit.ly/1wr66Kf","display_url":"bit.ly/1wr66Kf"},{"start":86,"end":108,"url":"http://t.co/mF6BYNc9Oy","expanded_url":"http://ow.ly/i/7ht68","display_url":"ow.ly/i/7ht68"}]},"conversation_id":"524193343476359168","source":"Hootsuite","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"What will European Healthcare be like in 2040? Cast your vote! http://t.co/O6ONRkeYd9 http://t.co/mF6BYNc9Oy","id":"524193343476359168","possibly_sensitive":false,"created_at":"2014-10-20T13:40:06.000Z","author_id":"487344065","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":94,"end":98,"tag":"fda"},{"start":99,"end":113,"tag":"medicaldevice"}],"urls":[{"start":71,"end":93,"url":"http://t.co/IdTsfSbhtK","expanded_url":"http://1.usa.gov/1tELBek","display_url":"1.usa.gov/1tELBek"}]},"conversation_id":"524193240489402368","source":"Hootsuite","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"eCopy Program for Medical Device Submissions - New Resources Available http://t.co/IdTsfSbhtK #fda #medicaldevice","id":"524193240489402368","possibly_sensitive":false,"created_at":"2014-10-20T13:39:42.000Z","author_id":"66367559","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":21,"end":34,"tag":"publichealth"}],"urls":[{"start":117,"end":139,"url":"http://t.co/U2nCBAcYbA","expanded_url":"http://bit.ly/1wP9pc4","display_url":"bit.ly/1wP9pc4"}]},"conversation_id":"524114163602558976","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Role of the media in #publichealth: EDQM-FAHMP journalist workshop to discuss impact and approaches in communication http://t.co/U2nCBAcYbA","id":"524114163602558976","possibly_sensitive":false,"created_at":"2014-10-20T08:25:28.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":16,"end":21,"probability":0.9735,"type":"Place","normalized_text":"Vienna"}],"hashtags":[{"start":24,"end":35,"tag":"EUagencies"},{"start":107,"end":110,"tag":"EU"}],"urls":[{"start":120,"end":142,"url":"http://t.co/hnZKnZfclD","expanded_url":"https://twitter.com/EURightsAgency/status/523132284598509568/photo/1","display_url":"pic.twitter.com/hnZKnZfclD"}]},"conversation_id":"523132284598509568","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Panel debate in Vienna: #EUagencies play a key role in helping efficient &amp; effective implementation of #EU policies http://t.co/hnZKnZfclD","id":"523132284598509568","possibly_sensitive":false,"created_at":"2014-10-17T15:23:50.000Z","author_id":"217422465","attachments":{"media_keys":["3_523132283604070400"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":106,"end":128,"url":"http://t.co/UzLXetgwGc","expanded_url":"http://bit.ly/1ughjJ2","display_url":"bit.ly/1ughjJ2"}]},"conversation_id":"523108597581246464","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"@EMA_News published its 2013 report on interaction with patients, consumers, and healthcare professionals http://t.co/UzLXetgwGc","id":"523108597581246464","possibly_sensitive":false,"created_at":"2014-10-17T13:49:43.000Z","author_id":"545343465","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"116716199"},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":4,"tag":"FDA"}],"urls":[{"start":114,"end":136,"url":"http://t.co/gyNRwxHMuI","expanded_url":"http://1.usa.gov/1vmSFeb","display_url":"1.usa.gov/1vmSFeb"}]},"conversation_id":"523100877490782208","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#FDA Issues Draft Guidance for Drug Sponsors Re: Two-Phased Chemistry, Manufacturing, and Controls Technical Data http://t.co/gyNRwxHMuI","id":"523100877490782208","possibly_sensitive":false,"created_at":"2014-10-17T13:19:02.000Z","author_id":"109290405","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":14,"end":16,"probability":0.6233,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/FNLsMipSrN","expanded_url":"http://www.nationaljournal.com/health-care/ebola-has-the-fda-working-overtime-on-reviewing-experimental-drugs-20141016","display_url":"nationaljournal.com/health-care/eb‚Ä¶"}]},"conversation_id":"523097557527191552","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Ebola Has the FDA Working Overtime on Reviewing Experimental Drugs http://t.co/FNLsMipSrN","id":"523097557527191552","possibly_sensitive":false,"created_at":"2014-10-17T13:05:51.000Z","author_id":"28870127","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/Tvtm40Lcqr","expanded_url":"http://bit.ly/1Fazw3t","display_url":"bit.ly/1Fazw3t"}]},"conversation_id":"523064293991120896","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Is your pre-natal toxicity information up-to-date? Read more about this information requirement in our Newsletter. http://t.co/Tvtm40Lcqr","id":"523064293991120896","possibly_sensitive":false,"created_at":"2014-10-17T10:53:40.000Z","author_id":"331604970","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":65,"end":69,"probability":0.8738,"type":"Place","normalized_text":"Parma"}],"hashtags":[{"start":41,"end":53,"tag":"flavourings"}],"urls":[{"start":71,"end":93,"url":"http://t.co/jIy43oaGo4","expanded_url":"http://bit.ly/1qHczev","display_url":"bit.ly/1qHczev"}]},"conversation_id":"523061931163545600","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"Register for EFSA‚Äôs info session on food #flavourings. 20 Jan in Parma http://t.co/jIy43oaGo4","id":"523061931163545600","possibly_sensitive":false,"created_at":"2014-10-17T10:44:17.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":16,"tag":"50thanniversary"},{"start":36,"end":41,"tag":"EDQM"},{"start":46,"end":55,"tag":"European"},{"start":56,"end":70,"tag":"Pharmacopoeia"}],"urls":[{"start":116,"end":138,"url":"http://t.co/mZ3YdHn9U2","expanded_url":"http://bit.ly/1sV6Q9M","display_url":"bit.ly/1sV6Q9M"}]},"conversation_id":"523052277821886464","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#50thanniversary workshops provided #EDQM and #European #Pharmacopoeia Commission with valuable feed-back. Read PR: http://t.co/mZ3YdHn9U2","id":"523052277821886464","possibly_sensitive":false,"created_at":"2014-10-17T10:05:55.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":18,"end":27,"username":"EMA_News","id":"116716199"},{"start":31,"end":37,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":0,"end":11,"probability":0.9536,"type":"Person","normalized_text":"Jane Moseley"}],"hashtags":{},"urls":{}},"conversation_id":"523024261322379264","source":"Twitter for Windows Phone","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Jane Moseley from @EMA_News at @EFPIA Collaboration Summit: \"Patient voice tells the suffering behind the statistics.\"","id":"523024261322379264","possibly_sensitive":false,"created_at":"2014-10-17T08:14:35.000Z","author_id":"600110872","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":13,"end":22,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":0,"end":11,"probability":0.9137,"type":"Person","normalized_text":"Jane Moseley"}],"hashtags":{},"urls":{}},"conversation_id":"523024161384693760","source":"Twitter for iPhone","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Jane Moseley @EMA_News at HCS event: \"The patient's voice can tell us the pain behind the statistics\".","id":"523024161384693760","possibly_sensitive":false,"created_at":"2014-10-17T08:14:12.000Z","author_id":"52084584","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":37,"end":49,"tag":"raredisease"}],"urls":[{"start":122,"end":144,"url":"http://t.co/LbjGaoc5uz","expanded_url":"http://ow.ly/CU3nQ","display_url":"ow.ly/CU3nQ"}]},"conversation_id":"523023887538593792","source":"Hootsuite","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"What do you think about sharing your #raredisease clinical or genetic data to advance research &amp;  develop treatments? http://t.co/LbjGaoc5uz","id":"523023887538593792","possibly_sensitive":false,"created_at":"2014-10-17T08:13:06.000Z","author_id":"26993786","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":16,"end":22,"tag":"polio"},{"start":80,"end":93,"tag":"vaccineswork"},{"start":94,"end":109,"tag":"immunizeEurope"}],"urls":[{"start":57,"end":79,"url":"http://t.co/x80mYlniRy","expanded_url":"http://bit.ly/1odJ8p7","display_url":"bit.ly/1odJ8p7"},{"start":110,"end":132,"url":"http://t.co/yCUFh4ZFW6","expanded_url":"https://twitter.com/WHO_Europe_VPI/status/523014320532516864/photo/1","display_url":"pic.twitter.com/yCUFh4ZFW6"}]},"conversation_id":"523014320532516864","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"A world without #polio is in reach...\nWe are this close: http://t.co/x80mYlniRy\n#vaccineswork #immunizeEurope http://t.co/yCUFh4ZFW6","id":"523014320532516864","possibly_sensitive":false,"created_at":"2014-10-17T07:35:05.000Z","author_id":"561122363","attachments":{"media_keys":["3_523014319420633088"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":34,"end":42,"username":"borgton","id":"1605512862"}],"annotations":{},"hashtags":[{"start":0,"end":3,"tag":"EU"},{"start":26,"end":32,"tag":"Ebola"}],"urls":[{"start":121,"end":143,"url":"http://t.co/Iwo786uhy6","expanded_url":"http://europa.eu/!mT96yh","display_url":"europa.eu/!mT96yh"}]},"conversation_id":"522690660999385088","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#EU high level meeting on #Ebola: @borgton opening speech  'We remain vigilant &amp; consider all means of preparedness' http://t.co/Iwo786uhy6","id":"522690660999385088","possibly_sensitive":false,"created_at":"2014-10-16T10:08:59.000Z","author_id":"606325697","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":52,"end":68,"tag":"50thanniversary"},{"start":76,"end":81,"tag":"EDQM"},{"start":86,"end":95,"tag":"European"},{"start":96,"end":110,"tag":"Pharmacopoeia"}],"urls":[{"start":111,"end":133,"url":"http://t.co/mZ3YdHn9U2","expanded_url":"http://bit.ly/1sV6Q9M","display_url":"bit.ly/1sV6Q9M"}]},"conversation_id":"522690794474717184","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"300 delegates from 45 countries participated in the #50thanniversary of the #EDQM and #European #Pharmacopoeia http://t.co/mZ3YdHn9U2","id":"522690794474717184","possibly_sensitive":false,"created_at":"2014-10-16T10:09:31.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":23,"end":32,"username":"Anses_fr","id":"1108628533"}],"annotations":{},"hashtags":[{"start":73,"end":84,"tag":"pesticides"}],"urls":[{"start":111,"end":133,"url":"http://t.co/i6HWTQddxF","expanded_url":"http://bit.ly/1F3gPP2","display_url":"bit.ly/1F3gPP2"}]},"conversation_id":"522728822161276928","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Two weeks left to EFSA/@Anses_fr  conference on occupational exposure to #pesticides: check the pre-programme  http://t.co/i6HWTQddxF","id":"522728822161276928","possibly_sensitive":false,"created_at":"2014-10-16T12:40:37.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":21,"end":26,"probability":0.7627,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":8,"end":17,"tag":"Dementia"}],"urls":[{"start":95,"end":117,"url":"http://t.co/81cYwUjYTR","expanded_url":"http://goo.gl/uPnz5z","display_url":"goo.gl/uPnz5z"},{"start":118,"end":140,"url":"http://t.co/d7A6xTGLYK","expanded_url":"https://twitter.com/AlzheimerEurope/status/522737596532031489/photo/1","display_url":"pic.twitter.com/d7A6xTGLYK"}]},"conversation_id":"522737596532031489","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our new #Dementia In Europe magazine - DIE issue 18 - is available for purchase on our website http://t.co/81cYwUjYTR http://t.co/d7A6xTGLYK","id":"522737596532031489","possibly_sensitive":false,"created_at":"2014-10-16T13:15:29.000Z","author_id":"1536274003","attachments":{"media_keys":["3_522737595063611392"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":51,"end":60,"username":"expo2015","id":"25518771"}],"annotations":[{"start":61,"end":65,"probability":0.5264,"type":"Place","normalized_text":"Milan"}],"hashtags":[{"start":18,"end":23,"tag":"EFSA"}],"urls":[{"start":83,"end":105,"url":"http://t.co/LWZMyg0fjQ","expanded_url":"http://bit.ly/1stT5wP","display_url":"bit.ly/1stT5wP"}]},"conversation_id":"522747327384412160","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":3,"quote_count":0},"lang":"en","text":"Save the date for #EFSA‚Äôs international conference @EXPO2015 Milan, 14-16 Oct 2015 http://t.co/LWZMyg0fjQ","id":"522747327384412160","possibly_sensitive":false,"created_at":"2014-10-16T13:54:09.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":17,"end":25,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":{},"urls":[{"start":45,"end":67,"url":"http://t.co/st2JDRfSh6","expanded_url":"http://bit.ly/ZwdtTI","display_url":"bit.ly/ZwdtTI"},{"start":88,"end":110,"url":"http://t.co/5Apk6dyRH1","expanded_url":"http://bit.ly/1cij9R1","display_url":"bit.ly/1cij9R1","status":200,"unwound_url":"https://echa.europa.eu/web/guest/subscribe"},{"start":111,"end":133,"url":"http://t.co/XZrrjM62Bq","expanded_url":"https://twitter.com/EU_ECHA/status/522753356994191361/photo/1","display_url":"pic.twitter.com/XZrrjM62Bq"}]},"conversation_id":"522753356994191361","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"October issue of @EU_ECHA Newsletter is out! http://t.co/st2JDRfSh6 Subscribe to it at: http://t.co/5Apk6dyRH1 http://t.co/XZrrjM62Bq","id":"522753356994191361","possibly_sensitive":false,"created_at":"2014-10-16T14:18:07.000Z","author_id":"331604970","attachments":{"media_keys":["3_522753355626852352"]},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":64,"end":86,"url":"http://t.co/sfMfOOlr9b","expanded_url":"http://iapo.org.uk/","display_url":"iapo.org.uk"},{"start":87,"end":109,"url":"http://t.co/B0SHhgDRjI","expanded_url":"https://twitter.com/IAPOtweets/status/522753468298457089/photo/1","display_url":"pic.twitter.com/B0SHhgDRjI"}]},"conversation_id":"522753468298457089","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"We launched the new IAPO website last week! Have a browse here: http://t.co/sfMfOOlr9b http://t.co/B0SHhgDRjI","id":"522753468298457089","possibly_sensitive":false,"created_at":"2014-10-16T14:18:33.000Z","author_id":"180728609","attachments":{"media_keys":["3_522753454238740480"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":43,"end":52,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":0,"end":5,"tag":"EFPC"},{"start":19,"end":31,"tag":"PrimaryCare"},{"start":35,"end":41,"tag":"India"}],"urls":[{"start":116,"end":138,"url":"http://t.co/cJWsPR4mnl","expanded_url":"http://www.euprimarycare.org/newsflash/newsflash-2014-%E2%80%93-19-efpc-wg-palliative-care-community-based-health-professional-educatio-0#.VD_YmDgX6sc.twitter","display_url":"euprimarycare.org/newsflash/news‚Ä¶"}]},"conversation_id":"522759633505501184","source":"Twitter for Websites","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#EFPC Newsflash19: #PrimaryCare in #India, @EMA_News interaction with patients, consumers, healthcare professionals http://t.co/cJWsPR4mnl","id":"522759633505501184","possibly_sensitive":false,"created_at":"2014-10-16T14:43:03.000Z","author_id":"164835748","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":71,"end":93,"probability":0.6361,"type":"Organization","normalized_text":"Alliance Regional Board"}],"hashtags":[{"start":18,"end":28,"tag":"hepatitis"}],"urls":[{"start":116,"end":138,"url":"http://t.co/4AOBQoFphB","expanded_url":"http://goo.gl/IbTfKb","display_url":"goo.gl/IbTfKb"}]},"conversation_id":"522765844125085696","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Want to represent #hepatitis patients in your region? Nominate for the Alliance Regional Board now. Closes tomorrow http://t.co/4AOBQoFphB","id":"522765844125085696","possibly_sensitive":false,"created_at":"2014-10-16T15:07:44.000Z","author_id":"20170584","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":4,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":60,"end":75,"tag":"clinicaltrials"},{"start":107,"end":117,"tag":"Alltrials"},{"start":118,"end":132,"tag":"Pharma4Health"}],"urls":[{"start":84,"end":106,"url":"http://t.co/htN77VmUsp","expanded_url":"http://www.who.int/ictrp/results/en/","display_url":"who.int/ictrp/results/‚Ä¶"}]},"conversation_id":"522416402041683968","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@WHO public consultation: Statement on Public Disclosure of #clinicaltrials Results http://t.co/htN77VmUsp #Alltrials #Pharma4Health","id":"522416402041683968","possibly_sensitive":false,"created_at":"2014-10-15T15:59:10.000Z","author_id":"164835748","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"14499829"},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":86,"end":97,"tag":"regaffairs"}],"urls":[{"start":63,"end":85,"url":"http://t.co/b4PwV5437k","expanded_url":"http://bit.ly/ZXMTnA","display_url":"bit.ly/ZXMTnA"}]},"conversation_id":"522412325442424832","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"TOPRA's 2013-2014 Annual Report is out now: download your copy http://t.co/b4PwV5437k #regaffairs","id":"522412325442424832","possibly_sensitive":false,"created_at":"2014-10-15T15:42:58.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/ocNuR3yW1T","expanded_url":"http://ow.ly/CNTED","display_url":"ow.ly/CNTED"}]},"conversation_id":"522411543846465536","source":"Hootsuite","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Early Access to Medicines scheme (EAMS) explained in latest edition of The Pharmacist page 27 http://t.co/ocNuR3yW1T","id":"522411543846465536","possibly_sensitive":false,"created_at":"2014-10-15T15:39:52.000Z","author_id":"330993102","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"522407798194585602","source":"Twitter for iPhone","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@EMA_News You write that the new patient pilot is for drugs \"likely to be refused.\" Isn't that a de facto refusal in public prior to CHMP?","id":"522407798194585602","possibly_sensitive":false,"created_at":"2014-10-15T15:24:59.000Z","author_id":"2830257207","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"116716199"},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.7672,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":115,"end":124,"tag":"research"}],"urls":[{"start":92,"end":114,"url":"http://t.co/R3StwP2PNY","expanded_url":"http://go.usa.gov/frMk","display_url":"go.usa.gov/frMk"}]},"conversation_id":"522399190824280064","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"FDA scientists are studying pediatric brain function‚Äîand they‚Äôre using an interesting tool: http://t.co/R3StwP2PNY #research","id":"522399190824280064","possibly_sensitive":false,"created_at":"2014-10-15T14:50:47.000Z","author_id":"208120290","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":15,"end":23,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":43,"end":61,"probability":0.6135,"type":"Other","normalized_text":"Ebola Virus Disease"},{"start":75,"end":83,"probability":0.9697,"type":"Place","normalized_text":"W. Africa"}],"hashtags":[{"start":0,"end":6,"tag":"Ebola"}],"urls":[{"start":93,"end":115,"url":"http://t.co/hhrakFegu6","expanded_url":"http://europa.eu/!Nf97kn","display_url":"europa.eu/!Nf97kn"},{"start":116,"end":138,"url":"http://t.co/cLFFDA2kNH","expanded_url":"https://twitter.com/EU_Health/status/522393137030123520/photo/1","display_url":"pic.twitter.com/cLFFDA2kNH"}]},"conversation_id":"522393137030123520","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":8,"quote_count":0},"lang":"en","text":"#Ebola Updated @ECDC_EU risk assessment on Ebola Virus Disease outbreak in W. Africa (13.10) http://t.co/hhrakFegu6 http://t.co/cLFFDA2kNH","id":"522393137030123520","possibly_sensitive":false,"created_at":"2014-10-15T14:26:44.000Z","author_id":"606325697","attachments":{"media_keys":["3_522393135943409664"]},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":9,"end":15,"tag":"Ebola"},{"start":48,"end":51,"tag":"EU"}],"urls":[{"start":52,"end":74,"url":"http://t.co/OaCCPLPP9z","expanded_url":"http://tinyurl.com/p54gq95","display_url":"tinyurl.com/p54gq95"}]},"conversation_id":"522399019008815105","source":"Twitter for iPhone","public_metrics":{"retweet_count":14,"reply_count":2,"like_count":5,"quote_count":0},"lang":"en","text":"Q&amp;A: #Ebola and health implications for the #EU http://t.co/OaCCPLPP9z","id":"522399019008815105","possibly_sensitive":false,"created_at":"2014-10-15T14:50:06.000Z","author_id":"80803819","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":14,"end":17,"tag":"EU"},{"start":77,"end":83,"tag":"Ebola"}],"urls":[{"start":109,"end":131,"url":"http://t.co/ejucLQ3mVz","expanded_url":"http://bit.ly/ZZ9LmB","display_url":"bit.ly/ZZ9LmB"}]},"conversation_id":"522374356249628672","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"Tomorrow, the #EU will hold a high-level meeting and press conference on its #Ebola response. Ebola Q&amp;A: http://t.co/ejucLQ3mVz","id":"522374356249628672","possibly_sensitive":false,"created_at":"2014-10-15T13:12:06.000Z","author_id":"429122255","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":36,"end":45,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":46,"end":60,"tag":"SMEinstrument"},{"start":72,"end":83,"tag":"Biomarkers"}],"urls":[{"start":104,"end":126,"url":"http://t.co/93m6ud3MvT","expanded_url":"http://ow.ly/CyOpK","display_url":"ow.ly/CyOpK"}]},"conversation_id":"522373986752401408","source":"Hootsuite","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":6,"quote_count":0},"lang":"en","text":"Out of 580 proposals in Phase 2 for @EU_H2020 #SMEinstrument 81 were on #Biomarkers /diagnostic devices http://t.co/93m6ud3MvT","id":"522373986752401408","possibly_sensitive":false,"created_at":"2014-10-15T13:10:38.000Z","author_id":"2361119438","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":27,"end":36,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":54,"end":76,"url":"http://t.co/qA2QnAOkNZ","expanded_url":"http://www.ifaheurope.org/ifah-media/press/228-ie-press-statement-4thesvac.html","display_url":"ifaheurope.org/ifah-media/pre‚Ä¶"}]},"conversation_id":"522371079214727168","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Check out our statement re/@EMA_News 4th ESVAC report http://t.co/qA2QnAOkNZ","id":"522371079214727168","possibly_sensitive":false,"created_at":"2014-10-15T12:59:05.000Z","author_id":"1017044760","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":4,"end":18,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":57,"end":61,"probability":0.4696,"type":"Other","normalized_text":"Ebola"}],"hashtags":{},"urls":[{"start":106,"end":128,"url":"http://t.co/E0fyAzykeg","expanded_url":"http://europa.eu/!jB63Rw","display_url":"europa.eu/!jB63Rw"}]},"conversation_id":"522365840121806849","source":"Twitter for Websites","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The @EU_Commission has prepared a useful Q&amp;A document on Ebola and the health implications for the EU http://t.co/E0fyAzykeg","id":"522365840121806849","possibly_sensitive":false,"created_at":"2014-10-15T12:38:16.000Z","author_id":"203357203","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":12,"end":18,"tag":"Ebola"},{"start":51,"end":54,"tag":"EU"}],"urls":[{"start":55,"end":77,"url":"http://t.co/CP1p7OzM5L","expanded_url":"http://bit.ly/1seWoYQ","display_url":"bit.ly/1seWoYQ"}]},"conversation_id":"522353768156135424","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Q &amp; A:  #Ebola and health implications for the #EU http://t.co/CP1p7OzM5L","id":"522353768156135424","possibly_sensitive":false,"created_at":"2014-10-15T11:50:17.000Z","author_id":"2754484003","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":72,"end":94,"url":"http://t.co/Er1MV5Jn9R","expanded_url":"http://europa.eu/rapid/press-release_MEMO-14-588_en.htm?locale=en","display_url":"europa.eu/rapid/press-re‚Ä¶"}]},"conversation_id":"522351120757587968","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"European Commission | Q&amp;A: Ebola and health implications for the EU http://t.co/Er1MV5Jn9R","id":"522351120757587968","possibly_sensitive":false,"created_at":"2014-10-15T11:39:46.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":102,"end":116,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":0,"end":6,"tag":"Ebola"},{"start":28,"end":35,"tag":"health"},{"start":75,"end":78,"tag":"EU"},{"start":131,"end":145,"tag":"EbolaResponse"}],"urls":[{"start":79,"end":101,"url":"http://t.co/sauX58R61j","expanded_url":"http://europa.eu/!jn37xX","display_url":"europa.eu/!jn37xX"}]},"conversation_id":"522342179059273728","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Ebola - read our Q&amp;A - #health implications &amp; preparedness in the #EU http://t.co/sauX58R61j @EU_Commission @ECSpokesFred #EbolaResponse","id":"522342179059273728","possibly_sensitive":false,"created_at":"2014-10-15T11:04:14.000Z","author_id":"606325697","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.8747,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":25,"end":36,"tag":"sicklecell"}],"urls":[{"start":89,"end":111,"url":"http://t.co/DREb7MWymC","expanded_url":"http://go.usa.gov/f3g9","display_url":"go.usa.gov/f3g9"}]},"conversation_id":"522058604829229056","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":2,"like_count":6,"quote_count":0},"lang":"en","text":"FDA is working to tackle #sicklecell disease and encouraging new treatments. Here‚Äôs how: http://t.co/DREb7MWymC","id":"522058604829229056","possibly_sensitive":false,"created_at":"2014-10-14T16:17:25.000Z","author_id":"208120290","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":12,"end":19,"tag":"Animal"},{"start":76,"end":80,"tag":"FDA"}],"urls":[{"start":53,"end":75,"url":"http://t.co/Y6m7QXiHuA","expanded_url":"http://bit.ly/hN7hpR","display_url":"bit.ly/hN7hpR"}]},"conversation_id":"522056399665496065","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"See Updated #Animal Related Federal Register Notices http://t.co/Y6m7QXiHuA #FDA","id":"522056399665496065","possibly_sensitive":false,"created_at":"2014-10-14T16:08:39.000Z","author_id":"109290405","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/jR3MDJRnCU","expanded_url":"http://bit.ly/1u0oq8h","display_url":"bit.ly/1u0oq8h"}]},"conversation_id":"522033764168253441","source":"twitterfeed","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"TOPRA Annual Report 2013-2014: TOPRA's Annual Report is out now, containing a comprehensive summary of all our... http://t.co/jR3MDJRnCU","id":"522033764168253441","possibly_sensitive":false,"created_at":"2014-10-14T14:38:42.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":30,"end":52,"url":"http://t.co/XaTSXQKOpR","expanded_url":"http://bit.ly/1u0iVGW","display_url":"bit.ly/1u0iVGW"}]},"conversation_id":"522027776363085824","source":"twitterfeed","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"TOPRA Annual Report 2013-2014 http://t.co/XaTSXQKOpR","id":"522027776363085824","possibly_sensitive":false,"created_at":"2014-10-14T14:14:55.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/eBHzYCoNts","expanded_url":"http://www.safescimet.eu/wp-content/uploads/2014/10/SafeSciMET_InBrief_18.pdf","display_url":"safescimet.eu/wp-content/upl‚Ä¶"}]},"conversation_id":"521966549696278528","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"IMI-TRAIN first steps summarized in the last SafeSciMET newsletter http://t.co/eBHzYCoNts","id":"521966549696278528","possibly_sensitive":false,"created_at":"2014-10-14T10:11:37.000Z","author_id":"420241833","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":33,"end":35,"probability":0.4517,"type":"Organization","normalized_text":"EMA"},{"start":61,"end":89,"probability":0.2693,"type":"Organization","normalized_text":"The European Medicines Agency"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/0eBgrp0UzJ","expanded_url":"http://bit.ly/1wyeNQK","display_url":"bit.ly/1wyeNQK"}]},"conversation_id":"521964766923726849","source":"twitterfeed","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Publication of clinical reports: EMA adopts landmark policy: The European Medicines Agency (EMA) has decided t... http://t.co/0eBgrp0UzJ","id":"521964766923726849","possibly_sensitive":false,"created_at":"2014-10-14T10:04:32.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":33,"end":35,"probability":0.4637,"type":"Organization","normalized_text":"EMA"}],"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/nnjQhYWVNY","expanded_url":"http://bit.ly/1sLnZCH","display_url":"bit.ly/1sLnZCH"}]},"conversation_id":"521964765820624898","source":"twitterfeed","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Publication of clinical reports: EMA adopts landmark policy http://t.co/nnjQhYWVNY","id":"521964765820624898","possibly_sensitive":false,"created_at":"2014-10-14T10:04:32.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":131,"end":139,"username":"EIP_AHA","id":"416925949"}],"annotations":[{"start":97,"end":102,"probability":0.9426,"type":"Place","normalized_text":"Madrid"}],"hashtags":[{"start":57,"end":73,"tag":"ChronicDiseases"}],"urls":[{"start":105,"end":127,"url":"http://t.co/vpdwME6BsN","expanded_url":"http://ow.ly/CFFKB","display_url":"ow.ly/CFFKB"}]},"conversation_id":"521701961788563456","source":"Hootsuite","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Stakeholder Forum of @EU_CHRODIS (the EU Joint Action on #ChronicDiseases) is on 24 Oct. 2014 in Madrid: http://t.co/vpdwME6BsN v/ @EIP_AHA","id":"521701961788563456","possibly_sensitive":false,"created_at":"2014-10-13T16:40:15.000Z","author_id":"24145340","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":1,"end":13,"probability":0.5783,"type":"Organization","normalized_text":"One Stop Shop"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/UbOrHGJFTG","expanded_url":"http://ow.ly/CGcHg","display_url":"ow.ly/CGcHg"}]},"conversation_id":"521688675437273088","source":"Hootsuite","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"'One Stop Shop' providing regulatory advice for those working in life sciences on regenerative medicines launched http://t.co/UbOrHGJFTG","id":"521688675437273088","possibly_sensitive":false,"created_at":"2014-10-13T15:47:27.000Z","author_id":"330990243","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":75,"end":96,"tag":"antibioticresistance"}],"urls":[{"start":99,"end":121,"url":"http://t.co/944y54VGF0","expanded_url":"http://www.nice.org.uk/news/article/tackling-the-rise-in-antibiotic-resistance","display_url":"nice.org.uk/news/article/t‚Ä¶"}]},"conversation_id":"521655193675763712","source":"Twitter Web Client","public_metrics":{"retweet_count":50,"reply_count":2,"like_count":18,"quote_count":0},"lang":"en","text":"NICE is developing two new guidelines to help tackle the growing threat of #antibioticresistance: \nhttp://t.co/944y54VGF0","id":"521655193675763712","possibly_sensitive":false,"created_at":"2014-10-13T13:34:24.000Z","author_id":"85555796","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":54,"end":76,"url":"http://t.co/Lau79o4LPs","expanded_url":"http://ow.ly/CFhrc","display_url":"ow.ly/CFhrc"}]},"conversation_id":"521635625049804800","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Frequently asked questions about biosimilar medicines http://t.co/Lau79o4LPs","id":"521635625049804800","possibly_sensitive":false,"created_at":"2014-10-13T12:16:39.000Z","author_id":"2315763655","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":50,"end":62,"tag":"raredisease"}],"urls":[{"start":113,"end":135,"url":"http://t.co/i94ph7yT8i","expanded_url":"http://ow.ly/CExP7","display_url":"ow.ly/CExP7"}]},"conversation_id":"521563586171510784","source":"Hootsuite","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Find out how patients are getting involved in EMA #raredisease benefit-risk marketing authorisation evaluations! http://t.co/i94ph7yT8i","id":"521563586171510784","possibly_sensitive":false,"created_at":"2014-10-13T07:30:23.000Z","author_id":"26993786","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":14,"tag":"CallForTender"}],"urls":[{"start":75,"end":97,"url":"http://t.co/KMZEObP4u7","expanded_url":"http://bit.ly/1oQo7LM","display_url":"bit.ly/1oQo7LM"}]},"conversation_id":"520242293635579904","source":"Clarabridge Engage","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#CallForTender ‚Äì Preparatory work for evidence-based scientific assessment http://t.co/KMZEObP4u7","id":"520242293635579904","possibly_sensitive":false,"created_at":"2014-10-09T16:00:03.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/MRtCejG3F9","expanded_url":"http://bit.ly/1pVjyQr","display_url":"bit.ly/1pVjyQr"}]},"conversation_id":"520240984626446336","source":"twitterfeed","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Information on suspected side effects now available through a single website: Information on suspected side ef... http://t.co/MRtCejG3F9","id":"520240984626446336","possibly_sensitive":false,"created_at":"2014-10-09T15:54:51.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":103,"end":112,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/6c82vrzThn","expanded_url":"http://bit.ly/1vR7xiU","display_url":"bit.ly/1vR7xiU"}]},"conversation_id":"520234190479302656","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Suspected adverse drug reactions of an additional 1,700 active substances now available on one website @EMA_News http://t.co/6c82vrzThn","id":"520234190479302656","possibly_sensitive":false,"created_at":"2014-10-09T15:27:51.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":77,"end":99,"url":"http://t.co/9fWffYGhUm","expanded_url":"http://bit.ly/1skIdCY","display_url":"bit.ly/1skIdCY"}]},"conversation_id":"520233988158259200","source":"twitterfeed","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Information on suspected side effects now available through a single website http://t.co/9fWffYGhUm","id":"520233988158259200","possibly_sensitive":false,"created_at":"2014-10-09T15:27:02.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":63,"end":67,"tag":"CNS"},{"start":68,"end":77,"tag":"diabetes"},{"start":78,"end":94,"tag":"neuropsychiatry"},{"start":95,"end":104,"tag":"vaccines"},{"start":105,"end":115,"tag":"pertussis"},{"start":116,"end":125,"tag":"patients"}],"urls":[{"start":40,"end":62,"url":"http://t.co/mrmP75WkAo","expanded_url":"http://bit.ly/futuretopics","display_url":"bit.ly/futuretopics"}]},"conversation_id":"520208718374645761","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"IMI 2 Call 2 indicative text now online http://t.co/mrmP75WkAo #CNS #diabetes #neuropsychiatry #vaccines #pertussis #patients","id":"520208718374645761","possibly_sensitive":false,"created_at":"2014-10-09T13:46:38.000Z","author_id":"153741027","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":55,"end":84,"probability":0.3549,"type":"Other","normalized_text":"Disease Prevention and Control"}],"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/Vm3pwE0Yz9","expanded_url":"http://bit.ly/ZtXtlv","display_url":"bit.ly/ZtXtlv"}]},"conversation_id":"520184638904762368","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Vacancy published: Director of the European Centre for Disease Prevention and Control. Deadline: 5 November http://t.co/Vm3pwE0Yz9","id":"520184638904762368","possibly_sensitive":false,"created_at":"2014-10-09T12:10:57.000Z","author_id":"204752573","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":24,"probability":0.4325,"type":"Organization","normalized_text":"European Medicines Agency"}],"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/EQVPMkXfe9","expanded_url":"http://www.pharmaceutical-journal.com//news-and-analysis/news/european-medicines-agency-reduces-clinical-trial-secrecy/20066722.fullarticle","display_url":"pharmaceutical-journal.com//news-and-anal‚Ä¶"}]},"conversation_id":"520174471571709954","source":"Twitter for Websites","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"European Medicines Agency reduces clinical trial secrecy | News | Pharmaceutical Journal http://t.co/EQVPMkXfe9","id":"520174471571709954","possibly_sensitive":false,"created_at":"2014-10-09T11:30:33.000Z","author_id":"203357203","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"URPLWMiPB","id":"556679074"}],"annotations":[{"start":32,"end":41,"probability":0.5977,"type":"Person","normalized_text":"Lamivudine"}],"hashtags":{},"urls":{}},"conversation_id":"520156358734516224","source":"Twitter for Android","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@EMA_News @URPLWMiPB what about Lamivudine anedoctal evidence of efficacy? Will EMA look into that?","id":"520173838819393537","possibly_sensitive":false,"created_at":"2014-10-09T11:28:02.000Z","author_id":"1223273226","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"520156358734516224"}],"in_reply_to_user_id":"116716199"},{"entities":{"mentions":{},"annotations":[{"start":14,"end":17,"probability":0.5068,"type":"Organization","normalized_text":"Eu2P"}],"hashtags":[{"start":49,"end":67,"tag":"pharmacovigilance"}],"urls":[{"start":108,"end":130,"url":"http://t.co/6QaOe7VlHd","expanded_url":"http://elearninginfographics.com/7-questions-ask-joining-online-learning-program-infographic/","display_url":"elearninginfographics.com/7-questions-as‚Ä¶"}]},"conversation_id":"520147471939694592","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Interested by Eu2P online training programmes in #pharmacovigilance? Make sure online learning is for you: \nhttp://t.co/6QaOe7VlHd","id":"520147471939694592","possibly_sensitive":false,"created_at":"2014-10-09T09:43:15.000Z","author_id":"420241833","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":10,"end":19,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":122,"end":144,"url":"http://t.co/oxG3UqQjOm","expanded_url":"http://bit.ly/1vJxH9k","display_url":"bit.ly/1vJxH9k"}]},"conversation_id":"520133125687357440","source":"Twitter for Websites","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Well done @EMA_News! Citizens &amp; HCPs can now access information on suspected ADRs associated with 100s more medicines http://t.co/oxG3UqQjOm","id":"520133125687357440","possibly_sensitive":false,"created_at":"2014-10-09T08:46:15.000Z","author_id":"203357203","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":87,"end":94,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":{},"urls":[{"start":95,"end":117,"url":"http://t.co/r3bjN5NIjV","expanded_url":"http://imi.efpia.eu","display_url":"imi.efpia.eu"},{"start":118,"end":140,"url":"http://t.co/jjhLi2BE5y","expanded_url":"https://twitter.com/EFPIA/status/520125321937682432/photo/1","display_url":"pic.twitter.com/jjhLi2BE5y"}]},"conversation_id":"520125321937682432","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"The launch of IMI2 marks the beginning of a new and exciting chapter in the IMI story \n@IMI_JU http://t.co/r3bjN5NIjV http://t.co/jjhLi2BE5y","id":"520125321937682432","possibly_sensitive":false,"created_at":"2014-10-09T08:15:14.000Z","author_id":"52084584","attachments":{"media_keys":["3_520125320653856768"]},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":14,"tag":"CallForTender"},{"start":28,"end":37,"tag":"journals"},{"start":50,"end":60,"tag":"databases"}],"urls":[{"start":91,"end":113,"url":"http://t.co/UCVmipSZ9Y","expanded_url":"http://bit.ly/1yMxTIo","display_url":"bit.ly/1yMxTIo"}]},"conversation_id":"519849708563755008","source":"Clarabridge Engage","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#CallForTender ‚Äì Electronic #journals, electronic #databases and books/e-books acquisition http://t.co/UCVmipSZ9Y","id":"519849708563755008","possibly_sensitive":false,"created_at":"2014-10-08T14:00:03.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":4,"tag":"FDA"},{"start":46,"end":57,"tag":"Veterinary"}],"urls":[{"start":101,"end":123,"url":"http://t.co/93dJvrzNVR","expanded_url":"http://1.usa.gov/1vMU4d3","display_url":"1.usa.gov/1vMU4d3"}]},"conversation_id":"519856325594218496","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#FDA Issues Final Guidance on Terminology for #Veterinary Medicinal Products Adverse Event Reporting http://t.co/93dJvrzNVR","id":"519856325594218496","possibly_sensitive":false,"created_at":"2014-10-08T14:26:21.000Z","author_id":"109290405","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":18,"end":23,"probability":0.9946,"type":"Place","normalized_text":"Europe"},{"start":76,"end":86,"probability":0.9638,"type":"Place","normalized_text":"West Africa"}],"hashtags":[{"start":8,"end":14,"tag":"Ebola"}],"urls":[{"start":88,"end":110,"url":"http://t.co/QwOSuoQh59","expanded_url":"http://bit.ly/1yMNVC4","display_url":"bit.ly/1yMNVC4"}]},"conversation_id":"519858442455248896","source":"TweetDeck","public_metrics":{"retweet_count":60,"reply_count":9,"like_count":10,"quote_count":0},"lang":"en","text":"Risk of #Ebola to Europe can only be eliminated by stopping the outbreak in West Africa http://t.co/QwOSuoQh59","id":"519858442455248896","possibly_sensitive":false,"created_at":"2014-10-08T14:34:45.000Z","author_id":"2754484003","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":96,"end":106,"tag":"Parkinson"}],"urls":[{"start":118,"end":140,"url":"http://t.co/Ro0dHs4j2y","expanded_url":"http://bit.ly/1rU6JJk","display_url":"bit.ly/1rU6JJk"}]},"conversation_id":"519865303019159552","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The dopaminergic system in upper limb motor blocks investigated during bimanual coordination in #Parkinson‚Äôs disease: http://t.co/Ro0dHs4j2y","id":"519865303019159552","possibly_sensitive":false,"created_at":"2014-10-08T15:02:01.000Z","author_id":"190227425","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":59,"end":77,"probability":0.3032,"type":"Organization","normalized_text":"Substances Division"}],"hashtags":[{"start":41,"end":55,"tag":"Certification"}],"urls":[{"start":115,"end":137,"url":"http://t.co/HDYTwZujnw","expanded_url":"http://bit.ly/1xp9Sm","display_url":"bit.ly/1xp9Sm"}]},"conversation_id":"519866336131162113","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The last monthly activity report for the #Certification of Substances Division is now available. September Report: http://t.co/HDYTwZujnw","id":"519866336131162113","possibly_sensitive":false,"created_at":"2014-10-08T15:06:07.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/aprtdHFPHV","expanded_url":"http://ow.ly/Crz5B","display_url":"ow.ly/Crz5B"}]},"conversation_id":"519871868673998848","source":"Hootsuite","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Good Manufacturing Practice (GMP) is one of the ways we ensure the quality of medicines. http://t.co/aprtdHFPHV","id":"519871868673998848","possibly_sensitive":false,"created_at":"2014-10-08T15:28:06.000Z","author_id":"330993102","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":22,"end":31,"tag":"diabetes"}],"urls":[{"start":69,"end":91,"url":"http://t.co/H94rN7kvay","expanded_url":"http://ow.ly/BYApd","display_url":"ow.ly/BYApd"}]},"conversation_id":"519887822388752384","source":"Hootsuite","public_metrics":{"retweet_count":16,"reply_count":1,"like_count":5,"quote_count":0},"lang":"en","text":"7 million people have #diabetes and do not know it. Learn the signs: http://t.co/H94rN7kvay (via @NDEP)","id":"519887822388752384","possibly_sensitive":false,"created_at":"2014-10-08T16:31:30.000Z","author_id":"65416742","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":5,"tag":"EDQM"},{"start":29,"end":40,"tag":"Laboratory"},{"start":125,"end":136,"tag":"employment"}],"urls":[{"start":102,"end":124,"url":"http://t.co/kGntfgE56x","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}]},"conversation_id":"519869288090705921","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#EDQM looking to hire Junior #Laboratory Technician to test medicinal products. Full job description: http://t.co/kGntfgE56x #employment","id":"519869288090705921","possibly_sensitive":false,"created_at":"2014-10-08T15:17:51.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/hmnpmfzdGR","expanded_url":"http://bit.ly/1s6Ix85","display_url":"bit.ly/1s6Ix85"}]},"conversation_id":"519531635138506752","source":"twitterfeed","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Human medicines highlights - Issue 67 - September 2014: The September 2014 issue of the European Medicines Age... http://t.co/hmnpmfzdGR","id":"519531635138506752","possibly_sensitive":false,"created_at":"2014-10-07T16:56:08.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":55,"end":77,"url":"http://t.co/DJ16ufSUP2","expanded_url":"http://bit.ly/1y1L5I6","display_url":"bit.ly/1y1L5I6"}]},"conversation_id":"519524391508398080","source":"twitterfeed","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Human medicines highlights - Issue 67 - September 2014 http://t.co/DJ16ufSUP2","id":"519524391508398080","possibly_sensitive":false,"created_at":"2014-10-07T16:27:21.000Z","author_id":"26739900","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/ZLAl3cOQqd","expanded_url":"http://go.usa.gov/wrsz","display_url":"go.usa.gov/wrsz"}]},"conversation_id":"519518677092536320","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"New! Drug Supply Chain Security Act (DSCSA) draft guidance: http://t.co/ZLAl3cOQqd.","id":"519518677092536320","possibly_sensitive":false,"created_at":"2014-10-07T16:04:39.000Z","author_id":"53039176","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":63,"end":73,"tag":"medicines"}],"urls":[{"start":114,"end":136,"url":"http://t.co/zyw7uq02B8","expanded_url":"http://bit.ly/1rU4MN2","display_url":"bit.ly/1rU4MN2"}]},"conversation_id":"519498891910066176","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Information on suspected side effects of nationally authorised #medicines now available through a single website: http://t.co/zyw7uq02B8","id":"519498891910066176","possibly_sensitive":false,"created_at":"2014-10-07T14:46:02.000Z","author_id":"190227425","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":57,"end":61,"username":"WHO","id":"14499829"}],"annotations":[{"start":103,"end":114,"probability":0.5131,"type":"Place","normalized_text":"N-hemisphere"}],"hashtags":[{"start":12,"end":16,"tag":"flu"}],"urls":[{"start":117,"end":139,"url":"http://t.co/f8mKvyoZnC","expanded_url":"http://bit.ly/1s8w7g4","display_url":"bit.ly/1s8w7g4"}]},"conversation_id":"519488005544116224","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Recommended #flu vaccine composition for S-hemisphere by @WHO - what are indications for flu season in N-hemisphere? http://t.co/f8mKvyoZnC","id":"519488005544116224","possibly_sensitive":false,"created_at":"2014-10-07T14:02:46.000Z","author_id":"1371668696","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":80,"end":102,"url":"http://t.co/905E0i1kX1","expanded_url":"http://ow.ly/CnctW","display_url":"ow.ly/CnctW"}]},"conversation_id":"519480079022583808","source":"Hootsuite","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Don't forget to join today's webinar on FDASIA 907 Action Plan today at 1pm ET! http://t.co/905E0i1kX1","id":"519480079022583808","possibly_sensitive":false,"created_at":"2014-10-07T13:31:16.000Z","author_id":"65416742","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":14,"end":23,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":78,"end":100,"url":"http://t.co/G1HaYopRMN","expanded_url":"http://bit.ly/1y0vfxi","display_url":"bit.ly/1y0vfxi"}]},"conversation_id":"519453791629111297","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Check out the @EMA_News' new leaflet on how to report adverse drug reactions! http://t.co/G1HaYopRMN","id":"519453791629111297","possibly_sensitive":false,"created_at":"2014-10-07T11:46:49.000Z","author_id":"429122255","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":84,"end":90,"tag":"Ebola"}],"urls":[{"start":91,"end":113,"url":"http://t.co/mcj9ViXJ9U","expanded_url":"http://goo.gl/DOPb8w","display_url":"goo.gl/DOPb8w"}]},"conversation_id":"519434861409742848","source":"Twitter Web Client","public_metrics":{"retweet_count":79,"reply_count":7,"like_count":24,"quote_count":0},"lang":"en","text":"WHO is convening an informal consultation on how science can inform our response to #Ebola http://t.co/mcj9ViXJ9U","id":"519434861409742848","possibly_sensitive":false,"created_at":"2014-10-07T10:31:36.000Z","author_id":"14499829","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":32,"tag":"OpenScience"},{"start":101,"end":110,"tag":"OpenEFSA"}],"urls":[{"start":112,"end":134,"url":"http://t.co/txHlshoGb4","expanded_url":"http://bit.ly/1xHslyl","display_url":"bit.ly/1xHslyl"}]},"conversation_id":"519429183362306048","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Public consultation #OpenScience at EFSA: 1 week left to comment on the paper  ‚ÄòTransformation to an #OpenEFSA‚Äô http://t.co/txHlshoGb4","id":"519429183362306048","possibly_sensitive":false,"created_at":"2014-10-07T10:09:02.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":112,"end":122,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":73,"end":75,"probability":0.4696,"type":"Organization","normalized_text":"GMP"}],"hashtags":[{"start":89,"end":105,"tag":"50thanniversary"},{"start":106,"end":111,"tag":"EDQM"}],"urls":{}},"conversation_id":"519425653083766784","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Greater oversight and enforcement through international collaboration on GMP inspections #50thanniversary #EDQM @edqm_news","id":"519425653083766784","possibly_sensitive":false,"created_at":"2014-10-07T09:55:00.000Z","author_id":"2315763655","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/Ui1CyquRZP","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002180.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?‚Ä¶"}]},"conversation_id":"519412191540563968","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":2,"like_count":2,"quote_count":0},"lang":"en","text":"EMA: Information on suspected side effects of nationally authorised medicines now available through a single website.http://t.co/Ui1CyquRZP","id":"519412191540563968","possibly_sensitive":false,"created_at":"2014-10-07T09:01:31.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":19,"probability":0.3405,"type":"Organization","normalized_text":"EMA Management Board"}],"hashtags":{},"urls":[{"start":57,"end":79,"url":"http://t.co/udc0HLCjG7","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002183.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?‚Ä¶"}]},"conversation_id":"519410358046687233","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EMA Management Board: highlights of October 2014 meeting\nhttp://t.co/udc0HLCjG7","id":"519410358046687233","possibly_sensitive":false,"created_at":"2014-10-07T08:54:14.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":114,"end":124,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":84,"end":100,"tag":"50thanniversary"},{"start":101,"end":106,"tag":"EDQM"},{"start":107,"end":113,"tag":"PhEur"}],"urls":{}},"conversation_id":"519399827416035328","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Regulatory convergence in pharmacopoeias &amp; quality standards should be pursued, #50thanniversary #EDQM #PhEur @edqm_news","id":"519399827416035328","possibly_sensitive":false,"created_at":"2014-10-07T08:12:23.000Z","author_id":"2315763655","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/cTSxBzHDRN","expanded_url":"http://bit.ly/1EnMOZP","display_url":"bit.ly/1EnMOZP"}]},"conversation_id":"519397501460557824","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EFPIA blog \"We are ready to contribute to the development of an innovative Clinical Trials IT infrastructure\" http://t.co/cTSxBzHDRN","id":"519397501460557824","possibly_sensitive":false,"created_at":"2014-10-07T08:03:08.000Z","author_id":"52084584","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":48,"end":57,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":15,"end":24,"tag":"patients"}],"urls":[{"start":58,"end":80,"url":"http://t.co/zqXfjk0HGo","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/10/WC500174806.pdf","display_url":"ema.europa.eu/docs/en_GB/doc‚Ä¶"}]},"conversation_id":"519397253384257536","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EGA encourages #patients to report side effects @EMA_news http://t.co/zqXfjk0HGo","id":"519397253384257536","possibly_sensitive":false,"created_at":"2014-10-07T08:02:09.000Z","author_id":"2315763655","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":78,"end":85,"username":"myESMO","id":"69232855"}],"annotations":{},"hashtags":[{"start":32,"end":44,"tag":"rarecancers"}],"urls":[{"start":55,"end":77,"url":"http://t.co/SGcBgpXTfU","expanded_url":"http://ow.ly/CmtTc","display_url":"ow.ly/CmtTc"}]},"conversation_id":"519391367823642624","source":"Hootsuite","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RCE consensus position paper on #rarecancers published http://t.co/SGcBgpXTfU @myESMO great example of patients/doctors collaboration","id":"519391367823642624","possibly_sensitive":false,"created_at":"2014-10-07T07:38:46.000Z","author_id":"140344419","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":27,"end":32,"tag":"PCOS"},{"start":86,"end":96,"tag":"studiorum"}],"urls":[{"start":63,"end":85,"url":"http://t.co/vhT9spls3L","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0252","display_url":"dx.doi.org/10.1530/EJE-14‚Ä¶"}]},"conversation_id":"519122209881616385","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Read the findings of ESE's #PCOS Special Interest Group survey http://t.co/vhT9spls3L #studiorum","id":"519122209881616385","possibly_sensitive":false,"created_at":"2014-10-06T13:49:14.000Z","author_id":"221055586","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":14,"end":27,"tag":"MSBoston2014"},{"start":91,"end":99,"tag":"ACTRIMS"},{"start":100,"end":108,"tag":"ECTRIMS"}],"urls":[{"start":117,"end":139,"url":"http://t.co/HZGpagg1ZY","expanded_url":"http://bit.ly/1trkxsR","display_url":"bit.ly/1trkxsR"}]},"conversation_id":"519126206458109952","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Check out our #MSBoston2014 report with key highlights from the insightful and informative #ACTRIMS #ECTRIMS Meeting http://t.co/HZGpagg1ZY","id":"519126206458109952","possibly_sensitive":false,"created_at":"2014-10-06T14:05:07.000Z","author_id":"600110872","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":58,"end":67,"username":"EURACTIV","id":"14808226"}],"annotations":{},"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/qv2FZhVlQH","expanded_url":"http://www.euractiv.com/sections/2014-2019-what-next-eu-healthcare/internet-causing-more-problems-health-literacy-308912","display_url":"euractiv.com/sections/2014-‚Ä¶","status":200,"unwound_url":"https://www.euractiv.com/section/all/news/the-internet-is-causing-more-problems-for-health-literacy/"}]},"conversation_id":"519128982860480512","source":"Twitter for Websites","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"The Internet is causing more problems for health literacy @Euractiv http://t.co/qv2FZhVlQH","id":"519128982860480512","possibly_sensitive":false,"created_at":"2014-10-06T14:16:09.000Z","author_id":"545343465","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":40,"end":46,"tag":"ebola"}],"urls":[{"start":115,"end":137,"url":"http://t.co/WpGEclooeY","expanded_url":"http://bit.ly/Z94309","display_url":"bit.ly/Z94309"}]},"conversation_id":"519132625790066688","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"New technical report weighs the risk of #ebola transmission via donated blood and other substances of human origin http://t.co/WpGEclooeY","id":"519132625790066688","possibly_sensitive":false,"created_at":"2014-10-06T14:30:37.000Z","author_id":"204752573","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":128,"end":136,"username":"nytimes","id":"807095"}],"annotations":{},"hashtags":[{"start":0,"end":11,"tag":"Healthcare"},{"start":24,"end":41,"tag":"interoperability"},{"start":77,"end":99,"tag":"DigitalMedicalRecords"}],"urls":[{"start":101,"end":123,"url":"http://t.co/fOUDZYKWMK","expanded_url":"http://ow.ly/Ckv7V","display_url":"ow.ly/Ckv7V"}]},"conversation_id":"519136742713348096","source":"Hootsuite","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Healthcare issues with #interoperability: \"Doctors Find Barriers to Sharing #DigitalMedicalRecords\" http://t.co/fOUDZYKWMK via @NYTimes","id":"519136742713348096","possibly_sensitive":false,"created_at":"2014-10-06T14:46:59.000Z","author_id":"24145340","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":28,"end":54,"probability":0.3357,"type":"Organization","normalized_text":"Good Manufacturing Practice"}],"hashtags":[{"start":109,"end":116,"tag":"GMDP14"}],"urls":[{"start":117,"end":139,"url":"http://t.co/GgmSwWHeTS","expanded_url":"http://ow.ly/Ckj7B","display_url":"ow.ly/Ckj7B"}]},"conversation_id":"519148683917791233","source":"Hootsuite","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Nearly fully booked for the Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Symposium #GMDP14 http://t.co/GgmSwWHeTS","id":"519148683917791233","possibly_sensitive":false,"created_at":"2014-10-06T15:34:26.000Z","author_id":"330993102","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":85,"end":94,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":57,"end":78,"probability":0.7249,"type":"Person","normalized_text":"Anabela de Lima Mar√ßal"}],"hashtags":[{"start":22,"end":32,"tag":"medicines"},{"start":95,"end":111,"tag":"50thanniversary"}],"urls":[{"start":112,"end":134,"url":"http://t.co/59Fj2I6coq","expanded_url":"https://twitter.com/edqm_news/status/519123610322354176/photo/1","display_url":"pic.twitter.com/59Fj2I6coq"}]},"conversation_id":"519123610322354176","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Safety and quality of #medicines is a shared goal, tells Anabela de Lima Mar√ßal from @EMA_News #50thanniversary http://t.co/59Fj2I6coq","id":"519123610322354176","possibly_sensitive":false,"created_at":"2014-10-06T13:54:48.000Z","author_id":"2242197968","attachments":{"media_keys":["3_519123608556564480"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":22,"end":31,"tag":"clinical"},{"start":76,"end":86,"tag":"medicines"},{"start":103,"end":110,"tag":"CTdata"}],"urls":[{"start":111,"end":133,"url":"http://t.co/AuUtzsHLA4","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}]},"conversation_id":"519097064220033024","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":".@EMA_News to publish #clinical reports underpinning the decision-making on #medicines from 1 Jan 2015 #CTdata http://t.co/AuUtzsHLA4","id":"519097064220033024","possibly_sensitive":false,"created_at":"2014-10-06T12:09:19.000Z","author_id":"606325697","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":19,"end":20,"probability":0.9753,"type":"Place","normalized_text":"UK"}],"hashtags":[{"start":49,"end":55,"tag":"colds"},{"start":72,"end":79,"tag":"asthma"}],"urls":[{"start":118,"end":140,"url":"http://t.co/R0WgD8Zv7c","expanded_url":"http://ow.ly/CeHV6","display_url":"ow.ly/CeHV6"}]},"conversation_id":"517992704232652800","source":"Hootsuite","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Researchers in the UK have been looking into why #colds seem to trigger #asthma attacks in people with the condition. http://t.co/R0WgD8Zv7c","id":"517992704232652800","possibly_sensitive":false,"created_at":"2014-10-03T11:00:59.000Z","author_id":"121759520","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":111,"end":116,"probability":0.9061,"type":"Place","normalized_text":"London"}],"hashtags":[{"start":14,"end":21,"tag":"autism"}],"urls":[{"start":118,"end":140,"url":"http://t.co/tp9AflWnyL","expanded_url":"http://bit.ly/ZAh18w","display_url":"bit.ly/ZAh18w"}]},"conversation_id":"518020563227660288","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Medicines for #autism: what are the ethical/social implications? Join our EU-AIMS project for a debate, 22/10, London http://t.co/tp9AflWnyL","id":"518020563227660288","possibly_sensitive":false,"created_at":"2014-10-03T12:51:41.000Z","author_id":"153741027","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":27,"end":36,"username":"Anses_fr","id":"1108628533"}],"annotations":[{"start":106,"end":111,"probability":0.9943,"type":"Place","normalized_text":"France"}],"hashtags":[{"start":87,"end":98,"tag":"pesticides"}],"urls":[{"start":118,"end":140,"url":"http://t.co/v7lrA2TftC","expanded_url":"http://bit.ly/1mmVqDQ","display_url":"bit.ly/1mmVqDQ"}]},"conversation_id":"518026938456481793","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Still time to register for @Anses_fr &amp; EFSA conference on occupational exposure to #pesticides, 28 Oct in France  http://t.co/v7lrA2TftC","id":"518026938456481793","possibly_sensitive":false,"created_at":"2014-10-03T13:17:01.000Z","author_id":"84582815","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":41,"end":50,"probability":0.9483,"type":"Person","normalized_text":"F. Santini"}],"hashtags":[{"start":0,"end":8,"tag":"Thyroid"},{"start":13,"end":21,"tag":"obesity"}],"urls":[{"start":83,"end":105,"url":"http://t.co/YDzuef9inS","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0067","display_url":"dx.doi.org/10.1530/EJE-14‚Ä¶"},{"start":106,"end":128,"url":"http://t.co/CpJDCiZYiQ","expanded_url":"http://www.eje-online.org/content/171/4/R137/F2.expansion.html","display_url":"eje-online.org/content/171/4/‚Ä¶"}]},"conversation_id":"518033777247809537","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"#Thyroid and #obesity - is there a link? F. Santini et al. review the relationship http://t.co/YDzuef9inS http://t.co/CpJDCiZYiQ","id":"518033777247809537","possibly_sensitive":false,"created_at":"2014-10-03T13:44:11.000Z","author_id":"221055586","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"517954714395480064","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@EMA_News how do you specify \"commercial use\"? what about all those EU SMEs that want to use this data in H2020 projects? \"commercial\"?","id":"517956602616639488","possibly_sensitive":false,"created_at":"2014-10-03T08:37:31.000Z","author_id":"22911650","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"517954714395480064"}],"in_reply_to_user_id":"116716199"},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":19,"end":34,"tag":"EPhearings2014"},{"start":38,"end":48,"tag":"Georgieva"},{"start":80,"end":91,"tag":"Bienkowska"}],"urls":[{"start":51,"end":73,"url":"http://t.co/JFrHp7Cc65","expanded_url":"http://bit.ly/1r2suD3","display_url":"bit.ly/1r2suD3"},{"start":94,"end":116,"url":"http://t.co/bL4BEdySxL","expanded_url":"http://bit.ly/1uEdPFq","display_url":"bit.ly/1uEdPFq"}]},"conversation_id":"517713982850080768","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"View the storified #EPhearings2014 of #Georgieva : http://t.co/JFrHp7Cc65 &amp; #Bienkowska : http://t.co/bL4BEdySxL","id":"517713982850080768","possibly_sensitive":false,"created_at":"2014-10-02T16:33:26.000Z","author_id":"199196447","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":10,"end":12,"probability":0.8912,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":74,"end":89,"tag":"ClinicalTrials"}],"urls":[{"start":111,"end":133,"url":"http://t.co/q1gs5klaAD","expanded_url":"http://ow.ly/BLTKp","display_url":"ow.ly/BLTKp"}]},"conversation_id":"517686639481868288","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Learn how FDA will help improve data and representation for minorities in #ClinicalTrials at a webinar on 10/7 http://t.co/q1gs5klaAD","id":"517686639481868288","possibly_sensitive":false,"created_at":"2014-10-02T14:44:47.000Z","author_id":"53039176","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":4,"tag":"FDA"},{"start":84,"end":89,"tag":"Food"},{"start":100,"end":108,"tag":"Animals"}],"urls":[{"start":109,"end":131,"url":"http://t.co/J1K4sLdP2f","expanded_url":"http://1.usa.gov/YT1PlG","display_url":"1.usa.gov/YT1PlG"}]},"conversation_id":"517673154173747201","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#FDA Annual Summary Report on Antimicrobials Sold or Distributed in 2012 for Use in #Food-Producing #Animals http://t.co/J1K4sLdP2f","id":"517673154173747201","possibly_sensitive":false,"created_at":"2014-10-02T13:51:12.000Z","author_id":"109290405","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":42,"end":44,"probability":0.8031,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":0,"end":9,"tag":"FDAVoice"}],"urls":[{"start":88,"end":110,"url":"http://t.co/SirsvYtYuo","expanded_url":"http://go.usa.gov/vnsH","display_url":"go.usa.gov/vnsH"}]},"conversation_id":"517671621893840896","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":8,"quote_count":0},"lang":"en","text":"#FDAVoice: New Data Dashboard Tool Shares FDA‚Äôs Inspection, Compliance and Recall Data  http://t.co/SirsvYtYuo","id":"517671621893840896","possibly_sensitive":false,"created_at":"2014-10-02T13:45:07.000Z","author_id":"208120290","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":6,"tag":"Ebola"}],"urls":[{"start":97,"end":119,"url":"http://t.co/IzqY7AmuVk","expanded_url":"http://bit.ly/1qUhtU7","display_url":"bit.ly/1qUhtU7"},{"start":120,"end":142,"url":"http://t.co/srtfsIZO7W","expanded_url":"https://twitter.com/ECDC_EU/status/517660882604929024/photo/1","display_url":"pic.twitter.com/srtfsIZO7W"}]},"conversation_id":"517660882604929024","source":"TweetDeck","public_metrics":{"retweet_count":51,"reply_count":2,"like_count":14,"quote_count":0},"lang":"en","text":"#Ebola: without interventions &amp; behaviour change, projections show increasing trend in cases http://t.co/IzqY7AmuVk http://t.co/srtfsIZO7W","id":"517660882604929024","possibly_sensitive":false,"created_at":"2014-10-02T13:02:26.000Z","author_id":"204752573","attachments":{"media_keys":["3_517660880918818816"]},"referenced_tweets":{}},{"entities":{"mentions":[{"start":41,"end":53,"username":"EP_Industry","id":"951326846"},{"start":60,"end":76,"username":"EP_SingleMarket","id":"951348098"}],"annotations":{},"hashtags":[{"start":5,"end":20,"tag":"EPHearings2014"},{"start":24,"end":35,"tag":"Bienkowska"}],"urls":[{"start":92,"end":114,"url":"http://t.co/pcrjGpYf77","expanded_url":"http://bit.ly/1qxWnuO","display_url":"bit.ly/1qxWnuO"},{"start":122,"end":144,"url":"http://t.co/skvsryEdey","expanded_url":"http://bit.ly/18C4yEr","display_url":"bit.ly/18C4yEr"}]},"conversation_id":"517637667014467584","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"NOW: #EPHearings2014 of #Bienkowska from @EP_Industry &amp; @EP_SingleMarket starts. LIVE:  http://t.co/pcrjGpYf77  &amp; http://t.co/skvsryEdey","id":"517637667014467584","possibly_sensitive":false,"created_at":"2014-10-02T11:30:11.000Z","author_id":"199196447","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/WAMYbjuvu6","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2014/10/WC500174575.pdf","display_url":"ema.europa.eu/docs/en_GB/doc‚Ä¶"}]},"conversation_id":"517632966693249024","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Agenda of today's Management Board of EMA meeting is available on EMA website: http://t.co/WAMYbjuvu6","id":"517632966693249024","possibly_sensitive":false,"created_at":"2014-10-02T11:11:31.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":91,"end":102,"tag":"Bie≈Ñkowska"}],"urls":[{"start":103,"end":125,"url":"http://t.co/v1tDAY2oEX","expanded_url":"http://www.europarl.europa.eu/ep-live/pl/committees/video?event=20141002-1330-COMMITTEE-HEARING2014EB","display_url":"europarl.europa.eu/ep-live/pl/com‚Ä¶"}]},"conversation_id":"517630179305615362","source":"iOS","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Hearing of Commissioner for Internal Market, Industry, Entrepreneurship and SMEs: El≈ºbieta #Bie≈Ñkowska http://t.co/v1tDAY2oEX","id":"517630179305615362","possibly_sensitive":false,"created_at":"2014-10-02T11:00:26.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/ByouqIK4Rz","expanded_url":"http://www.mhra.gov.uk/Howweregulate/Medicines/Medicinesregulatorynews/CON462292","display_url":"mhra.gov.uk/Howweregulate/‚Ä¶"}]},"conversation_id":"517599481618235392","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Simplified information requirements for advertising medicines to prescribers and suppliers, and updated Blue Guide: http://t.co/ByouqIK4Rz","id":"517599481618235392","possibly_sensitive":false,"created_at":"2014-10-02T08:58:27.000Z","author_id":"960436586","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"517582147256066049","source":"Twitter for iPhone","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"At the 85th meeting of the Management Board. Main topics are EMA policy on publication of access to clinical-trial data &amp;EMA mid-year report","id":"517582147256066049","possibly_sensitive":false,"created_at":"2014-10-02T07:49:34.000Z","author_id":"556859372","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":51,"end":53,"probability":0.8253,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":95,"end":117,"url":"http://t.co/l6G1zxFo11","expanded_url":"http://go.usa.gov/vkqh","display_url":"go.usa.gov/vkqh"}]},"conversation_id":"517334207786262528","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Here is the latest Patient Network Newsletter from FDA with all the most recent health updates http://t.co/l6G1zxFo11","id":"517334207786262528","possibly_sensitive":false,"created_at":"2014-10-01T15:24:21.000Z","author_id":"208120290","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":38,"end":43,"probability":0.9541,"type":"Place","normalized_text":"Madrid"},{"start":74,"end":79,"probability":0.9711,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":28,"end":34,"tag":"EAU15"},{"start":91,"end":102,"tag":"urological"}],"urls":[{"start":109,"end":131,"url":"http://t.co/p3m03XjkFx","expanded_url":"http://bit.ly/1pFUtYV","display_url":"bit.ly/1pFUtYV"}]},"conversation_id":"517335256727552000","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Online registration for the #EAU15 in Madrid has opened! Get a preview of Europe's biggest #urological event http://t.co/p3m03XjkFx","id":"517335256727552000","possibly_sensitive":false,"created_at":"2014-10-01T15:28:31.000Z","author_id":"114455333","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":36,"end":44,"tag":"ECE2015"}],"urls":[{"start":100,"end":122,"url":"http://t.co/E3X7SWuqZF","expanded_url":"http://www.ece2015.org/registration.aspx","display_url":"ece2015.org/registration.a‚Ä¶"}]},"conversation_id":"517335633472126976","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Abstract submission is now open for #ECE2015! Head to this link for all the details on the congress http://t.co/E3X7SWuqZF","id":"517335633472126976","possibly_sensitive":false,"created_at":"2014-10-01T15:30:01.000Z","author_id":"221055586","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":5,"tag":"EDQM"},{"start":96,"end":106,"tag":"reference"},{"start":107,"end":117,"tag":"standards"}],"urls":[{"start":118,"end":140,"url":"http://t.co/3TvhbvXU3m","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}]},"conversation_id":"517335407977959424","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#EDQM looking for a project coordinator to work on construction of a secondary storage site for #reference #standards http://t.co/3TvhbvXU3m","id":"517335407977959424","possibly_sensitive":false,"created_at":"2014-10-01T15:29:07.000Z","author_id":"2242197968","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":8,"end":14,"tag":"Ebola"}],"urls":[{"start":111,"end":133,"url":"http://t.co/qknQOAkdC8","expanded_url":"http://bit.ly/1mQCpjR","display_url":"bit.ly/1mQCpjR"}]},"conversation_id":"517338705498234880","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Once an #Ebola case is detected and infection control measures implemented, risk of transmission is very low:  http://t.co/qknQOAkdC8","id":"517338705498234880","possibly_sensitive":false,"created_at":"2014-10-01T15:42:13.000Z","author_id":"204752573","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":[{"start":24,"end":26,"probability":0.5494,"type":"Organization","normalized_text":"CoV"}],"hashtags":[{"start":18,"end":23,"tag":"MERS"},{"start":63,"end":68,"tag":"Hajj"},{"start":108,"end":115,"tag":"Europe"}],"urls":[{"start":116,"end":138,"url":"http://t.co/UUjWkvGo7Y","expanded_url":"http://bit.ly/1CGb2wP","display_url":"bit.ly/1CGb2wP"}]},"conversation_id":"517342404223844353","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":3,"quote_count":0},"lang":"en","text":"ECDC will enhance #MERS-CoV surveillance activities around the #Hajj to detect early any possible threat to #Europe http://t.co/UUjWkvGo7Y","id":"517342404223844353","possibly_sensitive":false,"created_at":"2014-10-01T15:56:55.000Z","author_id":"1371668696","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":82,"end":94,"tag":"RareDisease"},{"start":95,"end":104,"tag":"EYRD2019"}],"urls":[{"start":105,"end":127,"url":"http://t.co/FVYKTV06RR","expanded_url":"http://ow.ly/Ca5vF","display_url":"ow.ly/Ca5vF"}]},"conversation_id":"517343899632021504","source":"Hootsuite","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Webinar: Get involved in the exciting campaign to make 2019 the European Year for #RareDisease #EYRD2019 http://t.co/FVYKTV06RR","id":"517343899632021504","possibly_sensitive":false,"created_at":"2014-10-01T16:02:52.000Z","author_id":"26993786","attachments":{"media_keys":{}},"referenced_tweets":{}}]}
